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CHAPTER 1 
N-3 POLYUNSATURATED FATTY ACIDS, 
A LITERATURE REVIEW 
1.1 Introduction 
In the last decades the interest in the role of n-3 fatty acids in several diseases has 
grown. Low incidences of ischemic heart disease, diabetes, cancer, rheumatism and 
multiple sclerosis have been found in Arctic populations [1-8]. Fish consuming 
communities in Japan [9, 10], The Netherlands [11] and United States [12, 13] show 
also a lower incidence of ischemic heart disease. Several investigators have 
postulated that dietary n-3 polyunsaturated fatty acids (PUFA's), which are present 
in the fat of sea fish, may cause the lower incidence of ischemic heart disease [14-17]. 
Many experimental and human studies have been carried out with purified marine 
oils [18-32], but the reported results are often difficult to compare because of 
differences in doses and ratios of eicosapentaenoic acid (EPA, 20:5 n-3) and 
docosahexaenoic acid (DHA, 22:6 n-3) used. In this chapter the results of human 
studies are reviewed. An attempt has been made to clarify some of the differences by 
ranging the studies according to doses of EPA used. For a review of animal data the 
reader is referred to references 19, 20, 23, 24, 32. 
PUFA's can be divided in two major families: those of the n-6 and those of the n-
3 type. The n-6 PUFA's have their first double bond on the sixth carbon atom 
counting from the methyl end of the fatty acid. The n-3 PUFA's start with their first 
double bond at the third carbon atom (figure 1). 
Vegetable oils contain PUFA's of the n-6 type (linoleic acid; LA, 18:2 n-6), and 
of n-3 type (alpha-linolenic acid, a-LNA, 18:3 n-3). Some vegetable oils, like 
primrose oil, are relatively rich in dihomo-gamma-linolenic acid (20:3 n-6, g-LNA). 
Animal fats often contain some PUFA's of the n-6 type (LA and arachidonic acid; 
AA 20:4 n-6) and the n-3 type (a-LNA). Fish oils mainly contain PUFA's of the n-3 
type (EPA, DHA and docosapentaenoic acid; DPA 22:5 n-3). 
Fish do not synthesize the n-3 PUFA's themselves, but they derive their dietary 
n-3 PUFA's from the consumption of plankton. The marine phytoplankton and 
zooplankton n-3 PUFA contents depend on the water temperature. The colder the 
water the more n-3 PUF A's are synthesized by the plankton. It will be clear that 
there is a wide variation of n-3 PUF A content of fish depending on marine, 
terrestrial and seasonal circumstances. Another rich source of n-3 fatty acids are, 
except for fish, the large quantities of fish consuming animals, such as seals. 
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Figure 1. Chemical structures of the polyunsaturated fatty acids of the n-6 and n-3 
family. 
1.2 Cardiovascular effects of dietary n-3 fatty acids 
The American cardiologist Nelson already prescribed a diet with 3 fish meals a week 
to a large number of post infarction patients 25 years before the epidemiological 
studies among Eskimos [17], Japanese fishermen [9, 10] and citizens of Zutphen [11] 
became known. Nelson noted that the incidence of myocardial infarction was 
decreased among these individuals during the follow up period stretching beyond 16 
years [33]. These findings of Nelson did not receive much attention, in contrast with 
the high interest in later studies. In the following years, various actions of dietary n-3 
PUP A's on cardiovascular risk factors have since been described. In the next 
paragraphs the effects of dietary fish oil on these factors are summarized. 
1.2.1 The effects of dietary n-3 fatty acids on plasma cholesterol 
There is evidence that the n-3 PUPA's decrease the synthesis of the triglyceride-rich 
very low density lipoproteins (VLDL) [34, 35]. As VLDL is a precursor particle for 
low density lipoprotein (LDL) and its surface fragments are incorporated in the high 
density lipoprotein (HDL), a decrease in VLDL level will be reflected on the plasma 
levels of LDL and HDL [36-43]. Therefore, a decrease of total cholesterol by dietary 
fish oil is often seen in all lipoprotein fractions. 
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Table 1 
Effects of dietary n-3 PUPA's on plasma cholesterol (CHOL) and triglyceride (TG) 
levels in uncontrolled studies in normolipidemic individuals. 
PERIOD change in % 
grams IN -----------------
REFERENCE EPA/day WEEKS CHOL TG 
Singer et al. (44) 2 2 - 9 -28 
Bronsgeest et al. (45) 3 4 0 -39 
Lorentz et al. (46) 4 4 - 4 -20 
Saynor et al. (47) 4 104 - 5 -41 
von Schacky et al. (48) 4 4 - 2 -33 
Siess et al. (49) 6 3 - 4 -32 
Dyerberg et al. (50) 7 4 -13 -44 
Table 2 
Effects of dietary n-3 PUPA's on plasma cholesterol (CHOL) and triglyceride (TG) 
levels in controlled studies in normolipidemic individuals. 
% change 
PERIOD from control 
grams IN -----------------
REFERENCE EPA/day WEEKS CONTROL CHOL TG 
Sanders et a!. (51) 2 2 MAIZE+OLIVE 0 -29 
Mortensen et al. (52) 2 4 CORN+OLIVE 0 -47 
van Houwelingen et a!. (53) 2 6 MEAT 0 + 2 
Rogers et al. (54) 2 6 OLIVE - 5 -54 
Nagakawa et a!. (55) 2 4 PLACEBO -15 -25 
Pehily et a!. (56) 2 12 MEAT+LEAN FISH + 1 - 7 
Lossoncy et al. (57) 3 3 CHEESE 
- 8 -33 
Sanders et al. (58) 3 3 LINSEED 
- 5 -32 
Harris et a!. (59) 3 4 COCOA+ PEANUT+ -17 -40* 
EGG 
Illingworth et al. (60) 6 4 COCOA+ PEANUT -24 -43* 
Harris et al. (61) 11 4 SAFFLOWER+CORN -2 -33* 
* = control diet balanced for cholesterol content 
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In the studies of Bang and Dyer berg, the Eskimos consumed 80 mg EPA/kg/day, or 
6 g EP Nday [15]. This is probably the maximal dose that can be consumed by a fish 
diet in humans. In the following overview on the effects .of n-3 PUFA's on plasma-
lipids we have included only studies with doses of about 2 g EPA/day or more. We 
define controlled studies as those in which the effects of a fish (oil) diet were 
compared to those of a control diet by the same or by a parallel group. 
Uncontrolled studies reported maximal decreases in plasma cholesterol of nor-
molipidemic individuals up to 13% (table 1), but in controlled studies decreases up 
to 24% have been described (table 2). From the data of the two tables it appears that 
there is a dose dependent hypocholesterolemic effect of fish oil. Furthermore, it is 
clear that when the cholesterol contents of the diets are matched, the cholesterol 
lowering effects of the n-3 PUPA's are unmasked [59-61]. Many fish diets and fish 
oil supplements contain high levels of cholesterol. The purified fish oil concentrates, 
containing low amounts of cholesterol, are more suitable for dietary supplemen-
tation. 
In hyperlipidemic patients the cholesterol lowering effects of fish oil depend on 
the type of hyperlipidemia. In an uncontrolled study in type IIA patients there was 
no effect on plasma cholesterol [ 64], but in mixed groups the decreases where most 
marked (24%) in type IV and V hyperlipidemia [62], see table 3. 
In the controlled studies (Table 4) in hyperlipidemic patients the effects were 
maximal (-41%) in type V [66), intermediate (-12%) in type IV and carbohydrate 
induced hypertriglyceridemic individuals [67, 68], and minimal in the mixed groups 
and type liB [66, 69], but in only one study [69] the cholesterol content of the diets 
was balanced. There seems to be no obvious dose-dependent effect in hyper-
lipidemic individuals. From these data can be concluded· that plasmacholesterol is 
most affected in individuals with increased plasma triglyceride levels (phenotype 
liB, IV and V). 
Table 3 
Effects of dietary n-3 PUPA's on plasma cholesterol (CHOL) and triglyceride (TG) 
levels in uncontrolled studies in hyperlipidemic individuals. 
PERIOD change in % 
grams IN ------------------
REFERENCE TYPE EPA/day WEEKS CHOL TG 
Singer et al. (62) IV+V 1 2 -24 -72 
Hamazaki et al. (63) IIA+IIB+IV 2 13 -10 -31 
Singer et a!. (62) IV+V 2.2 2 -19 -66 
Brox et al. (64) IIA 2.4 6 - 1 -17 
Hay et al. (65) II+IV 3.5 3 0 -26 
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Table 4 
Effects of dietary n-3 PUPA's on plasma cholesterol (CHOL) and triglyceride (TG) 
levels in controlled studies in hyperlipidemic individuals. 
% change 
PERIOD from control 
grams IN ----------------
REFERENCE TYPE EPA/day WEEKS CONTROL CHOL TG 
Simons et al. (66) IIA+IIB+ 1.1 12 OLIVE - 1 -33 
IV+V 
Simons et al. (66) IIA+IIB+ 2.0 12 OLIVE - 5 -58 
IV+V 
Sanders et al. (67) IV 2.7 4 CORN+OLIVE -12 -36 
Simons et al. (66) v 2.9 12 OLIVE -41 -60 
Harris et al. (68) CHO- 9.0 1 CONTROL -11 -62 
induced 
Phillipson et al. (69) liB 9 - 17 4 SAFFLOWER - 2 -47* 
Phillipson et al. (69) v 9 - 17 4 SAFFLOWER -30 -41* 
* = control diet balanced for cholesterol content 
In a few studies fish oil has been shown to inhibit the increase in plasmacholesterol 
during dietary cholesterol loading [70, 71], but these results are controversial [72-
74]. In these last studies the atherogenic diet contained, however, also considerable 
amounts of saturated fat [72-74]. Evenso Eskimos consume high amounts of 
cholesterol without real disturbances of their plasma lipid levels, probably due to the 
action of n-3 fatty acids [17], but racial differences should be considered too. For 
instance, black workers on a chicken farm showed no elevated plasmacholesterol 
despite their high cholesterol intake [75]. The blacks consumed large amounts of 
chicken eggs and had a high PUF A intake, but the dietary fatty acid composition was 
not given [75]. It is quite feasable that these eggs were also rich in n-3 PUPA's 
because the chickens were fed fish flour. From this study we can therefore not 
conclude that racial influences may protect against cholesterol loading. 
There is some evidence for an increased excretion of bile in the faeces during fish 
oil consumption [76, 77]. A reduction in LDL synthesis has also been reported [60, 
78]. In human hepatoma cells incubation with eicosapentaenoic acid inhibited the 
binding of LDL while the binding of remnants was not affected [79]. However, the 
effects on the different cholesterol carrying lipoproteins are inconsistent and further 
research on the lipoprotein metabolism in a well-controlled experimental set-up is 
needed. 
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1.2.2 The effects of dietary n-3 fatty acids on plasma triglyceride 
N-3 PUPA's lower the synthesis of the VLDL particle by the suppression of hepatic 
triglyceride synthesis as well as by the apoprotein BlOO synthesis [34, 66, 68, 78-83]. 
An increased VLDL clearance has also been reported [84], but not generally 
accepted. Postprandial hypertriglyceridemia is decreased significantly, so the VLDL 
and chylomicron metabolism seems to be affected [47, 68]. 
In the uncontrolled analysis in normolipidemic individuals (Table I) a maximal 
decrease in plasma triglyceride level of 44% was found, while in controlled studies 
(Table 2) the decrease was maximally 54%. From these data it seems that the 
maximal hypotriglyceridemic effect of fish oil is already reached at a dose of about 2 
g EPA/day and within 2 weeks [44, 51]. 
In the uncontrolled studies in type IV and V hyperlipidemic patients a decline in 
plasma triglyceride of 72% was found, whereas the largest decreases were 31% and 
17% in the mixed and type II A group, respectively (Table 3). In the controlled 
studies (Table 4) the maximal decrease was 62%. There was no dose dependency for 
doses higher than 2 g EPA/day and the maximal effect was already observed after 2 
weeks [ 62, 68]. Thus, the overall effects depend on whether the individual is normo-
or hyperlipidemic, on the subtype of hyperlipidemia, and on the dose ofn-3 PUPA's 
taken. 
1.2.3 The effects of dietary n-3 fatty acids on membrane lipid composition 
The fatty acid composition of fat tissue or membrane phospholipids partially reflects 
the dietary fatty acid intake [28, 85-87]. The half life of fatty acids in adipose tissue is 
about 2 years or more [88, 89], whereas the turnover in cellular membranes is in the 
order of magnitude of days [87]. The fatty acid composition of phospholipids may 
affect membrane function [28, 87]. There is also a competition between the different 
unsaturated fatty acids for incorporation in membrane phospholipids. The PUP A's 
compete for the 2-position in membrane phospholipids [20]. Phospholipase A2 splits 
off these PUP A's, and AA or EPA are used for the prostanoid production. There-
fore, variation in the nature of dietary PUP A's can have an impact on prostaglandin 
and leukotriene production. 
Dyerberg has suggested that n-3 PUPA's possess anti-atheromatous actions [90], 
and related these actions with the inhibitory effects of n-3 PUPA's on platelet 
activity [91], see table 5. Several investigators have shown that ischemic heart 
disease is correlated with a low EPA and DHA content in platelet phospholipids 
[92-94]. In Japanese and Ind.ians living on Vancouver Island the effects of fish 
consumption on plasma fatty acid composition was demonstrated [9, 95], see also 
table 6. Reference data from European immigrants in Minnesota are also given in 
table 6 [96]. 
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Table 5 
Polyunsaturated fatty acid composition of platelet phospholipids. 
mole % of fatty acids 
-------------------------------------
18:2 20:4 20:5 22:5 22:6 
REFERENCE POPULATION n-6 n-6 n-3 n-3 n-3 
Dyerberg et a!. (91) eskimos 3.9 8.5 8.0 3.3 5.8 
danes 8.2 22.1 0.5 1.0 1.5 
Prisco et a!. (92) healthy volunteers 5.9 27.1 0.7 2.1 2.3 
angina pectoris 5.6 27.1 0.6 2.1 2.2 
myocardial infarction 5.3 25.6 0.6 2.0 2.2 
Wood et a!. (93) controls 4.2 26.8 0.4 1.5 1.7 
active angina 3.8 24.3 0.3 1.3 1.5 
Kristensen et a!. (94) angina pectoris 13.9 14.6 0.3 0.7 
Table 6 
Polyunsaturated fatty acid composition of plasma lipids 
mole % of fatty acids 
--------------------------------------
18:2 20:4 20:5 22:5 22:6 
REFERENCE POPULATION n-6 n-6 n-3 n-3 n-3 
Hirai et a!. ( 9) japanese fishermen 27.7 6.8 3.8 7.1 
japanese farmers 30.4 5.8 2.3 4.5 
Hamazaki et a!. ( 63) japanese hemodialysis 31.5 3.8 1.2 1.9 
patients 
Bates et a!. ( 95) europeans 21.4 11.4 1.0 0.9 3.5 
mixed race 30.7 7.5 1.4 0.6 3.0 
indians 28.8 4.8 0.5 0.5 2.8 
fish eating indians 24.2 4.7 2.6 0.8 6.0 
Holman et a!. ( 96) european immigrants 19.6 11.7 1.1 0.7 2.2 
From these data it appears that not the decrease in AA content is important [94], 
but the increased EPA and DHA contents are important for the protection against 
ischemic heart disease. Dyerberg has proposed that the presence of EPA and the low 
content of AA leads to a decreased production of thromboxane A2 and synthesis of 
inactive thromboxane A3 [17]. However, Goodnight and Hornstra suggest that 
cyclo-oxygenase is inhibited by the poorly metabolized substrate EPA, resulting in a 
decreased thromboxane production [20, 97]. It has also been demonstrated that only 
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Table 7 
Polyunsaturated fatty acid composition of platelet lipids (TL) or phosphocholine 
(PC) after fish( oil) consumption in uncontrolled trials. 
grams PERIOD 
EPA/ IN 18:2 20:4 20:5 22:5 22:6 
REFERENCE LIPID day WEEKS n-6 n-6 n-3 n-3 n-3 
Driss et al. (104) PC 0.15 4 13.3 16.8 0.8 0.8 1.4 
BEFORE 12.3 16.1 0.9 1.0 2.1 
Hirai et al. (105) TL 1.4 4 36.3 4.7* 3.0 
BEFORE 39.1 1.8 3.1 
Sanders et al. ( 58) TL 1.8 3 7.4 22.7* 4.2* 3.3* 4.3 
0.9 3 8.2 23.0* 3.2* 2.6* 3.3 
0.5 3 8.4 25.2* 2.3* 2.6* 3.1 
BEFORE 7.8 28.9 0.9 2.0 2.4 
Ahmed et al. (106) PC 1.8 2 7.9* 9.6* 2.9* 1.1 * 1.8* 
BEFORE 10.2 14.1 0.3 0.5 0.7 
Sanders et al. (107) TL 1.8 6 7.2 24.4* 3.2* 3.2 4.6* 
BEFORE 7.4 28.8 0.6 3.1 2.6 
Sanders et al. (108) TL 1.8 6 7.2 24.4* 3.2* 3.2 4.6* 
BEFORE 7.3 28.8 0.6 3.0 2.6 
Thorngren et al. (109) PC 2.5 6 6.2* 15.6* 2.0* 1.1 * 2.5* 
BEFORE 7.0 18.3 0.6 0.9 1.5 
Thorngren et al. (110) PC 2.5 11 5.9* 16.9 1.6* 1.2* 2.7* 
BEFORE 7.1 18.3 0.4 0.9 1.7 
Kristensen et al. ( 94) TL 2.7 1 12.8 11.8* 3.9* 2.6* 
BEFORE 13.7 14.8 0.3 0.9 
von TL 3.8 4 6.0 20.0 4.2* 5.4* 
Schacky et al. ( 48) 1.9 4 6.0 23.0 2.5* 4.0* 
0.9 4 6.0 25.0 2.2* 3.5* 
BEFORE 6.0 26.0 0.2 2.6 
Lorenz et al. ( 46) TL 4.4 4 6.4* 14.2* 4.5* 5.2* 
BEFORE 7.8 19.0 0.3 2.0 
Sanders et al. ( 51) TL 9.0 1 3.0* 15.0* 5.1 * 1.2* 6.0* 
BEFORE 6.4 25.5 1.0 1.0 1.5 
* = p < 0.05 versus before 
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a small amount of thromboxane A3 is produced after fish oil consumption [98, 99]. 
In vitro studies have shown that n-3 PUF A's are rapidly incorporated in various 
types of cells [100-102] and inhibit the prostanoid production [28, 100-102]. It was 
shown that there is competition between AA and EPA for cyclo-oxygenase [102]. 
For an review of the effects of n-3 PUPA's on myocardial function see chapter 3. 
Regarding human dietary studies on platelet phospholipid fatty acid composi-
tion, it is shown that incorporation of EPA is not detectable for doses of less than 
0.5 g EPA/day [103, 104]. The incorporation of n-3 PUPA's in the platelet 
membrane in uncontrolled trials is clearly dose dependent (table 7). The maximal 
EPA and DHA contents are 4.5% and 5.2%, respectively. 
Table 8 
Polyunsaturated fatty acid composition of platelet lipids (TL) or phosphocholine 
(PC) after fish( oil) consumption in controlled trials. 
grams 
EPA/day PERIOD 
----------- IN 18:2 20:4 20:5 22:5 22:6 
REFERENCE LIPID CONTROL WEEKS n-6 
Brox et al. (111) PC 2.0 6 8.6* 
CORN 6 10.5 
Nagakawa et al. ( 55) TL 2.0 4 
PLACEBO 2 
Brox et a!. ( 64) TL 2.4 6 
CONTROL 6 
Kristensen et al. ( 94) TL 2.7 12 12.8 
CORN 16 13.3 
Sanders et a!. ( 58) TL 3.0 2 7.0 
LINSEED 2 7.6 
Sanders et a!. (112) TL 3.5 2 
LINSEED 2 
Goodnight et a!. (113) TL 5.0 4 4.0* 
AMERICAN DIET 4 7.5 
* = p < 0.05 versus control 
n-6 
11.2* 
13.8 
16.8 
15.0 
7.5* 
10.0 
11.8 
13.7 
23.0* 
30.9 
20.2* 
27.6 
n-3 
2.4* 
0.7 
4.0* 
2.4 
2.7* 
1.3 
3.9* 
0.2 
4.1* 
1.2 
4.1* 
1.2 
6.1* 
0.1 
n-3 
1.1 
0.9 
n-3 
2.4* 
1.5 
2.6* 
0.8 
4.0* 
2.9 
3.9* 
2.9 
3.7* 
1.1 
The controlled studies on platelet fatty acid composition (Table 8) show maximal 
contents EPA and DHA of 6.1% and 4.0%, respectively. When we compare these 
data with those found in Eskimos (Table 5: 8.0% and 5.8%, respectively), it can be 
concluded that fish oil supplementation to patients yields roughly the same changes 
in PUF A composition of platelets. 
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1.2.4 The effects of dietary n-3 fatty acids on prostaglandin synthesis 
The prostaglandins (PG's) can be synthesized from different PUPA's: PGrseries (g-
LNA), PG2-series (AA) and PG3-series (EPA). The synthesis of PG's is dependent 
on the local production of the precursor fatty acids: g-LNA, AA and EPA. These 
precursor fatty acids are incorporated preferentially into the membrane phospho-
lipids at the 2-position and can be mobilized by phospholipase A2. The various 
PUF A's compete for cyclo-o:xygenase, the key enzyme of PG synthesis (Figure 2). 
For the platelet function thromboxane (TXA) and prostacyclin (PGI) are of 
relevance. The PG's are very labile substances and therefore act locally. The availabi-
lity of the various precursor fatty acids depends on the dietary fatty acids, that 
influences the PUF A composition of the membrane phospholipids. 
HEHBRANE PHOSPHOLIPIDS 
ARACHIDONIC ACID (20:4 n-6) 
1 
;=v=YV'""' 
~' 
EICOSAPENTAENOIC ACID ( 20: S n-3 l 
C'iCLO OXYGENASE ! 
r··<r~coo" 
L ..... V"=yvv 
! 
L~ 
'" 
COOH 
PROSTAGLANDIN C, (PGC.,l PROSTAGLANDIN G, CPCC.l 
! PEROXIDASE ! 
I 
"'" I - coo" 
a.· + + o. · 
,----~---/~ ,-----~--/\J\j\; 
Q ________ - q, ________ -
COOH OH 
PROSTACLANDIN H. ( PGH,) PROSTAGLANDIN Hs < PGH.) 
_ ............ , ... --------_ .. 
~ PROSTAGLANDIN SYNTHETASE ~ 
OH> 
OH 
HALONOIALDEHYOE CHDAl 
~-
'" 12 L-HYOROXY-5,6,10-HEPTA 
OECATRIENOIC ACID CHHTl 
! ! 
TXA, 
PC!, 
PCO, 
PCE, 
PGF, 
TXA• 
PGI • 
PCOa 
PCEo 
PGF. 
HALONOIALOEHYDE CHDA) 
12 L-HYDROXY-5,6,10-HEPTA 
OECATETRAENOIC ACID CHHTEJ 
Figure 2. Prostaglandin synthesis of the 2 and 3-series. 
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The biological role of the 1-series of the PG's is not clear at present. EPA is a poor 
substrate for cyclo-oxygenase so only minor amounts of the 3-series are formed after 
fish (oil) consumption [20, 97-99, 114]. However, after long term administration of 
fish oil (3.8 g EPA/day) almost 30% of the total PGI production is of the 3-series 
[48]. 
TXA3 has only a weak proaggregatory action [90, 115], while PGI3 is a potent 
antiaggregator and vasodilator [116, 117]. The TXA production is reduced [46, 48-
50, 103, 109] or unchanged [105] after fish oil consumption. Also in controlled 
studies the TXA production was decreased [51, 64, 104, 111] after fish (oil) 
consumption. Several factors could explain this effect: 
1. Phospholipid AA content is decreased, because of the exchange for n-3 PUPA's 
[48]. 
2. After platelet stimulation less AA is released in the presence of n-3 PUPA's, 
probably by an inhibition of phospholipase A2 [118]. 
3. AA and EPA compete for cyc!o-oxygenase [20, 97, 117, 120]. 
The unstable product TXA and its stable metabolites are shown in figure 3. The 
effects of fish oil on TXA2 generation have been described after doses as low as 0.15 
g EPA/day [104]. This is, however, difficult to comprehend because of the low 
incorporation of EPA into the membrane phospholipids at such a low dose [104]. 
~ OH 
THROMBOXANE A, CTXA,.) THROHBOXANE A~ ( TXA ~ ) 
(y~~ -~-" 0~ 
~ ~ 
THROHBOXANE 8,. CTXB,) THROMBOXANE s, CTXBa) 
! RENAL CLEARANCE f""' ! 
/)·"\JV\COOCH3 )1··\JV\COOCH3 
CH3o." ~"vvv CH,Of: ~
oM oTJIIS 
IHROMBOXANE B,..-!1 CTXB:r-H) THROKBOXANE B:a-M CTXB:a-K) 
Figure 3. Thromboxane metabolism. 
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The PGI production takes place mainly in the endothelium although monocytes 
produce some too [121]. It is possible to estimate the overall PGI synthesis by 
analysis of the urine. However, this analysis is very complicated and therefore 
acurate analysis has been carried out in only a few studies [99, 114, 122]. The 
metabolites of the labile PGI are shown in figure 4. The PGI production seems to be 
unaffected [48, 111] or moderately increased [114] after fish (oil) consumption. It 
seems that there is no competition between AA and EPA for the PGI production, as 
the PGI2 production is not affected and the PGI3 production is added to the total 
PGI production. Like PGI2, PGI3 has significant anti-aggregatory and vasodilatory 
properties [116, 117]. This leads to a modification of the TXA/PGI ratio resulting in 
less platelet aggregation [ 48, 123]. 
PROSTACYCLIN ( PCl ~ l 
! 
~ 
dM 
2, 3-0INOR-6-KETO-PROSTACLANDIN F'. 
CPCF,. l 
PROSTACYCLIN ( PGI ~ l 
o1l7-2, 3-DINOR-6-KETO-PROSTACLANDIN f,. 
(417-PCF, .) 
Si!CM3!3 OCH:t ! RENAL CLEARANCE I 
~ 
SIICMJ;13 ' 
~IICHJIJ 
OCHJ ..,.... 
~~ 
SoiCHlll · 
0 
::o!CHJ)l 
2, 3-01 NOR-6-KETO- PROSTACLAND IN f,. -M 417-2, 3-0 INOR-6 -KETO- PROSTAGLANDIN f'. -H 
(PCF,.-Hl (1117-PCF,.-Hl 
Figure 4. Prostacyclin metabolism. 
The effects of fish (oil) consumption on other PG's have not been fully elucidated. 
In Eskimo's the urinary excretion of PGE and PGFzaifa metabolites were not 
different [124]. Also in a volunteer study no effect of dietary cod liver oil supple-
ments was found on urinary PGE and PGFlalfa metabolites [46]. In animal experi-
ments different effects on PGD2, PGE2 and PGFzalfa have been shown while also 
production of the 3-series has been reported. 
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It must be noted that the PG plasmalevels can be influenced by the bloodsampling 
methods. Therefore the 24 hour urinary excretion of the PG metabolites is a more 
reliable technique which reflects the in vivo situation. 
1.2.5 The effects of dietary n-3 fatty acids on platelet function 
Platelets play a key role in the development of mural thrombosis, intimal prolifera-
tion and atherosclerosis as they adhere to damaged endothelium or denudated 
blood vessels [125]. The platelets are activated by the adherence to the vessel wall 
which leads to TXA production and release of several compounds, such as adeno-
sine diphosphate, serotonin, adrenalin, beta-thromboglobulin, platelet factor 4, 
Ieukotrienes and growth factors. Subsequently a thrombus is formed which is then 
stabilized by fibrin. Smooth muscle cells will proliferate and migrate into the 
thrombus after which it is transformed into an atherosclerotic lesion. It has been 
shown that ischemic heart disease is associated with increased thrombotic tendency 
of blood [126, 127]. 
Table 9 
Effects of fish(oil) consumption on platelet aggregation induced by low doses of 
collagen (COLL), adenosine diphosphate (ADP), adrenalin (ADR), thrombin 
(THR) and arachidonic acid (AA) in platelet rich plasma in uncontrolled human 
trials. 
PERIOD 
grams IN 
REFERENCE EPA/day WEEKS COLL ADP ADR THR AA 
Velando et a!. (103) 0.05 8 
Hirai et a!. (105) 1.4 4 
Sanders et a!. ( 58) 1.7 3 
Ahmed et a!. (106) 1.8 2 
Sanders et a!. (108) 1.8 6 + 
Nagakawa et a!. ( 55) 2 4 
Bradlow et a!. (128) 1-4 1-3 
Thorngren et a!. (109) 2-3 6 
Thorngren et a!. (110) 2-3 11 
Kristensen et a!. ( 94) 2.7 1 
Lorenz et a!. ( 46) 3.5 4 
Terano et a!. (129) 3.6 4 
von Schacky et a!. ( 48) 3.8 4 
Siess et a!. ( 49) 6 3 
Dyerberg et a!. ( 50) 6.3 4 
: unchanged; - : decreased; + : increased. 
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Table 10 
Effects of fish(oil) consumption on platelet aggregation induced by low doses of 
collagen (COLL), adenosine diphosphate (ADP), adrenalin (ADR), thrombin 
(THR) and arachidonic acid (AA) in platelet rich plasma in controlled human trials. 
PERIOD 
grams IN 
REFERENCE EPA/day WEEKS CONTROL COLL ADP ADR THR AA 
Driss et al. (104) 0.15 4 PLACEBO 
Sanders et al. ( 51) 1.7 2 OLIVE+MAIZE 
Mortensen et al. ( 52) 2 4 OLIVE+CORN 
Nagakawa et al. ( 55) 2 4 PLACEBO 
Brox et al. (111) 2 6 CORN 
Brox et al. ( 64) 2.4 6 CONTROL 
von Schacky et al. ( 48) 3.8 4 LOW FISH 
Goodnight et al. (113) 5 4 AMERICAN 
: unchanged; - : decreased. 
Tables 9 and 10 show the effects of fish oil consumption on platelet aggregation 
induced by different stimuli in platelet rich plasma In nearly all uncontrolled studies 
platelet aggregation is inhibited by fish (oil) consumption, except for AA induced 
aggregation. This is in agreement with the competition of AA and EPA for cyclo-
oxygenase [20, 97, 117-120]. 
The effects of fish (oil) consumption on platelet aggregation in the controlled 
studies is less impressive, because the vegetable oils used as control also decrease 
the platelet aggregation [51, 52, 64, 111]. 
The above described studies on platelet function were performed in platelet rich 
plasma. Thus, prior to aggregation measurements the isolation procedures must take 
place, which may interfere with the outcome of the measurements. Therefore, the 
assessment of aggregation in whole blood is preferred. Two whole blood methods 
have been developed. One method is based on the adherence of platelets to a glass 
column [130]. With this method platelet reactivity was found to be decreased after 
n-3 fatty acid consumption [131, 132]. The second method is based on changes in the 
impedance of blood during platelet aggegration [133, 134]. However, no data on the 
effects of fish oil on this elegant method are available. 
The in vitro studies of platelet function do not necessarily reflect the in vivo 
platelet activity. Techniques which better reflect platelet function in vivo should 
become available. The platelet survival time measured by lllindium labelling was 
increased after fish oil administration [65, 129]. The platelet specific proteins beta-
thromboglobulin (BTG) and platelet factor 4 (PF4) plasma levels are indicators of 
the in vivo platelet activity. The BTG plasma levels were shown to decrease [65, 122] 
15 
or to be unaffected [64] after fish oil consumption. The PF4 plasma levels were not 
affected by the fish oil diets [122], so from the behaviour of the concentrations of 
this protein one would conclude that fish oil has no effect on platelet activity. The 
blood sampling method does not exclude platelet activation sothat the afore-
mentioned data on platelet specific proteins should be considered with care. There-
fore, the urinary excretion of these compounds is a more reliable indicator for the 
platelet activity in vivo. 
1.2.6 The effects of dietary n-3 fatty acids on hemorheology 
Dietary n-3 PUPA's are incorporated into the erythrocyt membrane phospholipids, 
probably during the erythrocyte development [48]. These changes in membrane 
phospholipid composition lead to increased erythrocyte deformability [129, 135, 
136], and consequently to a decrease of whole blood viscosity [53, 129, 135-140]. 
However, in a few studies blood viscosity was not affected [ 63, 66]. It is tempting to 
attribute the enhanced erythrocyte deformability to an increased membrane fluidity. 
However, compensatory mechanisms in membrane composition with respect to 
cholesterol, phospholipid and protein content may occur sothat in some cases the 
fluidity is not changed significantly after fish oil consumption [87, 138]. 
1.2.7 The effects of dietary n-3 fatty acids on hemostasis 
In traditionally-living Greenland Eskimos the tendency to bleeding is increased and 
bleeding times are significantly prolonged [91]. In a Nordic historical document 
published in 1450 it was mentioned that when the Eskimos were injured the "blood 
almost did not stop flowing" [141]. Frequent massive nose bleedings have also been 
reported [142]. 
In nearly all uncontrolled studies the cutaneous bleeding time was increased 
after fish (oil) consumption [46, 47, 50, 58, 106, 108-110, 122], except for one study 
[55]. In half of the controlled studies the bleeding time was prolonged after fish (oil) 
consumption [52, 53, 59, 113, 143], whereas in the other studies it was not signi-
ficantly different from the control diet [54, 64, 66, 94, 111]. 
Following endothelial injury thrombin is released, which activates blood platelets 
[144]. The activated platelets then stimulate blood coagulation. The blood coagula-
tion is controlled by a number of natural anticoagulants like antithrombin III (AT 
III). Finally, the clot can still be dissolved by fibrinolysis. In Greenland Eskimos the 
prothrombin time (PT) and the activated partial thromboplastin time (APTT) are 
not different from Danes [91], yet the Eskimos had a higher fibrinogen content and 
AT III activity [91, 145]. In most human fish (oil) trials PTwas not affected [55, 110, 
146], but in one study the prothrombin time was increased [129]. APTT was not 
affected in any of the dietary studies [52, 55, 110, 129, 146]. The fibrinogen content 
was unchanged [52, 55, 66, 108, 110, 146]. The AT III activity was increased (52], 
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unchanged [145, 146] or decreased [108] in the human fish (oil) trials. Two studies 
on the effect of dietary fish oil on fibrinolysis have been published. In the first study 
using the lysis time of a diluted fibrin clot, no effect was found [108]. In the second 
study an increased fibrinolytic activity was found with enhanced levels of tissue 
plasminogen activator and reduced levels of inhibitors of plasminogen activator 
[147]. 
1.2.8 The effects of dietary n-3 fatty acids on arterial blood pressure 
From animal experiments is known that diets rich in saturated fatty acids are 
associated with increased blood pressure [148]. This increased blood pressure can be 
lowered by increasing the PIS ratio and LA content of the diet [148]. In man a 
negative relationship has been demonstrated between adipose tissue LA content 
and arterial blood pressure [149, 150]. 
The role of dietary n-3 PUPA's on arterial blood pressure is yet not clear. The 
blood pressure in Eskimos is not different from that of Danes (J. Dyerberg, personal 
communication). However, Japanese with high fish consumption have a lower mean 
blood pressure than the average Japanese [10]. 
The majority of evidence suggests that systolic arterial blood pressure, in both 
normotensive as well as hypertensive individuals, is more sensitive to modulation by 
fish oil than diastolic arterial blood pressure [44, 52, 54, 62, 63, 105, 108, 151-153]. 
1.2.9 The effects of dietary n-3 fatty acids on thrombosis, atherosclerosis and 
ischemia 
In patients undergoing coronary angioplasty the incidence of restenosis was lower in 
patients which had taken fish oil supplements [154-156], but fish oil was ineffective 
when supplementation was started only shortly before the angioplasty [157]. It has 
been suggested that fish oil exerts this beneficial action by reducing thromboembolic 
events and intimal proliferation. In studies on rats with an aortic loop model fish oil 
lowered the tendency to thrombosis [98, 158]. 
Arntzenius et a!. provided angiographic evidence that the progression of athero-
sclerosis can be retarded by a diet with an increased PIS ratio and at least one fish 
meal per week [159], probably by the diet-induced changes in lipoprotein meta-
bolism. However, the amount of dietary n-3 PUPA's was too low to assume that 
these could have contributed to the changes in lipoprotein metabolism. It must be 
noted that this study lacked a proper control group. In a controlled trial with dietary 
restrictions and lipid lowering drugs regression of coronary artery atherosclerosis 
has been demonstrated [160]. This study awaits further coformation because in man 
regression of atherosclerosis is difficult to assess when only angiographic evidence is 
used [160]. Fish oil diets retarded the development of atherosclerosis in the pig [74, 
161], dog [162] and nonhuman primate [163], although in one study the athero-
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sclerotic process in the pig was not affected by the fish oil supplement [164]. In 
atherosclerotic rabbits, fish oil has been shown to accelerate the development of 
atherosclerosis [97]. 
Epidemiological data indicate a protective effect of fish consumption against 
ischemic heart disease [11-13]. Nelson's first prospective study in patients with 
coronary heart disease showed a protective effect of a diet rich in polyunsaturated 
fatty acids and fish [33]. In patients suffering from angina pectoris fish oil lowered 
the incidence of anginal attacks [47, 165], but in another study fish oil was not 
superior to a vegetable oil supplement [95]. In peripheral vascular disease fish oil 
showed several beneficial effects although the studies were too short lasting to have 
an effect on the clinical symptoms [122, 147]. Dietary supplementation of fish oil 
exerted a protective effect on experimental cerebral infarction in cats [166] and 
myocardial infarction in dogs [167]. The effects of fish oil diets on the incidence of 
ischemia-induced arrhythmias in rats are still controversial [168, 169]. 
1.3 Adverse effects of dietary n-3 fatty acids 
The most common unappreciated effects of fish oil supplement intake are the smell 
and taste of the oils. However, with a capsulated supplement this effect is bypassed. 
The intake of high amounts of fish oil concentrates can lead to gastro-intestinal 
discomfort like nausea, diarrhea and obstipation. Because of environmental 
pollution, fish in coastal waters may have accumulated mercury and chlorinated 
carbons. Consumption of these fish twice a week has not yet lead to any harm [170]. 
In the refined fish oil concentrates these toxins are removed. 
Fish oil has been used for decennia as a vitamin A and D supplement. Intake of 
too high amounts of vitamin A and D can lead to hypervitaminosis. Therefore, the 
intake of vitamin A and D free fish oil is advised. As mentioned before, the purified 
fish oil concentrates are also cholesterol free. 
High n-3 PUPA intake can lead to anti-oxidant deficiency. The products of 
chemical reactions and free-radical induced auto-oxidation can cause membrane 
damage. Lipid peroxidation and vitamin E deficiency can lead to yellow fat disease 
and mulberry heart disease [171-173]. Fish protect themselves from body fat peroxi-
dation by storage of selenium and vitamin E. Fish oil concentrates should therefore 
be supplemented with natural antioxidants like vitamin E and C, and selenium. 
Some scepticism about the use of fish oil extracts also stems from the fact that 
the extracts contain rather high levels of long chain monoenes like cetoleic acid 
(22:1 n-11), an isomer of erucic acid (22:1 n-9), and gadoleic acid (20:1 n-9). Erucic 
acid has been shown to cause transient myocardial lipidosis and fibrosis in experi-
mental animal studies [174, 175]. Nowadays purified fish oil extracts are available 
that are low in cetoleic and gadoleic acid. The inhibitory effect on blood coagulation 
which is beneficial against ischemic heart disease can lead to increased bleeding. In 
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Eskimos the increased incidence of apoplexy is worrisome [ 6, 7], but in other fish 
consuming communities the incidence of cerebrovascular accidents is rather low [10, 
176]. In the Western World the combination of anticoagulants and fish oil supple-
ments should not be advised. 
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CHAPTER 2 
STUDY OBJECTIVES 
2.1 Introduction 
In the review of (most human) fish oil studies in chapter 1 it was shown that the data 
are not all confirmative and only a few studies were well-controlled. However, the 
safety of the needed experimental high doses of fish oil requires further 
investigation. 
The general aims of this thesis were to investigate the effects of high doses of 
dietary fish oil on: 1. plasmalipids, 2.membrane phospholipid fatty acid composition, 
3. membrane function, 4. sensitivity of membranes to lipid peroxidation, 5. morpho-
logy of various tissues 6. myocardial function during normoxia, and after ischemia 
and reperfusion, 7. platelet function 8. prostanoid synthesis, 9. platelet vessel wall 
interaction, and 10. rate of regression of atherosclerotic lesions. 
For the optimal control of our studies we performed the experiments in an 
animal model. The pig was chosen because its anatomy, physiology and lipid meta-
bolism are similar to that of man. Swine are also known to develop spontaneously 
atherosclerotic lesions, which are similar to the atherosclerotic lesions in man. 
2.2 Chapter outline 
The effects of dietary monoenes and polyunsaturated fatty acids (n-3 and n-6) on 
physiological and pathophysiological aspects of cardiac function are described in the 
review of chapter 3. In chapters 4, 5 and 6 the effects of different doses (daily 0.3 -
0.6 g EPA/kg body weight) of purified fish oil are reported on lipoprotein 
metabolism, cardiac membrane phospholipid fatty acid composition, and cardio-
vascular performance in the pig. 
The effects of a codliver oil diet on catecholamine stress in rats is described in 
chapter 7. In chapters 8, 9 and 10 the effects of different doses of purified fish oil in 
swine on platelet and cardiac membrane phospholipid fatty acid composition, 
prostanoids, lipid-peroxidation, and cardiac function and arrhythmias during 
recurrent brief coronary artery occlusions and reperfusions are evaluated. 
In chapter 11 the effects of fish oil on intimal thickening in a chronic model of 
partial coronary artery constriction in the pig is depicted. After reviewing briefly 
some aspects of the atherosclerotic process and providing a rationale for the 
30 
interference of fish oil in this process (chapter 12), a study on the effects of fish oil 
on the regression of atherosclerosis has been described in chapter 13. 
In the epicrisis (chapter 14) the main conclusions ofthis thesis are described in 
the light of the possible benefit of the consumption of fish oil supplements by 
patients with ischemic heart disease. 
CHAPTER 3 
Dietary fatty acids and myocardial function 
J. M. J. Lamers1, J. M. Hartog2 , P. D. Verdouw2 and W. C. Hiilsmann1 
Departments of Biochemistry 11 and Thoraxcenter2 , Medical Faculty, Erasmus University Rot-
terdam, Rotterdam, The Netherlands 
Summary 
It is widely recognized that dietary polyunsaturated fatty acids (PUF A's) and cholesterol can profoundly 
influence the development of atherosclerotic plaques in coronary vessels, which may lead to myocardial in-
farction. The possibility that dietary fatty acids may also directly influence cardiac function has received 
less attention. We therefore reviewed the evidence of the effects of dietary fatty acids, in particular n-3 and 
n-6 PUF A's, on myocardial phospholipid fatty acid composition and cardiovascular performance. Heart 
organelles appear to incorporate uncommon fatty acids like 22: 1 and trans- 18: 1. Diets enriched with 22: 1 
induce myocardial lipidosis. N-9, n-6 and n-3 families compete among membrane C20 and C22 acids. 
Several studies have dealt with the relation between diet-induced changes of cardiac membrane (sarcolem-
ma, sarcoplasmic reticulum and mitochondria) phospholipids and membrane function . .In view of the variety 
of diets used and of the membrane functions studied, the results do not permit equivocal interpretation. 
Several investigators have reported an altered stress response of the heart due to a change ofPUFA's in the 
diet. In rats fed with a low 18:2n-6/18:3n-3 ratio combined with relatively low amounts of saturated fatty 
acids, a high incidence of myocardial lesions has been observed. Pigs are less sensitive but more susceptible 
to the development of vitamin E deficiency, when the dietary PUF A content is high. Increased contractility 
and coronary flow rate have been reported for Langendorff-perfused hearts of rats fed 18:2n-6-rich diets. 
The effects on coronary flow rate are possibly related to alterations in eicosanoid synthesis, which may also 
contribute to the reduction by n-6 or n-3 PUF A's in infarct size, magnitude of recovery of function and sup-
pression of reperfusion arrhythmias following release of a coronary artery ligation. On the other hand, in-
creased peroxidation of membrane lipids, due to their high content of n-3 PUF A, may be deleterious. 
Keywords: dietary polyunsaturated fatty acids; heart function; membrane function; eicosanoid synthesis; 
lipid peroxidation. 
Introduction 
Since 1952, the plasma cholesterol lowering effect of dietary n-6 and n-3 PUPA's has been 
demonstrated repeatedly (23, 27, 35, 56). Epidemiological as well as primary and secondary 
prevention studies of ischaemic heart disease have revealed the protective effects of diets enrich-
ed with n-6 or n-3 PUPA's. In particular the n-3 PUPA's, also protect against thromboembolic 
events (23, 27, 35, 56) by inhibition of platelet aggregation. Hypertension, another risk factor 
in the development of coronary heart disease, may be favourably affected by n-6 PUP A's ( 67, 
74), but here the data on the effects ofn-3 PUPA's are conflicting (35). 
Since Burr and Burr (12) described that n-6 PUPA's prevented abnormal increase of trans-
epidermal water loss and decreased growth disturbances, the former are considered to be essen-
tial for growing rats. In spite of supplementation with n-3 PUP A, the symptoms still developed 
(48). Hence, as far as this is concerned, there is no compensatory role for n-3 PUPA's. 
Dietary n-6 and n-3 PUP A's are metabolically competitive. Desaturation and elongation, in-
corporation into membrane phospholipids, conversion into eicosanoids, oxidative breakdown, 
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storage in tissue triglyceride and incorporation into circulating lipoproteins may all be modified 
by competition between fatty acids of different chain length and different unsaturated fatty acid 
families. The 3 major unsaturated fatty acid families are of the n-9, n-6 and n-3 type. The 6-, S-
and 4-desaturase, handling the further desaturation of these acids, are principal regulatory en-
zymes in the biosynthesis of endogenous PUFA's (Fig. 1). The activity of these enzymes is not 
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Fig. 1. Main pathways ofPUF A biosynthesis and further elongation and desaturation of dietary fatty acids. 
only modified by hormones but also by dietary PUFA's (10). Competitive actions, increasing 
with the number of double bonds, of fatty acids on 6-desaturase are also evident between 18: 1n-9, 
18:2n-6 and 18:3n-3 acids (72). A number ofn-6 PUFA's, as arachidonic acid (20:4n-6) and 
docosapentanoic acid (22:5n-6), inhibit the desaturation of linoleic acid (18:2n-6) toy-linolenic 
acid (18:3n-6). Oxidative desaturation of 18:2n-6 is inhibited by n-3 PUPA's. It has also been 
shown that n-3 PUF A's of C20 and C22 chain length compete powerfully with the 5-desaturation 
ofC20fatty acids (69, 72). Competition between20:5n-3 and20:4n-6 for incorporation into car-
diac phospholipids is present after addition of labelled PUFA's to the perfusion medium of 
Langendorff-perfused rat hearts (26). 
In this review we only summarize the direct effects of dietary fatty acids, in particular the 
PUPA's, on myocardial membrane biochemistry, function and pathophysiology. We will not 
discuss the possibile benefits of balancing the relative amount of dietary n-3 and n-6 fatty acids 
with respect to their essentiality. Such investigations comparing high-fat diets with low-fat diets 
have also not been considered. 
Some attemps have been made to define the mechanism of the cardiovascular action of dietary 
fatty acids. So far four mechanisms have been envisaged: 1) the conversion of n-6 and n-3 fatty 
acids to eicosanoids (17, 20, 33, 36, 49, 74), 2) the contribution ofPUFA's to membrane struc-
ture fluidity and membrane protein interactions (1, 14, 15, 20, 25, 30, 48, 53, 69, 72), 3) the 
reduced capacity of the heart to oxidize docosenoic acid (22:1) leading to transient cardiac 
lipidosis and slow development of fibrosis (9, 58), 4) the PUF A -induced increased need for an-
tioxidants to prevent yellow fat disease (18, 23, 31, 35, 64). 
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Flow of dietary fatty acids into heart phospholipids 
Changes in fatty acid composition of membrane phospholipids reflect the composition of the 
diet, although not strictly (48, 69, 72). Metabolic effects distort this relationship, as is evident 
from the competition between n-9, n-6 and n-3 fatty acids for the desaturation system (Figs. 1 
and 2). There is also competition for incorporation offatty acid into the phospholipid molecule 
during de novo synthesis in the endoplasmic reticulum or reacylation processes within the 
organelles and sarcolemma membrane. Some fatty acids, 20:4n-6 and 20:5n-3, are precursors 
for eicosanoid synthesis, which independently influence membrane fatty acid composition (Fig. 
2). In the cell, the phospholipids phosphatidylethanolarnine (PE) and phosphatidylinositol (PI) 
are rapidly converted into the phospholipids phosphatidylcholine (PC) and phosphatidylinnosi-
tol-4, 5- biphosphate (PIP2), respectively. These processes are involved in hormone-mediated 
cell responses. In heart, 13-, and a 1-adrenergic receptor stimulation, respectively, initiate these 
phospholipid responses, but the conversion rates ofPE and PI conversion are extremely low ( 11, 
57). 
Regulation of the fatty acyl group composition of membranes occurs by enzymes within the 
endoplasmic reticulum, the mitochondria, sarcoplasmic reticulum or sarcolemma. In the en-
doplasmic retic;;ul urn de novo synthesis occurs, while fine adjustment takes place in the mitochon-
dria, sarcoplasmic reticulum and sarcolemma. Lysophospholipid formation, reacylation, trans-
acylation and headgroup exchange, responsible for this fine tuning, play an important role in the 
dietary fatty acid and excessive 13-adrenergic st4nulation-induced adjustment of membrane fatty 
acyl group composition (see below). 
The influence of dietary fatty acids on heart tissue fatty acid patterns has been studied exten-
sively (Table 1). The used diets contained large amounts of 18:2n-6 (SFO), saturated fatty acids 
(LF, CNO and SKF), monoenes 18:1n-9 (00) both 18:2n-6 and 18:3n-3 (SO), 18:3n-3 (LO), 
both20:5n-3 and22:6n-3 (FO), trans-18:1n-9 (PHCO andPHPO) andmonoenes 20:1 and22:1 
(HEAR and PHFO). Most studies have been carried out with rats (Table 1), but lack uniformity 
in fatty acid composition of basal and dietary food, tissue subfractionation and separation of 
DIETARY 
LIPIDS 
I 
EICOSANOIDS 
elongation 
ACYL -CoA -+ I 1-= desaturation 
oxidation 
Fig. 2. Metabolic effects that distort parallelism between dietary and tissue lipid fatty composition. 
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Table 1. Studies on the relation between dietary fats and cardiac membrane phospholipid composition 
Authors and reference Species Diets 
Egwin and Kummerov (24) rat PHSO,CO 
Szuha and McCarl (71) rat MM 
Ruiter eta! (64) pig FO,OO 
Gudbjamason eta! (30) rat FO 
Dewailly eta! (21) rat LEAR, HEAR, PNO 
Clandinin and Robblee (60) rat SO, LEAR, HEAR 
Kramer (44) rat LEAR, HEAR, 00, SO, CO 
Bellenand et al ( 6) rat SFO, CNO, HEAR 
Yasuda et al (78) rat synthetic 
De Deckere (20) rat SFO, LF, PHCNO 
Tahin eta! (72) rat SO, SFO, LF, FO 
Iritana and Fugikawa ( 40) rat FO,CO 
A wad and Chattopadhyay (4) rat CO, synthetic 
Menon and Dhopeshwarkar (54) rat HCO, synthetic 
Charnock eta! (13) rat SKF,SFO 
Arens et al (2) pig SFO, SO, LO,OO, LF 
Montfoort et al (55) rat FO 
Hartog eta! (32) pig FO,LF 
Takamura et a! (73) rat FO,CO 
Swanson and Kinsella (70) rat FO 
Abbreviations: PHSO, partially hydrogenated soybean oil; CO, com oil; MM, mother milk; FO, fish oil; 
00, olive oil; LEAR, low erucic acid rapeseed oil; HEAR, high erucic acid rapeseed oil; SO, soybean 
oil; PNO, peanut oil; PHFO, partially hydrogenated fish oil; SFO, sunflower oil; LF, lard dat; PHCNO, 
partially hydrogenated coconut oil; CNO, coconut oil; SKF, sheep kidney fat; PHCO, hydrogenated 
com oil; LO, linseed oil. 
phospholipid classes. Nevertheless, the results on phospholipid extracts from whole hearts pro-
vide valuable data on e. g. competition between n-9, n-6 and n-3 fatty acids. Low but adequate 
amounts of dietary 18:2n-6, decreases its membrane content. The 20:4n-6 membrane content is 
relatively insensitive to low amounts of dietary 18:2n-6 while the C20 and C22 n-3 fatty acid 
membrane contents increase despite the presence oflow amounts of 18:3n-3 in the diet (2, 13, 
20, 53, 72). Dietary C20 and C22 n-3 fatty acids drastically reduce myocardial20:4n-6levels 
by competition with 18:2n-6 for the 6-desaturase (13, 24, 30, 32, 40, 55, 70, 72, 73). None of 
these dietary interventions affect total saturated fatty acid and PUF A content of cardiac mem-
branes. Because membrane n-6 fatty acids are replaced by n-3 fatty acids, an 18:2n-6-rich diet 
slightly decreases the double bond index (DBI) of cardiac membranes (13, 20) whereas a large 
increase occurs with n-3 PUFA-rich diets (13, 24, 30, 32, 40, 55, 70, 72, 73). The changes in 
fatty acid composition of heart membranes usually begin within a few weeks after starting the 
diet (72). 
Although changes in dietary monoene content exert little effect on tissue fatty acid patterns, 
18: 1n-9 participates in the substitution of dietary PUFA's (4, 5, 13, 30, 32, 60, 70, 72). Dietary 
18: 1n-9 and22: ln-9 arereflectedinmyocardial fatty acid patterns (21, 38, 44, 64, 72, 78), which 
may be caused by the abundant presence of the phospholipid cardiolipin (CL) in the mitochon-
dria, as cardiolipin fatty acid composition is most sensitive to dietary docosanoenes (21, 38, 39, 
72, 78). Rats fed rapeseed oil, which contains the monoene 22: 1n-9, showed a persistent rise in 
22: 1n-9 inCLbutnotinmitochondrialPCorPE (21, 38, 39, 78). Thedissimilareffectsofdietary 
fat composition on mitochondrial PC and PE on the one hand, and of CL on the other hand is 
noteworthy in view of other biosynthetic differences between these phospholipids. Mitochon-
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drial PC and PE are mainly synthesized in the endoplasmic reticulum, whereas CL is exclusively 
of mitochondrial origin (39). Other uncommon fatty acids like elaidic acid (trans-18: ln-9) are 
incorporated into heart phospholipids (3, 3 8, 54, 72). The fatty acid trans-18 :2n-6 is, however, 
not incorporated (72). 
For the reasons outlined above it is likely that the membranes of sarcolemma, sarcoplasmic 
reticulum and mitochondria have different phospholipid fatty acid compositions and dietary 
responses (1, 4, 21, 38, 39, 53, 60, 72). A related problem is whether the diet-induced changes 
reflect only fatty acid changes or overall phospholipid composition modifications of cardiac 
membranes. In PE, for example, dietary fish oil induces a shift in n-6 and n-3 fatty acid distribu-
tion which is usually more pronounced than in PC (60, 55, 70). Mitochondrial CL contains 
relatively the largest amount of 18:2n-6, so that a reduced dietary 18:2n-6 content is more effec-
tive (30, 38, 39, 44, 70). The sarcolemmal sphingomyelin fraction contains mostly saturated and 
monoene fatty acids so that dietary PUF A's are not expected to produce any change (3, 28, 44, 
64, 78). In spite of the absence of the saturated fatty acids 22:0 and 24:1 in diets enriched with 
20:5n-3 or 22:6n-3, the 22:0 content decreases but that of24:1 decreases in myocardial sar-
colemmal sphingomyelin of pigs (unpublished data from this laboratory). Dietary fatty acids 
cause in general much smaller shifts in phospholipid class than in fatty acid composition (3, 55, 
60, 64, 70). 
The molecular species of individual phospholipid classes in phospholipid mixtures extracted 
from whole heart, pure organelles and sarcolemma (Fig. 3) has been studied by phospholipase 
A2 breakdown of a PE fraction of total phospholipids of rat heart (55), by conversion to 
monoacetyldiacylglycerols by phospholipase C/acetic anhydride pyrridine treatment and further 
separation on AgNOrthin layer chromatography (78) and separation by HPLC (73). Fatty 
acids in the PC and PE fraction show positional specificity with preferential location of saturated 
fatty acids and monoenes at the !-position and polyunsaturated fatty acids at the 2-position of the 
glycerol moiety (28, 55, 73, 78). In CL those fatty acids are randomly distributed between 1- and 
2-positions (39). Feeding rats with fish oil affects primarily the fatty acid composition on the 
2-position of PC and PE fractions of total heart phospholipids (55, 73). Canine sarcolemmal 
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phospholipids contain 40% plasmalogens which have a molecular species composition different 
from the overall composition (28). Whether these molecular species respond differently to 
dietary PUFA's is not known. 
It is now well established that proteins and phospholipids have an asymmetrical distribution 
over biomembranes. PE, phosphatidylserine (PS) and PI are predominantly localized at the 
cytosolic side of the plasma membrane bilayer, whereas PC and sphingomyelin are predominant-
ly localized at the surface ( 63, 69). The asymmetry partially serves a metabolic purpose because 
the substrate for cytosolic and membrane-bound enzymes must be at the appropriate leaflet of 
the bilayer. This stresses the importance of knowledge about diet-induced changes in fatty acid 
composition in all phospholipid classes (Fig. 3). 
Membrane function 
The consequences of extensive alterations in the fatty acid composition (of phospholipids) in 
the functions of the heart membranes is a key problem. It is generally assumed that the selectivity 
of many enzymatic and transport functions of membranes require the structural complexity of 
the protein molecules, whereas the phospholipids play only a supporting role. Although specific 
functions of phospholipids in membrane-linked processes have been described, their role is con-
sidered to be of secondary importance (25, 69). They provide the insulating barrier that limits 
the transfer of ions (Ca2 +, Na + and K +) across the membrane, especially by means of the apolar 
region provided by the paraffinic chains of their constituent fatty acids. Nevertheless, evidence 
has been obtained that the permeability of membranes of cells other than myocytes can be 
markedly influenced by the fatty acid composition of the phospholipids and in particular their 
degree ofunsaturation (37, 46, 63, 69). We measured Ca2 + permeability and Na+Jca2 + ex-
change activity in heart sarcolemmal membranes from pigs fed either mackerel oil or lard fat 
(4 7). The diet induced a marked change in membrane DBI (mackerel oil: 1. 85 and lard fat: 1.28, 
cf. [33, 47]) but not in Ca2 + movements in sarcolemmal membrane (47). Discrepancies were 
also noted in the response of cardiac sarcolemma Na + JK+ ATPase to 18:2n-6-rich diets (1, 22) 
which excludes extrapolation to possible changes in membrane function in vivo. 
The DBI is important for changes ·in fluidity of the membrane core (25, 69). Abeywardena et 
al. described the rotational diffusion of a diphenylhexatriene probe as a fluidity marker (1). They 
showed that in rats on a 18:2n-6-rich diet the fluidity of heart sarcoplasmic reticulum but not the 
Ca2+ pump activity was altered. On the other hand a different break in the Arrhenius plot of 
mitochondrial succinate dehydrogenase suggested a change in membrane fluidity (53). Before 
the change in fluidity of the membrane bilayer can be attributed to modified levels of unsatura-
tion, several other factors have to be considered. Whether changes occur in membrane composi-
tion as the neutral triglyceride content, the phospholipid/protein ratio, the phospholipid class 
distribution, and the cholesterol/phospholipid ratio should also be known. In most studies, these 
characteristics have not been assayed (Table 1). For example, an increase in the 
cholesterol/phospholipid ratio tends to increase the order oflipid motion in the bilayer (79). We 
( 4 7) found in the heart sarcolemma of mackerel oil fed pigs not only a marked increase of the DBI 
(from 1.28 to 1. 85), but also in the cholesterol/phospholipid ratio (from 0.38 to 0.64), while the 
phospholipid: protein ratio decreased from 0. 94 to 0. 69. The latter finding confirms our earlier 
observations in total heart phospholipid fraction of hearts rats fed with cod liver oil (55). 
Heart sarcolemma from mackerel oil fed pigs had increased 5' -nucleotidase and Ca2 + pump 
activity, while adenylate cyclase was more sensitive to isoproterenol stimulation ( 4 7). However, 
it is not clear whether these enzymatic changes were the consequence of increased DBI or 
cholesterol content of the membrane as e. g. a high cholesterol/phospholipid ratio has been 
shown to reduce cardiac sarcolemmal Ca2 + pumping ATPase activity (59) and to increase rat 
lung membrane adenylate cyclase f)-receptor sensitivity (65). 
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We also have to take into account the response of the myocardial membrane function to hor-
monal and neurotransmitter stimuli, such as ucadrenergic and muscarinic stimulation of PI 
breakdown and 13-adrenergic activation of PE-N-methylation. For example, the ucreceptor 
regulated phospholipase C may have a preference for a particular molecular species of PIP 2 • It 
may also be that a particular diglyceride species most powerfully activates the Ca2 + -dependent 
C-kinase. At present no information concerning this matter is available. 
Eicosanoid synthesis 
Eicosanoids are formed from 20:4n-6, a fatty acid which is produced by action of 6-desaturase 
on 18:2n-6. It is first cleaved from membrane phospholipids by phospholipase A2 • The cyclo-
oxygenase and lipoxygenase enzyme systems subsequently give various types of so-called 
leucotrienes (e. g. LTC4 , LTD4 , LTB4) and prostaglandins (e. g. PGI2 , TXA2 , PGE2 and 
PGF2). The eicosanoids are not stored in tissues and their release from organs is therefore in-
dicative of de novo synthesis. The precise sites and regulation of the rate of eicosanoid synthesis 
in the heart are not clear, as both the coronary vasculature and myocytes contribute to myocardial 
prostaglandin synthesis (36, 41, 66). The major 20:4n-6 metabolite released from the isolated 
perfused heart (endothelial cells and myocytes) is PGI2 (20, 66, 74) while platelets are a major 
site for TXA2 production. PGI2 and TXA2 play opposite roles in the regulation of platelet ag-
gregability, vasoconstriction and perhaps arrhythmogenesis (27, 66, 41). Hence, the ratio of 
their concentrations may be more important. Feeding rats with 18:2n-6-rich diets increased pro-
duction of the prostaglandins PGI2 , PGE2 and PGF2 in Langendorff-perfused myocardium (20, 
36, 74). Cardiac membrane phospholipids from rats fed with 18:2n-6-rich diet do not contain 
more 20:4n-6 (2, 13, 20, 53, 72). Therefore, in order to explain the increased prostaglandin pro-
duction, compartmentalization of20:4n-6 or alteration of membrane-bound phospholipase A2 
should be considered. In animals fed with fish oil a change in eicosanoid production is most likely 
due to the altered membrane fatty acid composition because of a displacement of 20:4n-6 by 
20:5n-3 within the phospholipids. The fatty acid 20:5n-3 inhibits formation and antagonizes ac-
tions of 20:4n-6-derived prostaglandins (Fig. 4). The 20:5n-3 is a competitive inhibitor and a 
poor substrate for cyclo-oxygenase (23, 27, 35, 56, 67). Small quantities ofTXA3 and PGI3 
(weak agonists) are also formed. We measured by radio-immunoassays the stable endproducts 
ofPGI2 (6-keto-PGI 1a.) and ofTXA2 (TXB2) in the coronary vein of mackerel oil fed pigs (33). 
Baseline values were reduced by 29% and 59%, respectively, compared to that of lard fat 
animals. Likewise, the TXA2/PGI2 balance was changed (55% reduced). Production of small 
amounts of the weak agonists TXA3 and PGI3 may also be expected. Concentrations of TXA2 
and PGI2 in the coronary vein during reperfusion following coronary artery occlusion were also 
lower in the mackerel oil than in the lard fat fed pigs. The more vigorous hyperaemic response 
in the mackerel oil fed animals observed under these circumstances could therefore be related 
to altered prostaglandin production (33). 
Coronary flow rate and contractility 
Elevated coronary blood flow and contractility have been measured in Langendorff-perfused 
hearts of rats which had been on 18:2n-6-rich diets (20, 36). On the other hand, no effects of this 
diet on tension in isolated papillary muscle could be demonstrated (14). That an increased PGI2 
production might be responsible for the effect of a 18:2n-6-rich diet on flow is supported by use 
of the prostaglandin synthesis inhibitors aspirin and indomethacin (20, 36). The mechanisms by 
which an 18 :2n-6 rich diet might affect heart contractility are largely unknown, although changes 
in Na+fK+ ATPase have been implicated (20). One must, however, be careful before ex-
trapolating observations obtained on myocardial performance in in vitro experiments to the in 
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Fig. 4. Antagonism by n-3 PUF A's of formation and action of n-6-derived prostaglandins. 
situ situation because of low TXA2 production in platelet-free perfused hearts. Indeed, we 
found no changes in in situ determined parameters of cardiac function of mackerel oil fed pigs, 
despite marked alterations in prostaglandin levels (32, 33). Monoene-rich diets, known to induce 
focal myocardial fibrotic lesions due to transient lipidosis, did not influence myocardial contrac-
tility of rat hearts (22). 
Cardiotoxicity of high doses of catecholamines 
Rona and coworkers first described an infarct-like necrosis in rats after administration of 
isoproterenol (see 62 for review). Since then, this has become a standard model for the study of 
protection against catecholamine-induced myocardial insult. Isoproterenol proved to be more 
toxic than epinephrine and norepinephrine, but this difference is related to their diverse effects 
on the coronary vasculature. Several factors such as relative hypoxia, formation of toxic oxida-
tion products, microcirculatory effects and myocardial Ca2+ overload have been implicated in 
the development of cardiac necrosis (62). Increased mortality in rats, fed with cod liver oil was 
found after chronic isoproterenol treatment (30). By the same group, a decreased mortality was 
found with 20:4n-6-rich diets (29). Protection by dietary 18:2n-6 against catecholamine-in-
duced necrosis has also been reported (16). We did not find an effect on mortality during 
catecholamine stress of cod liver oil fed rats, although ST -segment elevation in diethylether-in-
duced anaesthetized cod liver oil fed rats was more pronounced (55). Protection by cod liver oil 
feeding against fatal ventricular fibrillation in old rats subjected to subcutaneous injection of 1 
mg/kg of isoproterenol has also been reported (7). Because of the discrepancies in results and 
the lack ofknowledge about the cause of death (damage), a causal relation between dietary PUF A 
composition and the sensitivity of the heart to stress cannot be given. Moreover, the use of cod 
liver oil may be inappropriate for studying the effect of dietary fish oil because of the high content 
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of vitamin D and monoene fatty acid cetoleic acid and the low content of vitamin E. The possible 
role of endogenous antioxidant shortage caused by dietary PUF A's in the response of the heart 
to stress is discussed below. 
In the catecholamine stress experiments the phospholipids undergo partial replacement of n-6 
by n-3 PUPA's similar to that with dietary fish oil (30, 55). Perhaps the Ca2 + overload, induced 
by overstimulation of the heart 13-adrenoceptors, activates tissue phospholipase A2 thereby 
favouring the removal of 2-positional fatty acids from the membrane phospholipids rapidly 
followed by reacylation. 
Heart lesions due to a dietary fatty acid imbalance 
Rats fed with vegetable oils or partially hydrogenated marine oils appear to be more prone to 
myocardial lesions than other species such as pigs, monkeys and mice (5, 8, 9, 15, 51, 58). Le-
sions, detected by histometric analysis, exhibit microvascular alterations ( oedematous swelling 
and loosening of blood vessels) and myocardial necrosis (granular degradation of myocardial 
fibres, vacuolization of muscle fibres and sarcolysis, mononuclear cell infiltration). This type 
of necrosis, was first reported for male rats fed with high 22: 1 n-9 rapeseed oil for 5-7 weeks by 
Roine et al. in 1960 (61). Necrosis was not related to dietary 22:1n-9 intake, but the importance 
of alterations in the fatty acid composition of the diets has been demonstrated (8, 15). In a well-
controlled study (8)in which 18: 1n-9, 18:2n-6 and 18:3n-3 were gradually altered over a wide 
range by mixing several fat types (SFO, SO, LO, 00, LF, Table 1), the incidence oflesions was 
higher when dietary intake of 18:2n-6/18:3n-3 was less than 2-3 at constant 18:1n-9 content 
(50%). This has been confirmed by others (see [15] for review) employing mixtures of CO, 
LEAR, LF, SO (Table 1) and cocoabutter. The number oflesions correlated positively with 
18:3n-3, 18:1n-9, 22:1n-9 content and negatively with 16:0, 18:0 or 18:2n-6. Pigs are less sen-
sitive to a dietary fat imbalance, but yellow fat disease, due to vitamin E deficiency, is seen more 
frequently in this species (8). So far all studies relating dietary fat intake and the occurrence of 
myocardial lesions were purely descriptive (8, 15, 51). The mechanism by which an imbalance 
in dietary fatty acids produces the lesions is completely unknown. 
Arrhythmias, recovery of function and infarct size after coronary artery ligation 
A lower incidence of arrhythmias and mortality of rats on 18:2n-6 rich diets after coronary 
artery ligation has been described (49, 52), but the same diet did not affect the incidence of 
aconitine and CaCl2-induced arrhythmias in rats (50). Dietary supplementation with fish oil 
also showed a reduction in the incidence of arrhythmias and infarct size after ligation of a cor-
onary artery in dogs (7). However, we could not observe any difference in the incidence of ven-
tricular arrhythmias and recovery of regional myocardial function during and after multiple cor-
onary artery occlusions in anaesthetized pigs, which had been fed either mackerel oil or lard fat 
for 8 to 16 weeks (33, 34). The mechanism by which dietary n-6 or n-3 PUF A's might exert pro-
tection can only be speculated upon but an altered membrane phospholipid composition, which 
modifies eicosanoid production has been suggested (17, 49). However, since eicosanoids might 
be beneficial as well as deleterious it is difficult to define their role, if any, during myocardial 
ischaemia. 
Lipid peroxidation 
Membrane PUPA's are very susceptible to 0 2 free radicals (02· and OH·) and organic free 
radicals are formed from these. The divinyl methane structure within the PUFA chains is par-
ticularly prone to abstraction of the allylic hydrogen, resulting in formation of fairly stable lipid-
40 J. M. J. Lamers et al. 
free radicals. In the presence of 0 2, these lipid-free radicals initiate a subsequent chain of auto-
oxidation reactions. 0 2 , having free radical-like properties, is far more soluble within the non-
polar lipid phase of the membrane (see review in ref [ 68]). Cells contain a broad spectrum of an-
tioxidants and free radical-controlling enzymes such as superoxide dismutase and catalase. The 
antioxidant vitamin E is largely found in association with membrane lipids and this localization 
probably serves as a local defence mechanism against PUF A peroxidation. Evidence is growing 
that free radicals play a pivotal role in the extension of myocardial damage during reperfusion 
following a period ofischaemia (42, 68, 77). It has indeed been shown that superoxide dismutase 
and catalase protected porcine hearts subjected to one hour of normothermic regional ischaemia, 
followed by one hour of global hypothermic arrest and one hour of normothermic reperfusion 
(19). A significant amount of thiobarbituric acid reactive material (malondialdehyde, MDA) ap-
peared in the perfusate, demonstrating free radical-mediated peroxidation of PDF A containing 
3 or more double bonds which was prevented by addition of superoxide dismutase and catalase. 
In addition there was an improvement in the contractile recovery of the heart (19). Because of 
their susceptibility to lipid peroxidation, harmful effects of dietary PUF A may be expected dur-
ing myocardial ischaemia and reperfusion. 
The first symptoms of vitamin E deficiency are a disorder of fat depots: adipose, liver cell 
degeneration, inflammation, fibrosis and accumulation of lipofuscin pigment (18). Although 
yellow fat disease can occur in rats, pigs are especially sensitive. Cardiomyopathy is frequently 
observed in animals with selenium-vitamin E deficiency (75). This deficiency (in pigs) is also 
termed ''mulberry heart disease'' because of a reddish purple gross appearance of the heart. Pigs 
on cod liver oil, mackerel oil- or 18:3 enriched diets developed mild symptoms of vitamin E defi-
ciency (8, 18, 64). None of the symptoms were present in pigs fed mackerel oil supplemented 
with vitamin E and selenium (32, 33). We observed no increase in venous plasma MDA levels 
during the dietary period. However, the MDA production induced by the addition of Fe2 +, 
ADP and dihydrofumarate to isolated cardiac sarcolemmal membranes obtained from mackerel 
oil fed animals was increased by about 2 fold (unpublished observations from our laboratory). 
This result is in qualitative agreement with studies ofliver micro somes isolated from rats fed her-
ring oil (31). In the latter investigation it was also shown that dietary supplementation of vitamin 
E markedly reduced the in vitro induced MDA formation (31). In coronary venous blood of 
mackerel oil-fed pigs, collected immediately after a period of.ischaemia, we found a much higher 
MDA production than in lard fat-fed pigs, but no difference in the short-term recovery of 
myocardial function (33, 34). This might indicate that in pigs the enhancement oflipid peroxida-
tion due to a PUF A diet is not critical in the development of contractile failure after myocardial 
infarction. 
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CHAPTER 4 
Comparison of mackerel-oil and lard-fat enriched diets on 
plasma lipids, cardiac membrane phospholipids, 
cardiovascular performance, and morphology 
in young pigs 1- 3 
Johannes M Hartog, MD; Jos MJ Lamers, PhD; Ad Montfoort, PhD; AntonE Becker, MD, PhD; 
Marjolein Klompe. PhD; Howard Morse, BS; Folkert J ten Cate, MD, PhD; 
Leonore van der Weif, BS; Willem C Hillsmann, MD, PhD; Paul G Hugenholtz, MD; 
and Pieter D Verdouw, PhD 
ABSTRACT Purified mackerel-oil extract or lard fat (9.1% wt/wt) was added to a basal diet 
of young pigs for 8 wk. Effects on plasma lipids, glucose and insulin, cardiac membrane phos-
pholipids, cardiovascular performance. and morphology were studied. A time-dependent re-
duction of plasma triglyceride (62%), total cholesterol (41%), and HDL cholesterol (47%) was 
found in the mackerel-oil-fed pigs. The postprandial glucose and insulin response may indicate 
a mackerel-oil-induced resistance of insulin receptors. Although the polyunsaturated fatty acid 
composition of cardiac sarcolemma widely differed between the two groups, all determined 
indices of heart function were equal. It is concluded that consumption of a fish-oil diet witb a 
low content of monoenes and supplemented with antioxidants reduces plasma lipid levels without 
producing pathological side effects. Am J C/in Nutr 1987;46:258-66. 
KEY WORDS Fish oil, lipids, phospholipids. cardiac function, morphology, pig, selenium, 
vitamin E, insulin. glucose 
Introduction 
Epidemiological studies have revealed direct correla-
tions between heart-attack rate (and mortality) and the 
level of serum cholesterol. For almost 30 y it has been 
appreciated that polyunsaturated fatty acids can lower 
serum cholesterol. The hypocholesterolemic effect of veg-
etable oils, which contain predominantly w-6 polyunsat-
urated fatty acids, has been attributed to the polyunsat-
urated:saturated fatty acid (P:S) ratio and to the cholesterol 
content of the oil (I). 
Bang and Dyerberg (2, 3) showed that ingestion offatty 
seafish. containing more w-3 than w-6 fatty acids, is also 
negatively related to morbidity and mortality of coronary 
heart disease. In some dietary studies in rats and pigs, the 
hypocholesterolemic effects of fish-oil-enriched food was 
equivalent to that of the vegetable-oil-enriched. food de-
spite the higher degree of unsaturation of the w-3 fatty 
acids in fish oil (4-6). In chicken, fish oil was shown to 
be more hypocholesterolemic than a diet containing lin-
olenic or linoleic acids (7). 
In men the hypolipidemic effects of fish-oil and vege-
table-oil diets have been reported to be similar (8. 9), but 
in these studies the relati¥e amount of fish oil present in 
the food was lower than that of vegetable oil. Moreover, 
the fish-oil diet contained higher amounts of cholesterol 
than the vegetable-oil diet. This suggests that dietary w-3 
fatty acids are more potent than w-6 fatty acids in reducing 
serum cholesterol. Indeed, a more marked hypocholes-
terolemic effect of fish oil has been observed in hyperli-
pidemic patients following diets with equal amounts of 
cholesterol and fat (I 0). 
Some scepticism exists about the use of dietary fish oil 
to prevent atherosclerosis because rather high levels of 
cetoleic acid (C22:1 w-11), an isomer of erucic acid (C22: 
I w-9) and gadoleic acid (C20: I w-9), are present. Erucic 
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acid has been shown to cause transient myocardial lipi-
dosis and fibrosis in experimental animals (II, 12). How-
ever, in men these fatty acids could not be detected in the 
serum after intake of high levels of fish oil probably due 
to a poorer resorption or a more rapid metabolism (GP 
Walsh, unpublished observations). 
Because of the high-unsaturation degree of the fish-oil 
fatty acids, an increased need for exogenous antioxidants 
is expected. Indeed, vitamin E deficiency causing yellow-
fat disease ( 6) or even mulberry-heart disease ( 13) occurs 
in animals fed with fish oil. In one study yellow-fat disease 
could not be prevented by dietary supplement of vitamin 
E, but because the dietary selenium appears to be low in 
this report, the supplemented vitamin E may still be sub-
optimal (6). Fish oil, depending on origin of species and 
manner of preparation, may also contain high levels of 
vitamin A and D. Toxic effects of these vitamins can be 
expected after consumption of large amounts of fish oil. 
Recently, purified fish-oil extracts have been produced 
that are low in vitamins A and D, cetoleic acid, and gad-
oleic acid and to which optimal amounts of mixed to-
copherols are added. The use of these extracts could cir-
cumvent most of the above-mentioned problems (14). 
In this study we describe the effects of addition of a 
purified mackerel-oil extract, enriched in vitamin E and 
selenium, to the diet of young pigs. A control group of 
animals received a diet enriched with equal weight oflard 
fat. Plasma triglyceride and cholesterol were followed 
during the dietary period. Because it is known that dietary 
lipids affect fatty acid composition of cardiac membranes 
and thereby may cause changes in cardiac performance 
(15-17), sarcolemmal membranes, isolated from myo-
cardial biopsies at the end of the feedihg period, were 
characterized. Cardiac performance was recorded during 
and at the end of the nutritional period. At the end of the 
nutritional period, several organs were examined mor-
phologically to see whether lipidosis or fibrosis of heart 
or liver, mulberry-heart disease, and yellow-fat disease had 
occurred. 
Materials and methods 
Experimental animals 
Twenty-four newborn Yorkshire piglets (0.8-1.3 kg) of either 
sex were nourished by sows and supplied with pig starter gruel 
during the first 4 wk. During the first week the piglets received 
vitamin and iron injections. In the second week all boars were 
castrated. After 4 wk the pigs were separated from the sows and 
housed individually in slat-bottomed cages in temperature-
controlled animal quarters. Subsequently they were divided ar-
bitrarily over two groups, each group consisting of six male and 
six female piglets. and the two diets were followed for 8 wk. The 
National Research Council's guide for the care and use of lab-
oratory animals was followed. 
Experimental diets 
The basal diet ofboth experimental groups was identical. The 
composition of the basal diet was described by Ruiter eta! (6) 
except for the selenium and vitamin E contents. The present 
basal diet was prepared by Hope Farms (Woerden, The Neth-
erlands) and low in fat ( < 2% wt/wt) although sufficient amounts 
of linoleic acid remained present. For the control animals 9.1% 
wt/wt lard fat (Gebro Smilde BV, Heerenveen, The Netherlands) 
and 0.01% wt/wt mixed tocopherols were added to the basal 
diet. For the experimental animals 9.1% wt/wt mackerel oil (AS 
Johan C Martens en Co, Bergen, Norway) and 0.01% wt/wt 
mixed tocopherols were added to the basal diet. Care was taken 
to minimize oxidation of mackerel-oil fatty acids before con-
sumption. To this end the mackerel oil, delivered in vacuum-
sealed cans, was divided into small batches for daily use and 
sealed under nitrogen gas. The compositions of the two isocaloric 
diets are shown in Tables 1 and 2. A difference in the cholesterol 
content was noticed but. because of the rather low amounts. no 
adjustment was made. The animals were fed in the morning 
and the portions were consumed within I h. To avoid problems 
during adaptation to the new diet, the animals were fed only 
200 g/d during the first week. In the following weeks the daily 
food intake was gradually increased equally in both groups to 
800 g/d in the last week. No scours occurred during the exper-
imental period. 
The day before the start of the experimental dietary period 
the 24-h fasted animals were anesthetized with im injections of 
30 mgfkg ketamine (Aescoket®. Aesculaap BV, Boxtel, The 
Netherlands) and inhalation of a mixture of 0 2 :N20 (1:2) to 
which I% halothane (Fiuothane®, Macclesfield, UK) was added. 
Echocardiography was carried out using a two-dimensional ap-
paratus (77020A Hewlett-Packard Ultrasound System, Andover, 
MA) with a 5 MHz transducer of 32 elements giving an exam-
ination sector of90°. The two-dimensional images were recorded 
TABLE I 
Composition (Ell 00 g) of the two experimental diets 
Lard-fat diet Mackerel-oil diet 
Com (extruded) 32 32 
Wheat (extruded) 18 18 
Soybean meal I4 14 
Wheat middlings 9 9 
Dehydrated skimmed~milk 
powder 14 I4 
CaHPO, • 2H20 1.3 1.3 
CaCo 1.1 1.1 
Na03• iodized 0.3 0.3 
MgO 0.05 0.05 
MgSO, 0.05 0.05 
KH2P04 · 2H20 0.36 0.36 
Choline chloride 50% 0.18 0.18 
Vitamin C coated 0.02 0.02 
Vitamin and trace-element 
mixes• 0.68 0.68 
Lard fat 9.1 
Mackerel oil 9.1 
Mixed tocopherols O.Ql O.OI 
Cholesterol O.Ql 0.03 
• Vitamin and trace element mixes supply the following per 100 g 
food: vitamin A, 1400 IU; cholecalciferol, 140 IU; vitamin E, 8 mg; 
menadione, 0.2 mg~ thia~in hydrochloride, 1.8 mg; riboflavin, 1.8 mg; 
pyridoxine hydrochloride, 1.4 mg; niacin, 3.6 mg; d-Ca pantothenate, 
3.6 mg; folic acid, 0.4 mg; vitamin B-12, 0.004 mg; biotin, 0.1 mg; inositol, 
4.5 mg; Iron subcarbonate (57% Fe). 9.1 mg; FeSO,·H20 (30% Fe). I4 
mg; Copper carbonate (55% Cu), 2.3 mg; ZnO (78% Zn), II mg; MnO 
(62% Mn), 9.1 mg; sodium selenite (45% Se), 0.08 mg; Ca (103)2 (65% 
1), 0.2 mg; and CoCO, (47% Co), O.Q9 mg. 
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TABLE2 
Fatty acid composition (%) of the two experimental diets 
Fatty acids Lard-fat diet Mackerel-oil diet 
14:0 
16:0 24 18 
16:1 3 8 
18:0 10 I 
18:1 42 17 
18:2 w-6 15 8 
18:3 
20:1 
20:5 «>-3 17 
22:1 4 
22:6 w-3 9 
24:1 
others 2 
on videotape (Panasonic VHS, Matsushita Electric Trading Ltd, 
Osaka, Japan) with a rate of 30 frames/s. Both parasternal long-
axis and short~axis cross sections at several levels. of the heart 
(mitralvalve, papillary muscles, apex) were used. In addition, 
we recorded M-mode echo tracings of the anterior wall of the 
left ventricle. Electrocardiographic recordings were made via 
Einthoven leads I, II, and Ill. This procedure was repeated every 
2 wk during the dietary period to screen for disturhances in left 
ventricular wall motion and other signs of selenium-vitamin E 
deficiency (ie, hydropericardium). 
Chemical analysis of plasma during the dietary period 
At the time of the echocardiografic recordings, a I 0 mL 
bloodsample was taken by puncturing the subclavian vein. Part 
of the blood sample was used for determination of hemoglobin 
(OSM 2 Hemoximeter, Radiometer, Copenhagen, Denmark) 
and the remainder was centrifuged. The plasma was frozen in 
liquid nitrogen and stored at -80°C. 
After 8 wk a catheter was placed in the right internal jugular 
vein in eight animals of each group. This was done under halo-
thane anesthesia after pretreatment with an im injection of a 
mixture of 300 000 U procain penicillin-G and 300 000 U be-
zathin penicillin-G (Duplocilline®, Gist Brocades, Delft, The 
Netherlands). The catheters were flushed twice a day with 4 mL 
saline containing 20 IU heparin. Two days after insertion of the 
catheter the animals were starved for 24 h. After withdrawal of 
a bloodsample the animals received their daily food, which was 
consumed by all animals within I h. Subsequent bloodsarnples 
were taken at hourly intervals for 8 h postprandially. 
Cholesterol, triglyceride, free fatty acids, and glucose concen-
trations were determined in the plasma. Glucose (18) and cho-
lesterol (19) were assayed spectrophotometrically with hexoki-
nase and cholesterol oxidase-peroxidase reactions, respectively, 
with test combinations from Boehringer (Mannheim, FRG). In-
sulin was measured by radioimmunoassay with an Ins-Ria-100 
kit (IRE-Medgenix, Fleurus, Belgium) using human insulin 
standards, which have a I 00% cross reactivity with porcine in-
sulin. Triglycerides (20) were estimated using the peroxidase re-
action-coupled assay by the Test Combination 17 of Biomed 
(Oberschleissheim, FRG). The HDL fraction was determined 
after centrifugal separation ( 13 000 g, 5 min) of the Mn2+ -heparin 
precipitate (21 ). The cholesterol content of the HDL-containing 
supernatant was determined enzymatically (19). 
On the next day the procedure of postprandial follow-up was 
repeated. After withdrawal of a 4-h postprandial blood sample, 
an intravenous bolus of heparin (50 IU /kg) was administered 
to induce the release of lipoprotein lipase into the blood. Four 
minutes after heparin administration a blood sample was col-
lected and the lipoprotein lipase activity was measured with ra-
dioactive labeled triolein as a substrate (22). At the end of the 
dietary period, plasma levels of selenium, a-tocopherol, and vi-
tamin A were determined (23, 24). 
Hemodynamic evaluation after the dietary period 
After -8 wk all animals were sedated with 120 mg azaperone 
(StresniJ®, Janssen Pharmaceutica, Beerse, Belgium) im and 15 
min later were anesthetized with !50 mg metomidate (Hypno-
dii®, Janssen Pharmaceutica. Beerse, Belgium) and intravenous 
pentobarbital (20 mg • kg-• • min-1). Subsequently, the animals 
were intubated and connected to a respirator for artificial ven-
tilation with a mixture of 0 2 :N20 (1:2). Left ventricular and 
central aortic pressures were obtained from microtipped Millar 
catheters. After exposure of the heart via a midstemal split, elec-
tromagnetic flow probes (Skalar, Delft, The Netherlands) were 
placed around the ascending aorta and the proximal left anterior 
descending coronary artery (LAD) and the great cardiac vein 
was cannulated. Myocardial wall thickness was monitored with 
an epicardial 5 MHz ultrasonic transducer (Krautkramer-Bran-
son, Lewistown, PA). From the tracings systolic wall thickening 
(swt) was calculated by 
swt(%)= IOOX(EST-EDT)/EDT (I) 
in which EST and EDT are the wall thickness at end-systole and 
at end-diastole, respectively. The mean velocity of systolic wall 
thickening (vswt) was calculated by 
vswt (mm/s) =(EST- EDT)/L VET (2) 
in which L VET is the left ventricular ejection time in seconds. 
Hemodynamic measurements were obtained after a stabilization 
period of at least 30 min. Except for anesthetics, heparin, and 
antibiotics no other drugs have been used in this study. 
Chemical analysis of myocardial biopsies taken at the end of 
the dietary period 
After completion of the hemodynamic measurements, the 
heart was excised and rapidly cooled in ice. The posterior wall 
of the left ventricle was cut out and homogenized in buffer and 
heart sarcolemmal membranes were separated (25). The phos-
pholipids were extracted from the sarcolemmal membranes with 
19 val of a mixture of chloroform:methanol (2: I vol/vol) ac-
cording to the method of Folch (26). The phospholipids were 
separated from the other lipids by thin-layer chromatography. 
The developing system was a mixture ofhexane:ether (70:3 val/ 
val). The plates were washed with the same mixture and acti-
vated at I l0°C for 30 min. Phospholipid hydrolysis, formation 
of fatty acid methylesters, subsequent extraction of these meth-
ylesters, and gas-chromatographic separation have all been de-
scribed. (I 6). 
M orphologica/ examination 
Tissue samples of the heart, aorta, liver, spleen, kidneys, ad-
renal, lymph nodes, skeletal muscle, subcutaneous fat, and peri-
renal fat tissue were fixed in 10% formalin for morphological 
examination. The tissues were routinely processed and embedded 
in paraffin. Sections were cut at 7 I'm thickness and stained with 
hemotoxilline and eosine, aldan blue, periodic acid Schiff(with 
and without diastase digestion), and different connective tissue 
stains. Oil red 0 and sudan III stains were used on formalin-
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FIG 1. Weight gain of the animals during the dietary period. e 
= lard~fat-fed animals (n = 12): 0 =mackerel-oil-fed animals (n = 12). 
fixed frozen sections. Additional stains, such as fibrin stains, 
were used only when considered necessary. 
Statistical analysis 
In many cases data are expressed as percentage of values ob-
tained at the beginning of the dietary period. For comparison 
of the values at the different times, the Student's t test was used. 
For statistical evaluation of the difference between the two dietary 
groups, analysis of variance was used. Statistical significance was 
accepted at p < 0.05 (two-tailed). All data have been expressed 
as mean ± SEM. 
Results 
Peiformance of the pigs during the dietary period 
The growth patterns of the two groups of animals are 
shown in Figure t'. During the first 4 wk, the weight gain 
TABLE 3 
was nearly identical in the lard-fat- and mackerel-oil-fed 
animals and then the mackerel-oil-fed animals gained 
weight faster than the lard-fat-fed animals. The electro-
cardiographic recordings and the analysis of the echocar-
diograms showed no abnormalities in either group during 
the feeding period. At the end of the dietary period, the 
hemoglobin content of both groups of animals had sta-
bilized at slightly lower than predietary values(-24 ± 2% 
vs -23 ± 2% in the lard-fat- and mackerel-oil-fed pigs, 
respectively, Table 3). 
Alpha-tocopherol was not detectable in the plasma of 
both animal groups. Plasma selenium was 136 ± 8 l'g/L 
vs 143 ± 81'g/L (1.72 ± O.ll'molfL vs 1.81 ± O.ll'molf 
L) in the lard-fat- and mackerel-oil-fed animals, respec-
tively. The plasma vitamin A level was significantly higher 
in the mackerel-oil-fed animals (392 ± 49 l'g/L or 13.7 
± 1.7 l'mol/L) than in the lard-fat-fed animals (278 ± 20 
l'g/L or 9.7 ± 0.7 l'molfL). 
Plasma levels of lipids and glucose 
during the dietary period 
The plasma levels of triglyceride, cholesterol (total and 
HDL fraction), and glucose, determined in starved ani-
mals, are presented in Figure 2- In the lard-fat-fed animals 
plasma triglyceride levels decreased by 20 ± 4% (p < 0.05) 
after 2 wk but returned later to predietary values. During 
the first 2 wk of the dietary period, plasma triglycerides 
in the mackerel-oil-fed animals decreased by 40 ± 8% (p 
< 0.05) and after 8 wk the total decrease was 62 ± 6% (p 
< 0.05 vs 2-wk value). Plasma cholesterol increased 
slightly in the lard-fat-fed animals ( + 23 ± 7%, p < 0.05) 
but decreased in the mackerel-oil-fed animals (-28 ± 7%, 
p < 0.05, after 2 wk and -41 ± 4%, p < 0.05 vs 2-wk 
value). HDLcholesterol increased by 29 ± 8% (p < 0.05) 
in the lard-fat-fed pigs but decreased by 4 7 ± 5% (p < 0.05) 
in the mackerel-oil-fed animals. However, the HDL:total 
cholesterol ratio remained 0.48 in both groups. The 
plasma glucose levels of the starved animals remained 
constant at -5 mM in both groups during the entire di-
etary period, and because no differences existed between 
the two groups, the data were pooled. 
Postprandial increase of plasma triglyceride level de-
termined after 8 wk showed a similar pattern for both 
groups with peak values -5 h (+ 183 ± 64% for the lard-
fat-fed animals vs +247 ± 86% for the mackerel-oil-fed 
animals, Fig 3). The postprandial curve of free fatty acids 
of the lard-fat-fed animals peaked sharply again -5 h 
postprandially (+283 ± 121%). However, no sharp, de-
fined maximum was observed in the free fatty acid curve 
Blood hemoglobin content (mM) of animals in the two experimental groups during the dietary period 
Lard-fat diet (n ~ 12) 
Mackerel-oil diet (n = 12} 
"' = p < 0.05 vs predietary value. 
8.6 ±0.2 
8.9±0.1 
8.1±0.2* 
7.5 ± 0.2* 
Week 
7.7±0.1* 
7.5 ± 0.2* 
7.7±0.1" 
6.9 ±0.2* 
6.4±0.1* 
6.9 ± 0.2* 
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FIG 2. Plasmalipidsduringthedietaryperiod. • ~lard-fat-fed animals 
(n ~ 12): 0 ~mackerel-oil-fed animals (n ~ 12): • ~ p < 0.05 vs predietary 
value; t == p < 0.05 vs lard-fat-fed animals. 
of the mackerel-oil-fed pigs as these animals exhibited a 
plateau which lasted ~ 5 h. Plasma cholesterol showed a 
minor response to the foqd intake in both dietary groups 
as can be expected from the low-cholesterol content of 
either diet. Because of the difference in plasma triglyceride 
levels between the two groups at the end of the dietary 
period, it was of interest to know the clearing factor activity 
when peak plasma triglyceride level was reached. The 
heparin releasable lipoprotein lipase showed the same ac-
tivity in both groups: 168 ± 17 mUjmL vs 188 ± 18 mU/ 
mL (2.80 ± 0.28 JLkat/L vs 3.13 ± 0.30 JLkatjL) plasma 
for the mackerel-oil- and lard-fat-fed pigs, respectively. 
In the lard-fat diet group the plasma glucose level was 
unchanged after the food intake, but in the mackerel-oil 
group it had increased by 45 ± 12% (p < 0.05 vs lard-fat-
fed animals) 2 h after food intake. Insulin levels also were 
determined in these samples. The preprandial insulin lev-
els were similar in both groups (6.6 ± 1.0 mU/L or 47 
± 7 pmoljL in the lard-fat- and 7.7 ± 1.3 mU/L or 55 ± 
9 pmoljL in the mackerel-oil-fed animals), but the insulin 
level 2 h after the meal was significantly higher in the 
mackerel-oil-fed animals (34.4 ± 4.3 mU/L vs 23.6 ± 3.6 
mUjL or 247 ± 31 vs 169 ± 26 pmoljL in the lard-fat-
fed group). 
Fatty acid pattern of cardiac membrane phospholipids 
The P:S ratio of fatty acids esterified in cardiac sarco-
lemmal phospholipids did not differ significantly between 
groups of animals (0.76 ± 0.06 vs 0.81 ± 0.06 in the lard-
fat- and mackerel-oil-fed animals, respectively). However, 
as illustrated in Figure 4, the distribution of the polyun-
saturated fatty acid molecules became markedly different. 
In the mackerel-oil-fed animals the w-6:w-3 ratio was 0.69 
± 0.3 vs 17.9 ± 2.2 (p < 0.05) in the lard-fat-fed animals. 
This results in a wide variation of double-bond indices: 
1.85 ± 0.06 and 1.28 ± 0.06 (p < 0.05) for mackerel-oil-
and lard-fat-fed animals, respectively. 
Global hemodynamics at the end of the dietary period 
No significant differences in blood pressure, left ven-
tricular filling pressure, cardiac output, myocardial con-
tractility, and peripheral resistance were found between 
the two experimental groups (Table 4). Regional myo-
cardial performance expressed as coronary blood flow, 
coronary venous oxygen saturation, and systolic wall 
thickening were not different between the different groups. 
The quantitative analysis of regional wall function at the 
end of the dietary period was in agreement with the qual-
TRIGLYCERIDES 
0 
FREE FATTY ACIDS 
02 
mM 
0.1 
0 
p 0 4 8 
Time (hours) 
TOTAL CHOLESTEROL 
3 
mM 
0 
GLUCOSE 
10 
mM 
p 0 4 
Time {hours) 
8 
AG 3. Postprandial responses of plasma triglyceride. free fatty acids, 
total cholesterol, and glucose. p ;- preprandial value; 8 =feeding period; 
o = lard-fat-fed animals (n = 8); 0 = mackerel-oil-fed animals (n = 8); 
* = p < 0.05 vs preprandial value: t = p < "0.05 vs lard-fat-fed animals. 
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itative analysis of the two-dimensional and M-mode 
echorecordings made during the dietary period. 
Morphology 
Macroscopic evaluation of the different organs revealed 
no signs ofliver enlargement or hypertrophy of the adrenal 
glands. Microscopic examination did not provide any ev-
idence for yellow-fat disease, cardiac or hepatic lipidosis, 
and fibrosis. 
TABLE4 
Hemodynamic values after the 8-wk dietary period 
Heart rate (b/min) 
Systolic arterial blood pressure (mmHg) 
Diastolic arterial blood pressure (mmHg) 
Mean arterial blood pressure (mmHg) 
Left ventricular end-diastolic· pressure (mmHg) 
Stroke volume (mL) 
Cardiac output (L/min) 
Peak rate of rise in left ventricular pressure (mmHgfs) 
Systemic vascular resistance (mmHg·min/L) 
Coronary blood flow (mL/min) 
Caron~ venous blood oxygen saturation (%) 
End-diastolic wall thickness (mm) 
End-systolic wall thickness (rom) 
Systolic wall thickening (%) 
Mean velocity of systolic wall thickening (mmjs) 
Discussion 
The markedly lower plasma triglyceride levels in the 
animals on the mackerel-oil diet agree with other reports 
( 4--9). However, at variance with these studies, we found 
a dramatic reduction of plasma cholesterol content. Phil-
lipson et al (10) observed similar hypocholesterolemic ef-
fects in a study with hyperlipidemic patients who con-
sumed about the same daily dose offish oil, but the effect 
of a lower dose of fish oil in normolipidemic man was 
Lard-fat diet Mackerel-oil diet 
(n~8) (n~8) 
101 ± 8 106 ± 15 
105 ± III ± 6 
69 ± 78 ± 6 
89 ± 4 94 ± 6 
8.3± U.9 10.2± 1.5 
18 ± 19 ± 2 
1.9± 0.2 1.8± 0.1 
2290 ±340 2080 ±300 
50 ± 3 53 ± 4 
34 ± 5 36 ± 
21 ± 2 23 ± 
11.4± 0.5 11.0± 0.9 
15.4± 0.6 14.5± 0.9 
36 ± 3 33 ± 3 
6.3± 0.6 6.0± 0.5 
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less (9). The decrease in cholesterol took place predomi-
nantly in the first 2 wk (-28 ± 7% ), but at the end of the 
dietary period the total decrease of plasma cholesterol was 
41 ± 4% (p < 0.05 vs 2-wk value). The HDL fraction of 
plasma cholesterol fell similarly (-47 ± 5%) but the HDL: 
total-cholesterol ratio was unchanged (0.48 ± 0.04). The 
values for HDL:total-cholesterol ratio in the pig are rather 
high as compared with those found in men (0.25). In a 
parallel study of animals receiving only 4.6% wtfwt 
mackerel oil in their diet, the reduction in total cholesterol 
was less, but the HDL cholesterol was unchanged, re-
sulting in a HDL:total-cholesterol ratio of 0.49 ± 0.02. 
The large decrease in total cholesterol in animals receiving 
9.1% wtfwt mackerel oil in their diet probably leads to a 
reduction in HDL cholesterol. The lard-fat diet, contain-
ing mainly saturated fatty acids, only slightly influenced 
the plasma cholesterol and triglyceride levels during the 
nutritional period. 
It is unlikely that a difference in the rate offat resorption 
explains the hypolipidemia after mackerel-oil nutrition 
because postprandial responses of plasma lipids after a 
24-h period of starving were similar in both diet groups. 
The changes in plasma lipids in mackerel-oil-fed animals 
are probably also not due to a different rate of plasma 
lipid breakdown because the activity of the postheparin 
lipoprotein lipase, measured 4 h after a morning meal, 
was similar in both nutritional groups. Changes in the 
composition of the lipoprotein particles may account for 
enhanced clearance (8) but a more likely cause is a de-
creased rate ofVLDL synthesis after fish-oil nutrition (27-
30). The hypolipidemic effect of mackerel oil probably is 
dose-dependent because in animals receiving 4.5% wt/wt 
mackerel oil mixed with 4.5% wtfwt lard fat in their diet 
plasma cholesterol was lowered by 19 ± 8% compared 
with 41 ± 4% for the 9 .I% wt/wt mackerel-oil-fed animals, 
and plasma triglycerides fell by 49 ± 8% vs 67 ± 6% in 
the 9 .I% wt/wt mackerel-oil fed group (compare Fig 2). 
Therefore it is not surprising that in human studies in 
which lower doses offish oil are used, no effect on plasma 
cholesterol 'level is observed (28-30). 
The postprandial response of plasma glucose was sig-
nificantly higher in the mackerel-oil-fed pigs. The insulin 
levels in plasma, however, were significantly higher in the 
mackerel-oil-fed animals. It has been suggested that insulin 
receptor mobility in a more fluid membrane bilayer of 
fatty acids with a high double bond index is increased 
(31-33). As long as data on membrane cholesterol:phos-
pholipid ratio and spinprobe mobilities are not available, 
fluidities of membranes with a different polyunsaturated 
fatty acid composition are difficult to predict (34). Others 
have reported increased insulin receptor sensitivity after 
fish-oil supplementation although membrane fluidity was 
unchanged (35). An alternative factor producing changes 
in plasma glucose could be an increased intestinal re-
sorption of glucose due to variations in membrane fluidity. 
A relatively slow fatty acid resorption after a saturated 
fatty acid load has been reported previously (36). This 
may result in a prolonged increase of gastric inhibitory 
polypeptide release, which promotes insulin release and 
stimulates the lipoprotein lipase reaction thereby increas-
ing free fatty acid levels in plasma The postprandial 
plasma lipid response of the mackerel-oil-fed animals, 
however, did not indicate a slower rate of fatty acid ab-
sorption and plasma free fatty acids increased to less extent 
(Fig 3). 
Different effects of polyunsaturated fatty acids on ar-
terial blood pressure have been reported. A hypotensive 
effect of linoleic acid has been found in rat (37-40) and 
human (41-48). More recently, a similar effect has been 
shown for fish oils in animal experiments ( 49) and in hu-
man studies (50-52). The fall in blood pressure could be 
explained by changes in the synthesis of prostaglandin E2 
(PGE2) and prostaglandin F2• (PGF2a) in the kidneys (39, 
53). Scherhag (54) on the other hand claimed that diets 
providing fish oil induce hypertension. We found no dif-
ferences in blood pressure between the lard-fat- and 
mackerel-oil-fed animals during anesthesia. This is in 
agreement with the results reported by others for studies 
in man using diets with high P:S ratios (55, 56). 
Dietary linoleic acid in rats augments coronary flow 
and contractility of the Langendorff perfused heart (15). 
In this in vivo study no differences between myocardial 
contractility, systolic wall thickening, and coronary blood 
flow ofboth dietary groups were detectable despite marked 
changes in polyunsaturated fatty acid composition of car-
diac membranes. 
The decrease in blood hemoglobin content is probably 
age dependent and not diet induced as in the experiments 
by Ruiter eta! ( 6). In a parallel series with a longer dietary 
period, a similar decrease was found after 8 wk but the 
hemoglobin content returned to baseline value after 16 
wk. Although the plasma levels of vitamin A were signif-
icantly higher in animals after the mackerel-oil diet (392 
± 49 p.g/L or 13.7 ± 1.7 p.mol/L), the levels are still within 
the normal range for men (200-500 p.g/L or 3.5-17.5 
p.mol/L). 
No signs of vitamin E deficiency nor of any other pa-
thology (II, 12) were found after morphological exami-
nation of several organs of the mackerel-oil-fed pigs. The 
low content of monoenes in the mackerel-oil preparation 
used is one favorable factor. Furthermore, the present diets 
were not only enriched in vitamin E but also in selenium 
(Table 1). This was not the casein the diets used by Ruiter 
eta! (6), who observed that increased supply only of vi-
tamin E did not prevent yellow-fat disease. 
In conclusion, this study shows that a mackerel-oil diet 
markedly lowered plasma lipids, in particular total cho-
lesterol. In cardiac membrane phospholipids w-6 fatty ac-
ids were partially replaced by w-3 fatty acids. These 
changes in fatty acid composition of sarcolemma did not 
lead to any variation in cardiac function. Moreover, 
pathological side effects of mackerel-oil nutrition were not 
found. The favorable effects of consumption of purified 
mackerel-oil extracts by the pig, an animal which is very 
sensitive for vitamin E deficiency, indicate that high dos-
age of fish oil,can be applied, provided that selenium and 
vitamin E delivery is controlled. n 
The authors wish to thank Prof Dr AJ V ergroesen (Department of 
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CHAPTER 5 
Dietary Mackerel Oil in Pigs: Effect on Plasma Upids, 
Cardiac Sarcolemmal Phospholipids and Cardiovascular 
Parameters1 
JOHAJYNES M. HARTOG, PIETER D. VERDOOW,2 MARJOLEIN KLOMP£* AND 
JOS M.J. lAMERSt 
Laboratory for Experimental Cardiology, Thoraxcenter, *Oogziekenhuis, tDepartment of Biochemistry I, 
Erasmus University Rotterdam, 3000 DR Rotterdam, The Netherlands 
ABSTRACT T.he influence of substitution of eicosapen-
tanoic acid to the diet has been investigated in juvenile 
domestic pigs (7-8 kg) fed either a mixture of 4.5% (wt/ 
wt) mackerel oil and 4.5% (wt/wt) lard fat (n = 12, ML 
group) or a 9% (wt/wt) lard fat (n = 12. L group) diet for 
16 wk. Plasma triglyceride and total cholesterol did not 
change in L, but had decreased in ML to 51 ± 8 and 81 
± 8% of the initial values. respectively, at the end of this 
period; the largest decreases already occurred during the 
first 8 wk. HDL cholesterol of both L and ML were not 
affected. After 16 wk, postprandial responses of plasma 
triglyceride, total cholesterol and glucose and insulin, de-
termined at hourly intervals during the first 8 h postfeeding, 
did not show any differences for the two dietary groups. In 
spite of a marked replacement of n-6 fatty acids by n-3 
fatty acids in cardiac sarcolemmal membranes in ML, there 
were no major differences in cardiovascular performance 
(myocardial contractility, pre- and afterload, cardiac output 
and myocardial work) between L and ML, when measured 
under baseline conditions and after the heart was stressed 
by atrial pacing (heart rate: 160 beats/min). In conclusion, 
feeding moderate amounts of mackerel oil [0.3 g 20:5 n-
3/(kg body weight-d)] to pigs during 16 wk produces de-
creases of the plasma levels of total cholesterol and tri-
glyceride, but does not affect plasma HDL cholesterol and 
routine cardiovascular parameters. J. Nutr. 117: 1371-
1378, 1987. 
INDEXING KEY WORDS: 
fish oil • plasma lipids • cardiac function 
pigs 
Consumption of fish oil has a beneficial effect on the 
development of cardiac disease, probably by modifi-
cation of risk factors such as high levels of plasma tri-
glyceride and total cholesterol, low levels of plasma 
HDL cholesterol, high aggregability of platelets, high 
viscosity of blood and possibly hypertension (1-7). The 
effects are believed to be caused by the n-3 polyunsa-
turated fatty acids (PUFAs) present in fish oil. However, 
the time course of changes in the risk factors after daily 
intake of fish oil is largely unknown. 1n many studies, 
the quantity of consumed fish and, therefore, the re-
sulting n-3 PUFA intake have been in excess of what 
could reasonably be consumed by the public at large 
(1). The Greenland Eskimos, for instance, consume ap-
proximately 0.1 g 20:5n-3 fatty acid/(kg body weight·d), 
which they obtain predominantly from seafood (1). 
1n a recent study we investigated the effect on plasma 
lipids of a purified mackerel oil extract that we added 
to a basal diet for young growing pigs ( 8 ). The intake 
of 0.6 g 20:5n-3/(kg body weight·d) over 8 wk decreased 
not only plasma triglyceride and total cholesterol but 
also plasma high density lipoprotein (HDL) cholesterol 
levels (8). In the present study pigs were fed only half 
the mackerel oil content [0.3 g 20:5n-3/(kg body 
weight·d)], but for twice the duration to allow a more 
accurate extrapolation from the results obtained in an-
imals to humans. 
It is possible that dietary fish oil also directly influ-
ences cardiac function, independent of changes in blood 
lipids, coronary vasculature and hemostasis because 
consumption of n-3 PUFAs also leads to changes in 
fatty acid composition of cardiac membrane phospho-
lipids (9). The exchange of heart sarcolemma n-6 PUFA 
by dietary n-3 PUFAs alters the double bond index of 
cardiac membranes and may thereby affect membrane 
fluidity, receptor, intrinsic enzyme or ion transport 
properties (9-13). It is also feasible that prostanoid syn-
thesis is affected (1, 9). Moreover, it has also been shown 
that mortality of rats on a fish oil diet was increased 
during catecholamine stress (9, 12, 13). Effects on in-
farct size, recovery of cardiac function and ventricular 
arrhythmias during coronary artery occlusion and re-
perfusion in dogs have also been described (14). 
The goal of this study was to investigate the effects 
1This study was supported by a grant from the Dutch Heart Foun-
dation. 
2Author to whom reprint requests should be addressed. 
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of the substitution of fish oil to a diet comparable to 
that of humans (30 E% fat and polyunsaturated-satu-
rated fatty acid ratio of 0.78) on plasma lipid levels, 
cardiac membrane fatty acid composition and routine 
cardiovascular parameters. We performed a pacing stress 
test to see whether this led to cardiovascular dysfunc-
tion. The results were compared to pigs fed a lard fat 
diet (30 E% fat and polyunsaturated-saturated fatty acid 
ratio of 0.50). The pig was chosen because its lipopro-
tein metabolism and many aspects of its cardiovascular 
system resemble those of humans (15, 16). 
MATERIALS AND METHODS 
Experimental animals. Twenty-four weanling pigs (5 
wk old and 7.7 :±: 0.2 kg) were separated from their 
sows and housed individually in slat-bottomed cages 
in temperature-controlled animal quarters and divided 
into two groups, each group consisting of six castrated 
males and six females. Each group followed a different 
diet for 16 wk. 
Experimental diets. The diets were prepared by add-
ing either 9% (wt/wt) lard fat (L group) or a mixture of 
4.5% (wt/wt) mackerel oil and 4.5% (wt/wt) lard fat 
(ML group) to a low fat(< 2%) nonpurified basaJ diet 
(Hope Farms BV, Woerden, The Netherlands). Lard fat 
was obtained from GEBRO Smilde BV (Heerenveen, 
The Netherlands) and the mackerel oil was purchased 
from NS Tohan C. Martens and Co. (Bergen, Norway). 
The mackerel oil was sealed under N 2 gas and added 
to the basal diet immediately before consumption to 
minimize oxidation. A detailed description of the two 
experimental diets is given in Tables 1 and 2. Besides 
the difference in fatty acid composition, there was a 
difference in cholesterol content of the diets that orig-
inated mainly from the addition of mackerel oil extract 
(Table I). It should, however, be noted that cholesterol 
contents of both diets were extremely low. The animals 
were fed in the morning and the portions were con-
sumed within 1 h. To facilitate adaptation to the new 
diet, the animals were fed only 200 g( d during the first 
week. In the following weeks the daily food intake was 
gradually increased to 1500 g/d in the last week No 
scour occurred during the experimental feeding period. 
Chemical analysis of plasma during the dietary pe-
riod. Before the start of the dietary period and there-
after at 4-wk intervals plasma triglyceride, total and 
HDL cholesterol and hemoglobin levels were deter-
mined in blood samples with the methods described 
earlier (17-19). Blood was collected from animals de-
prived of food for 24 h by puncturing the subclavian 
vein. After 16 wk, the postprandial response in plasma 
triglyceride, glucose, insulin and total and HDL cho-
lesterol (8, 17, 18, 20) was followed for 8 h. Three days 
before the postprandial follow-up a catheter was placed 
in the external jugular vein. Because of technical fail-
TABLE 1 
Composition of the two experimental diets fed to the 
Yorkshire piglets 
9% lard 4.5% mackerel oil + 
Ingredient fat diet 4.5% lard fat diet 
Com [extruded) 32 32 
Wheat [extruded) 18 18 
Soybean meal (solvent 
extracted, toasted) 14 14 
Wheat middlings 9 
Dehydrated skimmed 
milk powder 14 14 
CaHP04 ·H,O 1.3 1.3 
CaCO, Ll Ll 
NaCl, iodinized 0.3 0.3 
MgO 0.05 0.05 
Mg$04 0.05 0.05 
KH2P04 ·2H2 0 0.36 0.36 
Choline chloride 50% [wtlwt) 0.18 0.18 
Vitamin and trace element 
mixes1 0.7 0.7 
Lard fat 9.10 4.55 
Mackerel oil 4.55 
Mixed tocopherols 0.01 0.01 
Cholesterol O.Dl 0.02 
1Vitamin and trace element mixes supply the following per 100 g/ 
diet: retinol, 1400 IU; cholecalciferol, 140 IU; a-tocopherol, 8 mg; 
menadione, 0.2 mg; thiamin hydrochloride, 1.8 mg; riboflavin, 1.8 
mg; pyridoxine HCl, 1.4 mg; niacin, 3.6 mg; vitamin C coated, 20 
mg; o-calcium pantothenate, 3.6 mg; folic acid, 0.4 mg; cyanocob-
alamin, 0.004 mg; biotin, 0.1 mg; inositol, 4.5 mg; iron subcarbonate 
[57%' Fe), 9.1 mg; FeSO,·H,O [30% Fe), 14 mg; Cu,[OH),CO, [55% 
Cu), 2.3 mg; ZnO [78% Zn), 11 mg; MnO [62% Mn), 9.1 mg; 
Na2Se,·5H20 [45% Se), 0.08 mg; Ca[IO,), [65% I), 0.2 mg; CoCO, 
(47% Co), 0.09 mg. The composition (g/100 g) is on an as-fed basis. 
TABLE2 
Fatty acid composition {%} of the two experimental diets 
fed to the Yorkshiie piglets 
Fatty 4.5% mackerel oil + 
acids 9% lard fat diet 4.5% lard fat diet 
14:0 2 5 
16:0 24 21 
16:1 3 6 
18:0 10 6 
18:1 42 29 
18:2n-6 15 11 
18:3 1 1 
20:1 4 
20:5n·3 
22:1 2 
22:6n-3 5 
24:1 
Others 2 
ure, postprandial blood samples could be obtained in 
only 10 of 12 animals in each group. 
Hemodynamic measurements. The day after the 
postprandial follow-up experiment seven animals (three 
male and four female), randomly selected from ea~h 
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FIGURE 1 Preparapon of the heart for hemodynamic measurements, after midstemal thoracotomy. The signals of the 
transducers are shown on the right: AoP = aortic pressure, L VP = left ventricular pressure, LVdP/dt = rate of change of left 
ventricular pressure, AoF = ascending aortic blood flow (cardiac output), CBF = coronary blood flow. The ultrasonic crystal 
measured the change in myocardial wall thickness. SWT = systolic wall thickening, which is calculated as described in the 
text. 
group, were anesthetized and catheterized according to 
standard procedures (21). The five remaining animals 
in each group were used for a different protocol in a 
model of partial coronary artery constriction. After ex-
posure of the heart through a midstemal split, electro-
magnetic flow probes (Skalar, Delft, The Netherlands) 
were placed around the ascending aorta and the prox-
imalleft anterior descending coronary artery. An elec-
trode was sutured to the right atrium to pace the hearts. 
Myocardial ~all function was monitored with a min-
iature 5-MHz ultrasound transducer (Krautkramer 
Branson, Lewiston, P A) sutured onto the epicardium 
for continuous measurement of regional myocardial wall 
thickness (21). From the registrations, systolic wall 
thickening (SWT) was calculated as 
SWT(%) = 100(%) x (EST- EDT)/EDT, 
in which EST and EDT are the local wall thicknesses 
at end-systole and end-diastole, respectively. Finally, 
the great cardiac vein was cannulated with polyethyl-
ene tubing (Fig. 1). 
Baseline measurements were obtained after stabili-
zation for at least 30 min. Subsequently, the heart rate 
was raised by atrial stimulation with increments of 20 
beats/min at 5-min intervals up to 160 beats/min and 
hemodynamic measurements were repeated at the end 
of each 5-min interval. 
Chemical analysis of myocardial biopsies. After the 
last set of hemodynamic measurements were obtained 
at 160 beats/min, atrial pacing was discontinued and 
the hearts were excised and immediately cooled on ice. 
The posterior wall of the left ventricle was excised and 
a homogenate was prepared in buffer from which heart 
sarcolemma membranes were isolated from four ani-
mals (two male, two female) of each group (8, 22). The 
procedures for phospholipid hydrolysis, production of 
fatty acid methyl esters, extraction of methyl esters 
and their gas chromatographic separation have been 
described (8, 23, 24). 
Morphological examination. Aliquots of heart and 
liver were fixed in 10% Formalin. The tissues were 
routinely processed, embedded in paraffin, cut at 7 fJ.m 
thickness and stained with hematoxylin and eosin, al-
cian blue, periodic acid Schiff with and without dias-
tase digestion and with different connective tissue stains 
(8, 25). 
Medication. Drugs other than those described in the 
Materials and Methods section were not administered 
during the 16-wk dietary period. 
Sta.tistical analysis. The values at different time points 
were compared with analysis of variance. The differ-
ences between the two dietary regimens groups were 
evaluated by Student's t-test. Statistical significance 
was accepted at P < 0.05 (two-tailed). All data have 
been expressed as mean ± SEM. 
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RESULTS 
Performance of the pigs during the 16-wk dietary pe-
riod. After 16 wk the weight was 50 ± 2 kg in 1 (initial 
weight 7.7± 0~2kg) and46 ± 2kginML (initial weight 
8.1 ± 0.2 kg). Anemia, one of the signs of vitamin E 
deficiency, was not observed. At the end of the dietary 
period hemoglobin was 10.2 ± 0.3 nimol in 1 (initial 
value 10.6 ± 0.3 =ol) and 9.5 ± 0.4 =ol in ML 
(initial value 10.6 ± 0.2 =ol). 
Plasma lipid levels during the dietary period. Plasma 
triglyceride and total and HD1 cholesterol levels did 
not change in 1 during the 16-wk dietary period (Fig. 
2). In M1 plasma triglycerides decreased to 51 ± 8% 
of the initial value after 16 wk; most of the change (to 
69 ± 9% of initial value) occurred, however, in the first 
4 wk. Total cholesterol decreased to 79 ± 5% of the 
initial value during the first 8 wk, but did not decrease 
further during the following 8 w k ( 81 ± 8% after 16 
wk). Although the animals were divided randomly, the 
predietary HD1 cholesterol levels in ML were lower 
than those in 1, but significant changes did not occur 
in either group during the dietary period. Thus, in spite 
of the higher cholesterol content in the mackerel oil 
diet (which is still very low, Table 1), a marked reduc-
tion in plasma cholesterol occurred in ML. There were 
no noticeable sex-related differences in plasma choles-
terol, triglyceride and HD1 cholesterol. In addition, the 
plasma lipid responses to the diets were equal when 
the animals were grouped according to their sex (not 
shown). 
Postprandial plasma lipid and glucose levels at the 
end of the dietary period. The postprandial responses 
of plasma triglyceride, total cholesterol and glucose were 
determined at the end of the dietary period (Fig. 3). 
Because the response of the triglyceride levels in L was 
highly variable in time, no conclusion about a differ-
ence in response compared with M1 can be drawn. The 
data demonstrate that the rate of fat resorption of the 
two dietary groups was about the same. Postprandial 
plasma total cholesterol did not change in 1 but started 
to increase in ML 4 h after the feeding period. This late 
rise in total cholesterol could be due to the higher cho-
lesterol content in the diets of ML [0.02 and 0.01% (wt/ 
wt) for M1 and 1, respectively; see Table 1]. Plasma 
glucose levels of 1 were already increased l h after 
ingestion of the meal, whereas it took 2 h in ML (Fig. 
3). This small difference cannot be explained by changes 
in insulin because 1 insulin rose from preprandial val-
ues of 4.0 ± 0.7 to 31.7 ± 3.4 mu/1 and ML insulin 
rose from 6.5 ± 1.2 to 39.6 ± 9. 7 mu/1 h postpran-
dially. These data do not support a decreased insulin 
receptor sensitivity caused by mackerel oil feeding as 
postulated in a previous study (8). 
Fatty acid composition of cardiac membrane phos-
pholipids after the 16-wk dietary period. Although the 
polyunsaturated-saturated fatty acids ratio (P-S ratio) 
differed between the two diets (0.44 in 1 and 0. 78 in 
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FIGURE 2 Plasma lipid levels of the Yorkshire pigs dur-
ing the 16-wk experimental period. * P < 0.05 vs. initial value; 
tP < 0.05 vs. 9% lard fat diet group; *p < 0.05 vs. 4 wk value. 
Data are presented as mean ± SEM. 
ML), the P-S ratio of cardiac sarcole=a phospholipids 
was similar for both groups of animals: 1.15 ± 0.07 for 
1 and 1.06 ± 0.02 for M1. However, the distribution 
of the n-6 and n-3 PUFAs was markedly different (Fig. 
4). The n-6:n-3 fatty acid ratio was ll.8 ± 1.3 for 1 and 
1.02 ± 0.08 for ML (P < 0.05). As can be seen from Fig. 
4, l8:2n-6 and 20:4n-6 were partially exchanged for 
20:5n-3 and 22:6n-3. This implies that fish oil nutrition 
caused a large increase in the double bond index (mean 
number of double bonds per mole fatty acid): 1.65 ± 
0.03 for 1 and 1.94 ± 0.04 for ML (P < 0.05). 
The 20:3n-9 was not found in the cardiac phospho-
lipids, which indicates that the l8:2n-6 content of the 
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FIGURE 3 Postprandial responses of plasma levels of 
triglyceride, total cholesterol and glucose at the end of the 
16-wk experimental period. p = preprandial value; • P < 0.05 
vs. preprandial value; t P < 0.05 vs. 9% lard fat diet group. 
Data are presented as mean ± SEM. 
diets (Table 2) was sufficient to prevent essential fatty 
acid deficiency (26). 
Cardiovascular performance after the 16-wk dietary 
period. Under baseline conditions the heart rate was 
significantly higher (29%) in ML than in L (Table 3), 
but no differences were found in mean arterial blood 
pressure, left ventricular filling pressure, cardiac out-
put, max LV dP /dt, coronary blood flow, myocardial work, 
myocardial 0 2 consumption, systolic wall thickening 
and total systemic vascular resistance (Table 3). There 
were also no metabolic differences as the arterial-cor-
onary venous pH differences were 0.06 ± 0.02 inLand 
0.06 ± 0.02 in ML. The material-coronary venous Pco2 
differences were 13.3 ± 1.5 mmHg and 11.1 ± 1.3 
mmHg, respectively, in L and ML. 
Stress on the heart created by raising its rate gradu-
ally to 160 beats/min caused similar responses in cor-
responding cardiovascular variables in the two groups 
and, therefore, only the data obtained at 160 beats/min 
are presented (Table 3). Despite the higher heart rate, 
coronary blood flow was not increased during pacing 
at a rate of 160 beats/min. However, it is noteworthy 
that coronary blood flow increased by 18 ± 9% in L 
and 20 ± 9%in ML over its baseline value when the 
hearts were stimulated at 140 beats/min, but started 
to decrease when the heart rate was further raised to 
160 beats/min. The data do not point toward any in-
sufficiency of cardiac function. The arterial-coronary 
venous differences in pH and Pco2 were not affected 
by the pacing stress test (not shown). 
Morphological examination of heart and liver biop-
sies. Macroscopic evaluation revealed no cardiac hy-
pertrophy or liver enlargement after mackerel oil feed-
ing. Microscopic examination did not provide any 
evidence for cardiac or hepatic lipidosis and fibrosis. 
DISCUSSION 
Anemia, cardiac and hepatic lipidosis or fibrosis have 
been reported in pigs fed for 4 wk with a diet containing 
0.2 g 20:5n-3/(kg body weight· d) (27). However, no such 
effects were observed with higher doses [0.6 g 20:5n-3/ 
(kg body weight-d)] for 8 wk (8) or 0.3 g 20:5n-3/(kg 
body weight· d) for 16 wk (present study). Our animals 
also showed normal and identical growth patterns. The 
presence of adequate doses of natural antioxidants (vi-
tamin E and selenium) in the diet used in our experi-
ments explains the above difference. 
After a rapid decrease during the first 4 wk, plasma 
triglyceride levels in ML decreased linearly at a slower 
rate during the next 12 wk. Plasma cholesterol also 
initially decreased but remained constant after 8 wk. 
Therefore, we concl].lde that ML feeding decreased both 
plasma triglyceride and cholesterol levels during the 
first 8 wk of the dietary period. It is noteworthy that 
with this diet, which contained less eicosapentanoic 
acid [20:5n-3 intake of 0.3 g/(kg body weight-d)] than 
in our previous study [(20:5n-3 intake of 0.6 g/(kg body 
weight· d), see ref. 8], the decrease in plasma triglyceride 
(-35 ± 9 vs. -62 ± 6%) and total cholesterol (-21 
± 5 vs. -41 ± 4%) were also less after 8 wk. Feeding 
pigs 0.2 g 20:5n-3/(kg body weight·d) during a 4-wk 
period lowered plasma triglyceride levels by 44%, 
whereas plasma cholesterol was not affected (27). These 
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studies confirm other reports that dietary n-3 PUFAs 
affect plasma triglyceride levels to a larger extent than 
plasma cholesterol ( 1, 28-32). Another finding is that 
plasma HDL cholesterol in ML was not affected during 
the entire period (Fig. 2). Previously, we observed that 
plasma HDL cholesterol decreased from 1.06 ± 0.08 to 
0.55 ± 0.04 IDM in pigs fed with 0.6 g 20:5n-3 g/(kg 
body weight·d) for 8 wk (8). In the present study the 
initial HDL cholesterol was 0.88 ± 0.07 IDM. It is, 
therefore, highly unlikely that HDL cholesterol did not 
decrease in ML because of an initial low value. Some 
trials in humans and rats showed rises in HDL choles-
terol levels during fish oil consumption, but the levels 
may be more sensitive to the intake of 22:6n-3 than of 
20:5n-3 (28, 29). In most other studies using lower doses 
of fish oil no effect on HDL cholesterol was found, 
which is in agreement with our present findings(!). 
The change in membrane P-S ratio from 0.76 ± 0.06 
(see ref. 8) to 1.15 ± 0.07 between 8 and 16 wk of the 
9% (wt/wt) lard fat diet compares with our previous 
"study and is primarily due to the increase of the !8:2n-
6 content of cardiac membranes. This is in agreement 
with studies of Gudbjarru~son et al. in rats ( 13 ). In view 
of the changes in membrane phosphohpid composition 
(9-14), it is remarkable that 16 wk of 4.5% (wt/wt) 
mackerel oil consumption (ML) did not cause any dif-
TABLE3 
Cardiovascular par3D1eter in anesthetized Yorkshire pigs fed 9% lard fat or 4.5% mackerel oil :md 
4.5% lard fat diets for 16 wk, at baseline :md during atrial pacing at a rate of 160 beats/min' 
9% lard fat (n = 7) 4.5% mackerel oil + 4.5% lard fat (n = 7) 
Parameters Baseline Pacing Baseline Pacing 
HR, beats/min 94 ± 6 161 ± 1" 121 ± 10b 163 ± 1" 
MAP,=Hg 86 ± 3 80 ± 5 84 ± 6 81 ± 8 
LVEDP,=Hg 9.0 ± 1.0 8.8 ± 1.3 11.6 ± 0.4b 10.8 ± 0.6 
SV,mL 47 ± 4 30 ± 2" 33 ::t 2b 23 ± 3"b 
co, Llmin 4.4 ± 0.5 4.8 ± 0.3 3.9 ± 0.4 3.7 ± 0.5 
maxLVdP/dt, =Hg/s 1870 ± 310 1930 ± 250 2510 ± 570 2620 ± 560 
SVR, (mmHg·min)IL 21 ± 3 19 ± 1 22 ± 1 23 ± 2 
MW, I=Hg·L)Imin 381 ± 41 397 ± 31 339 ±56 310 ± 61 
CBF,mL/min 71 ± 6 70 ± 8 66 ± 9 63 ± 8 
CVR, I=Hg·min)fmL 1.27 ± 0.09 1.15 ± 0.09 1.44 ± 0.22 1.44 ± 0.26 
cv02-sat,% 18 ± 3 18 ± 2 22 ± 3 22 ± 3 
MVO, =ollmin 0.56 ± 0.06 0.56 ± 0.07 0.50 ± 0.08 0.50 ± 0.04 
SWT,% 34 ± 3 26 ± 4 29 ± 3 18 ± 5 
1Abbreviations: HR = heart rate, MAP = mean arterial blood pressure; L VEDP = left ventricular end-diastolic pressure; SV = stroke volume; 
CO = cardiac output; maxLVdP/dt =maximum rate of rise in left ventricular pressure; SVR = systemic vascular resistance (MAP/CO); MW 
= myocardial work (MAP x CO); CBF = coronary blood flow; CVR = coronary vascular resi~tance (MAP/CBF); cv02-sat = coronary venous 
0,. saturationi MV02 = myocardial oxygen consumption [hemoglobin X (arterial - coronary venous) 0 2-sat x CBF}; SWT = systolic wall 
thickening; •p < 0.05 vs. baseline; bp < 0.05 vs. 9% lard fat diet group. 
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ference in the cardiovascular parameters when com-
pared with L, except for a higher heart rate and sub-
sequent lower stroke volume in ML. When the heart 
was paced at a rate of 160 beats/min, no significant 
differences in cardiovascular performance due to diet 
were observed. It is premature to suggest that the dif-
ferences in baseline heart rate of the two groups were 
due to the differences in diets because the use of anes-
thesia may also be a contributing factor. Despite the 
differences in baseline heart rate between L and ML, 
which is an important determinant of the myocardial 
0 2 demand, no differences in coronary blood flow and 
myocardial 0 2 consumption were observed. At heart 
rates of 160 beats/min no increases in coronary blood 
flow and myocardial 0 2 consumption were found. Sim-
ilar observations during atrial pacing in dogs and pigs 
have been described (33-35). ln earlier studies carried 
out in pigs, atrial pacing at 160 beats/min and higher 
led to pulsus alternans and contracture of the left ven-
tricle, resulting in severe hemodynamic deterioration 
(34, 35).ln the present study cardiovascular dysfunction 
was not observed in either group during atrial pacing. 
ln su=ary, in conjunction with our previous study 
( 8) the results of our present investigation show that 
the addition of mackerel oil [4.5 and 9% (wt/wt)] to 
basal diets of pigs reduces both plasma triglyceride and 
cholesterol. HDL cholesterol, which decreases with a 
9% (wt/wt) mackerel oil diet, is not affected after intake 
of 4.5% (wt/wt) mackerel oil. Despite marked changes 
in fatty acid composition of cardiac membranes, car-
diovascular parameters, as well as their changes after 
atrial pacing, are not significantly different in animals 
fed with fish oil. This study in pigs indicates that the 
addition of eicosapentanoic acid to a typical Western 
diet lowers plasma lipid levels. Moderate amounts of 
dietary eicosapentanoic acid are required to lower plasma 
cholesterol, which is one of the major risk factors for 
coronary heart disease. Cardiovascular parameters were 
only minimally affected. Changes in cardiac parame-
ters induced by right atrial pacing were independent of 
the diets. 
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THE EFFECTS OF DIETS SUPPLEMENTED WITH LARD FAT 
OR MACKEREL OIL ON PLASMA LIPOPROTEIN LIPID 
CONCENTRATIONS IN DOMESTIC SWINE 
Pieter H.E. Groot 1)*, Johannes M. Hartog 2), Marie-Louise Dubelaar 1), Leo M. 
Scheek1 ), Pieter D. Verdouw 2) and Jos M.J. Lamers 1). 
1)Department of Biochemistry I, 2)Laboratory for Experimental Cardiology, Thorax-
center, Erasmus University Rotterdam, Rotterdam, The Netherlands. * Presently 
affiliated with Smith Kline and French Research Ltd, The Frynthe Welwyn AL6 
GAR U.K. 
Summary 
Levels of plasma lipoprotein were measured in overnight fasted pigs which were fed 
a diet containing either 21 energy % mackerel oil or 21 energy % lard fat for 8 
weeks. Lipoprotein fractionation was performed by density gradient ultracentri-
fugation or agarose gel chromatography. After 8 weeks levels of plasma triglyceride 
(-62%) and cholesterol (-55%) were lower in the mackerel oil than in the lard fat fed 
animals. In triglyceride the fall was exclusively in the VLDL fraction, while choleste-
rol was reduced in all lipoprotein fractions (VLDL, IDL, LDL and HDL). These 
results support the hypothesis that regular intake of fish oil reduces VLDL 
secretion. 
Introduction 
Studies in man and animal have revealed diverse effects of n-3 polyunsaturated fatty 
acids on plasma lipid composition [1-9]. Considerable evidence has been presented 
that these fatty acids reduce levels of plasma cholesterol and triacylglycerol, but the 
effect on levels of plasma cholesterol is not always evident (see refs. 6 and 7). HDL-
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cholesterol has been shown to decrease, not to change as well as to increase. The 
discrepancies can probably be explained by differences in species, the kind of dietary 
treatment and the quantitity of n-3 fatty acids consumed [6, 7]. Moreover, some of 
the used fish oil extracts contain relatively high amounts of cholesterol. 
In the present study the pigs received a basal fat-poor diet to which either a 
purified mackerel oil extract, containing 30% n-3 fatty acids, or lard fat was added. 
The fish oil extract contained only very low amounts of vitamins A and D and 
cholesterol. We used pigs because in these animals, similar to man but in contrast to 
rats, LDL is a prominent cholesterol carrying lipoprotein [10]. Furthermore, we 
have shown that the changes in the levels of triglyceride, total cholesterol and HDL 
cholesterol are minimal with 8 weeks of lard feeding while the decreases in total 
cholesterol and HDL cholesterol by 21 energy% mackerel oil are evident [11]. We 
therefore determined the lipoprotein profiles only in samples collected after 8 weeks 
of the dietary period. 
Methods 
Twenty four young Yorkshire piglets (7.9 ± 0.2 kg) of either sex were divided 
arbitrarily over two groups and housed individually in slat-bottomed cages in 
temperature-controlled animal quarters. The pigs were fed isocaloric diets (3830 
kCal/kg), consisting of 56 energy% (E%) carbohydrates, 18 E% proteins and 26 E% 
fat. The latter was composed of. a 5 E% basis to which either 21 E% lard fat (Gebro 
Smilde BV, Heerenveen, The Netherlands) or 21 E% mackerel oil (AS Johan 
Martens and Co, Bergen, Norway) was added. The composition of the two isocaloric 
diets are shown in Table 1. A small difference in cholesterol was noticed but because 
of the rather low amounts, no adjustment was made. The main difference was in the 
fatty acid composition (Table 2). The animals were fed initially 200 g of the diet 
daily. This was gradually increased gradually to 800 g daily over a period of 8 weeks. 
After these 8 weeks blood samples were drawn by puncturing the subclavian vein 
from the 24 hours fasted animals. Full details of the diets have been described 
earlier [11]. 
The lipoprotein fractions were separated by isopycnic density gradient ultracentri-
fugation. The plasma lipoproteins were also fractionated according to size by 2% 
agarose gel chromatography using Biogel A-50, 100-200 mesh Bio-Rad (Richmond 
Calif, USA), and a column of 90 x 1.6 em, operated at 4°C. Cholesterol and 
triglyceride were measured by enzymatic procedures using commercially available 
test kits (CHOD-PAP and GPO-PAP, Boehringer, Mannheim, FRG). 
For statistical evaluation of the differences between the 2 dietary groups analysis 
of variance was used. Statistical significance was accepted at p<0.05 (two-tailed). All 
data have been expressed as mean ± standard error of the mean (X ± SEM). 
Table 1 
Composition (g/100g) of the diets 
Lard fat 
corn (extruded) 
wheat (extruded) 
soybean meal 
wheat middlings 
dehydrated skimmed milk powder 
Dicalcium-phosphate 
CaCo3 
NaCI, iodinized 
MgO 
MgS04 
KH2P04.2H20 
Choline-chloride 50% 
Vitamin and trace element mixesa) 
lard fat 
mackerel oil 
mixed tocopherols 
cholesterol 
32 
18 
14 
9 
14 
1.3 
1.1 
0.3 
0.05 
0.05 
0.36 
0.18 
0.7 
9.1 
0.01 
0.01 
Mackerel oil 
32 
18 
14 
9 
14 
1.3 
1.1 
0.3 
0.05 
0.05 
0.36 
0.18 
0.7 
9.1 
0.01 
0.03 
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a) Vitamin and trace element mixes supply per 100 g food: Vitamin A 1400 IU; 
Vitamin D3 140 IU; Vitamin E 8 mg; Vitamin K3 0.2 mg; Vitamin B1, Thiamin 
hydrochlorid 1.8 mg; Vitamin B2, Riboflavin 1.8 mg; Vitamin B6, Pyridoxin HCl 
1.4 mg; Niacin 3.6 mg; Vitamin C coated 20 mg; d-Ca Pantothenate 3.6 mg; Folic 
acid 0.4 mg; Vitamin B12 0.004 mg; Biotin 0.1 mg; Inositol 4.5 mg; Iron 
subcarbonate (57% Fe) 9.1 mg; FeS04.H20 (30% Fe) 14 mg; Coppercarbonate (55% Cu) 2.3 mg; ZnO (78% Zn) 11 mg; MnO (62% Mn) 9.1 mg; Na-selenite 
(45% Se) 0.08 mg; Ca(I03)2 (65% I) 0.2 mg; CoCo3 (47% Co) 0.09 mg. 
Table 2 
Fatty acid composition (g/100g) of the diets 
14:0 
16:0 
16:1 
18:0 
18:1 
18:2 n-6 
18:3 
20:1 
20:5 n-3 
22:1 
22:6 n-3 
24:1 
others 
lard fat 
2 
24 
3 
10 
42 
15 
1 
1 
2 
mackerel oil 
7 
18 
8 
1 
17 
8 
1 
6 
17 
4 
9 
1 
3 
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Results 
In the mackerel oil fed animals (M) the levels of serum VLDL, LDL and HDL 
cholesterol were all approximately 50% and of IDL cholesterol only 25% of those in 
the lard fat fed animals (L) (Table 3). Levels of serum triglyceride were also only 
50% of those in L. The lower plasma triglyceride value in M was entirely due to the 
lower VLDL levels (40% of L) as IDL, LDL and HDL triglyceride did not differ in 
both groups. 
Table 3 
The effect of dietary n-3 fatty acids on serum lipoprotein lipid concentrations 
(determined by ultracentrifugation) of pigs after an 8 week dietary period 
Fraction 
Serum 
VLDL 
IDL 
LDL 
HDL 
Lard fat (n=12) 
-----------------------------------
triglyceride cholesterol 
JLg/ml JLg/ml 
139 ± 14 949 ± 24 
98 :t. 17 23 :t. 3 
2.9 :t. 1.2 16.3 :t. 4.0 
21 ± 4 436 :t. 42 
3.2 :t. 1.4 399 :t. 10 
Values are expressed as x :t. S.E.M. 
* p<0.05 versus Lard fat group. 
Mackerel oil (n=12) 
-------------------------------------
triglyceride cholesterol 
JLg/ml JLg/ml 
67 ± 7* 429 :t. 27* 
36 ± 7* 11 ± 2* 
1.6 ± 0.8 3.8 ± 0.7* 
26 ± 4 210 :t. 14* 
6.8 ± 2.7 181 :t. 13* 
Independently, in pooled plasma samples from four animals, the lipoproteins were 
fractionated in agarose columns. Elution profiles obtained by 2% agarose gel 
chromatography from 3 sets of experiments are shown in Fig. 1. Plasma cholesterol 
elutes in two major peaks representing LDL (left peak) and HDL (right peak) while 
VLDL is eluted just ahead of the LDL peak. The fish oil induced changes in 
cholesterol and triacylglycerol contents that were calculated from the peak areas 
agree with those measured after ultracentrifugal separation of VLDL, LDL and 
HDL (results not shown). 
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Figure L Lipoprotein 'triglyceride and cholesterol profiles in overnight fasted pigs 
after an 8 week dietary period,obtained by 2% agarose gel chromato-
graphy. The data shown are average values from three independent 
fractionation studies in pooled samples from four animals each. 
Discussion 
The increasing interest in the effects of n-3 fatty acids on the suppression and 
regression of atherosclerosis [6, 12, 14] and the use of pigs in atherosclerotic 
research [12, 14-18] led us to investigate the effect of n-3 rich fatty diets on serum 
lipoprotein lipids in domestic pigs. Pigs and man have in common that in both 
species LDL and HDL are important cholesterol carrying lipoproteins although the 
total mass of the lipoproteins in particular that of VLDL is somewhat lower in the 
pig than in man [10, 19]. 
In the present study we showed that after 8 weeks serum VLDL triglyceride as 
well as cholesterol present in VLDL, LDL and HDL were all more than 50% lower 
in the mackerel oil than in the lard fat fed pigs. These lower values are caused by a 
profound hypotriglyceridemic and hypocholesterolemic action of mackerel oil, 
rather than by a hyperlipidemic effect of the lard feeding. This conclusion is based 
on the earlier findings that under the same experimental conditions, dietary lard fat 
has only a minimal effect on plasma lipids of domestic pigs [11]. 
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A comparison with rats, in which LDL is only a minor fraction of the plasma 
lipoproteins, is of interest. Balasubramanian eta! [4] fed a fat-rich diets (30 E%) 
containing either coconut oil, sunflower oil or fish oil to rats. In that study fish oil 
induced a larger decrease ( 40%) in plasma cholesterol than coconut oil, but had 
similar to the present study no effect on the ratio of LDL and HDL cholesterol. As 
in rats, HDL is the prominent cholesterol-carrier in porcine plasma [10, 19], the 
decrease in cholesterol is to a large extent caused by the decrease in HDL. It should 
be noted, however, that feeding pigs a diet with a lower mackerel oil content (4.5% 
wt/wt) reduces total cholesterol but does not affect HDL cholesterol, thereby 
decreasing the ratio of LDL and 2HDL cholesterol [20]. 
Fish oil exerts in man a larger effect on plasma VLDL triglyceride than on LDL 
triglyceride [3, 5-7, 21-24]. The same pattern was seen in the present study. Levels of 
HDL triglyceride in man have been reported not to change [3], but most reports 
describe a decrease after a fish oil diet (22-29]. In the present study HDL triglyceride 
was not significantly affected but it tended to increase rather than decrease. 
N-3 polyunsaturated fatty acids decrease the synthesis of VLDL probably due to 
decreased lipogenesis and increased oxidation of fatty acids [19, 25-28]. Less LDL 
was secreted from the perfused livers of EPA-fed rats [26]. The suppression of 
triacylglycerol synthesis of rat hepatocytes in culture by EPA may be caused partially 
by the inhibition of diacylglycerol acyltransferase [27]. This is, however, not 
supported by the results of another study in which the effect of fish oil-enriched diet 
on changes rat liver enzyme activities was investigated [28]. The hypotriglyceridemic 
action of fish oil may also be· related to a stimulation of the peroxisomal beta-
oxidation activity in the liver [29]. The reduced levels of plasma VLDL triglyceride 
are not caused by a higher lipolytic breakdown by lipoprotein lipase and hepatic 
lipase [30]. As LDL is a metabolic product of VLDL catabolism and surface 
fragments of VLDL may be used to assemble plasma HDL [24], secondary effects of 
fish oil-rich diets on LDL and HDL synthesis and plasma concentration can be 
expected. Our data in pigs are in line with these findings. 
In conclusion, the results of the present study performed in domestic pigs support 
the hypothesis of a primary reduction of VLDL secretion by dietary fish oil. This is 
probably followed by secondary changes in the cholesterol content of IDL, LDL and 
HDL fractions. 
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CHAPTER 7 
The influence of fish oil diet and norepinephrine treatment on 
fatty add composition of rat heart phospholipids and the 
positional fatty add distribution in phosphatidylethanolamine 
A. Montfoorta), L. van der Werfb), J. M. Hartogb), P. G. Hugenholtzb), P. D. Verdouwb), 
W. C. Hlilsmann c), and J. M. J. Lamers c) 
a) Department of Pathology I, b) Department of Experimental Cardiology and 
c) Department of Biochemistry I 
Medical Faculty, Erasmus University Rotterdam, Rotterdam (The Netherlands) 
Summary: The effect of chronic norepinephrine (NE) administration with increasing dosage from 
1-4 mg/kg over a period of 2 weeks was studied on cardiac phospholipids and their fatty acid 
distribution in rats. Animals were fed a control diet or a 10% cod liver oil (CLO)-enriched diet. The 
relative distribution ·of various polyunsaturated fatty acids esterified to the 1- and 2-position of the 
phosphatidylethanolamine fraction was estimated. NE stress during control feeding significantly 
reduced the total phospholipid content in rat heart. No differences in the phospholipid class distribution 
were found. However, CLO feeding as well as chronic NE administration resulted in a decrease of w 6 
fatty acids, mainly C 18:2 w 6 and C 20:4 w 6, which was compensated with an increase in w 3 fatty 
acids, mainly C 20:5 w 3 and C 22:6 w 3. The changes in fatty acid composition qualitatively agree with 
those reported by Gudbjarnason et al. (23), except that the mortality in our NE-treated control or CLO-
fed groups was considerably lower. It can probably be attributed to a different mode ofNE administra-
tion. On the other hand, at the end of the CLO feeding period in rats treated with NE or not, comparing 
with control fed rats without NE treatment, the incidence rate of ST segment elevation in electrocar-
diogram (ECG) recorded under light diethylether-induced anesthesia was higher. Independent of 
whether the fatty acid composition of myocardial phospholipids was dietary or pharmacologically 
manipulated, most of the polyunsaturated fatty acids were found at the 2-position of the phosphatidyl-
ethanolamine molecules. The polyunsaturated fatty acids account for 45-50% of the fatty acyl residues 
and preferentially occupy the 2-position, where they can exchange for each other. 
Key words: phospholipids, fish oil diet, catecholamines, polyunsaturated fatty acids, positional fatty 
acid distribution 
Introduction 
Disturbances in phospholipid metabolism and subsequent changes in membrane function 
have been implicated in the development of irreversible cell injury during both chronic 
catecholamine treatment and myocardial ischemia (7, 8, 22, 25, 27, 31, 50, 51, 53). 
Accelerated phospholipid degradation is generally thought to result from activation of 
endogenous membrane-bound phospholipase A2 . During ischemia but also during beta-
adrenergic overstimulation of the heart, increased levels of intracellular Ca2+ very likely 
occur. That phospholipase A2 activation is dependent on Ca2+ ions has repeatedly been 
demonstrated (4, 5, 49). One of the lysophospholipid products can either be reacylated to 
form newly synthesized phospholipid molecules or can be further degraded by the activity of 
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lysophospholipase. In normal heart the concentrations of these phospholipid breakdown 
products are extremely low because lysophospholipids as well as free polyunsaturated fatty 
acids are detergent-like compounds which at higher concentration can be harmful for 
membrane functions (27, 31, 53, 56). Membrane phospholipid products indeed have been 
implicated in the development of cardiac arrhythmias and the pathogenesis of myocardial 
ischemia (27, 28, 34, 42, 53). Also changes in the phospholipid fatty acid composition due to 
dietary or hormonal manipulation can give rise to alterations in properties of cardiac 
membranes, e.g. the fluidity and ion permeability (1, 9, 33, 34, 43). Furthermore it can have 
implications for enzyme and transport protein properties (27) and thereby for the regulation 
of transmembrane Ca2+-, Na+- and K+ ion gradients. Therefore, it is important to know to 
what extent heart membrane phospholipids are modified due to changes in external factors 
like diet, stress or age (2, 23, 37). 
Cardiac phospholipids, particularly the phosphatidylethanolamine component, are 
characterized by their high content of polyunsaturated fatty acids (13, 29, 30, 38). Bang et al. 
(3) suggested that the low incidence of ischemic heart disease in Greenlandic Eskimos is 
linked to the high daily intake of polyunsaturated fatty acids (e.g. eicosapentanoic acid, 
C 20:5 CD 3 and docosahexaenoic acid C 22:6 CD 3) through feeding with fish and marine oils. 
Diets rich in CD 3 fatty acids derived from fish oils have been demonstrated to lower the 
plasma concentrations of low density and very low density lipoproteins (35), cholesterol as 
well as triglyceride content (35, 46) and to affect platelet reactivity (6, 21, 24, 26, 40, 45, 47). 
These hypolipidemic and anti thrombotic effects of fish oil diet may offer the explanation for 
their beneficial effects in ischemic heart disease. Diets rich in CD 3 fatty acids also influence 
the biosynthesis of CD 6 fatty acids and supplementation of diets with menhaden oil (rich in 
C 20:5 CD 3 and C 22:6 CD 3) have been demonstrated to depress the A 6 desaturase activity 
in rats resulting in a diminished synthesis of C 20:4 CD 6 and C 22:4 CD 6 from C 18:2 CD 6 (44). 
On the other hand, it has .been reported that unsaturation of the fatty acids in heart cell 
membranes may enhance lipid peroxidation. This unfavorable effect of fish oil diet which 
could occur especially at low vitamin E content of the diet may result in the accumulation of 
lipofuscin (39) and a disturbance of the membrane integrity producing metabolic and 
functional abnormalities in the heart. Stress has been found to stimulate myocardial lipid 
peroxidation (2, 37) and impair the contractile function of the myocardium. Therefore it is 
interesting to note that the stress tolerance of rats is decreased under the influence of dietary 
cod liver oil (CLO) (23). In rats subjected to catecholamine stress for two weeks heart 
phospholipid fatty acid components undergo replacement of linoleic acid (C 18:2 CD 6) by 
docosahexaenoic acid (C 22:6 CD 3) and this is similar to the response seen after CLO diet or 
at increasing age (13, 14). Apparently, a large increase in polyene fatty acid content of 
membrane phospholipids influences the sensitivity of rats to catecholamine-induced necrosis 
(13, 14, 23). As noted before, increased phospholipase A2 activity is a factor in 
catecholamine-induced myocardial necrosis (27, 42). Thus it is interesting to know the 
relative 1- and 2-position of polyene fatty acids in phospholipids under influence of a dietary 
change. We therefore analysed the phospholipid composition and fatty acid distribution of 
the major phospholipids in rats receiving either a control or CLO diet without and after 
chronic treatment with norepinephrine (NE). The positional fatty acid distribution of 
phosphatidylethanolamine was determined by stepwise hydrolysis of the phospholipid 
component of the heart in either group of rats. In the work of Emilsson and Gudbjarnason 
(14) no indication was given of the cause of death of the rats under the influence of CLO diet 
or NE treatment. Another recent study, however, suggested correlation between 
catecholamine and lipidperoxidation-induced damage in heart cells (41). Therefore in the 
present work attention was paid to possible abnorrrJ.alities in the electrocardiogram (ECG) 
pattern at the end of the nutritional and catecholamine treatment periods. 
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Materials and methods 
Animal treatment 
Normal Wistar rats of either sex were used. 33 adult rats (2 months old) were divided into 2 groups, 
17 animals received a 10% CLO diet supplied by Unilever, Vlaardingen, The Netherlands, whereas 16 
animals were fed with a control diet (standard laboratory food, from Hope Farms, Woerden, The 
Netherlands) for 6 weeks. No difference existed between vitamin E content of control and CLO diet. 
Water and food were supplied ad libitum. The diets had the following mean fatty acid composition: 
Control diet: 14°+, 16° 21.6%,161 w 9 2.2%, 18° 3.5%, 181 w 9 26.5%,182 w 6 39.3%, 183 w 3 
4.5 %, 22° 0.5 %, 204 w 6 0.6 %, others 1.3 %. 
CLO diet: 14° 7.2 %, 16° 15.7 %, 161 w 9 9.0%, 18° 3.1 %, 181 w 9 16.8 %, 182 w 6 1.5 %, 183 w 3 
0.8%, 184 1.5%, 201 5.1%,204 (I) 6 4.8%, 205 (I) 3 13.7%, 224 (I) 6 0.6%, 225 (I) 3 2.7%, 226 (I) 3 
11.0%, others 6.5%. · 
Eight animals with control diet and 9 animals with CLO diet after 6 weeks were daily injected with 
NE over a period of 2 weeks. NE was suspended by sonication in polyethylene glycol (PEG 400). The 
other animals received only PEG 400. The NE dosage increased from 1 mg/kg during the first 3 days to 
4 mg/kg during the last 3 days, which was achieved by increasing the dosage with 1 mg/kg every 4th day 
(23). The feeding of rats with the two different diets was continued during the daily control or NE 
injections. 
Phospholipid analyses 
The lipids were extracted from the heart according to the method of Folch (17) with 19 volumes of a 
mixture of chloroform-methanol (2:1, by volume). Two dimensional separation of the phospholipid 
classes and phosphorus analysis was carried out as described before (38). The total phospholipids were 
separated from the other lipids by thin layer chromatography. The developing system was a mixture of 
hexane-ether (70:30 v/v). The plates were first washed with the same mixture and activated at 110 oc 
during 30 min. Phosphatidylcholine and phosphatidylethanolamine were separated from other phos-
pholipids by thin layer chromatography using a solvent mixture of chloroform-methanol-4N NH40H 
(65:35:4, by volume) after the same washing procedure as described before (38). Phospholipase A2 
degradation with snake venom from Crotalis Adamanteus was used to determine the fatty acid 
composition at the 1- and 2-position of the phosphatidylethanolamine fraction by gaschromatography as 
described before (38). After separation of the phospholipids (total, phosphatidylcholine or phos-
phatidylethanolarnine fraction) and the breakdown products of phospholipase A2 degradation (free 
fatty acids and lysophosphatidylethanolarnine) 15 ml of methanolic HCL containing 2.6% HCL (w/v) 
were added and the mixture was heated for 2 h at 70 °C. A nitrogen atmosphere was used to prevent 
oxidation. The methylesters of the fatty acids were extracted with three portions of pentane, after 
adding 15 ml of water. The combined extracts were dried over anhydrous Na2S04 and after concentra-
tion applied on a Carlo Erba gaschromatograph (4160 series) equipped with a 50 m capillary column 
(0.32 mm diameter, 0.2 [.liD thick stationary phase CPS1L88) and temperature programming 
(70-200 °C). 
Determination of ECG pattern 
At the end of the experimental periods (after 8 weeks, including the 2 final weeks of daily control or 
NE injections in which the control or CLO diets were continued) light anesthesia was induced by 
diethylether and peripheral ECG was recorded, after which the animals were sacrificed. Heart rates 
were calculated and special attention was paid to changes in the ST segment. ST elevation was defined 
as an elevation higher than 0.1 mV. 
Statistical analysis 
Where possible, the results were expressed as mean ± S.E.M. Different groups of rats were 
compared with each other using the t-test. 
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Results 
NE administration 
Initial experiments demonstrated that catecholamines dissolved in 0.9% NaCl solution 
and given subcutaneously already at the lowest concentration (1 mg/kg) resulted in a 100% 
mortality which is higher than the 50% observed by Emilsson and Gudbjarnason (14) after 
the same mode of administration. The differences in the sensitivity for stress hormones 
between various strains of rats could represent one explanation. Nevertheless in subsequent 
experiments we administered subcutaneously NE suspended in PEG 400 to decrease the rate 
of plasma uptake. Mortalities: 10% in the control fed plus NE injected group (1 out of 10) 
and 22% in the. CLO fed plus NE injected group (2 out of 9). The low incidence of death 
in the NE injected animals does not allow to draw conclusions as to whether CLO nutrition 
increased the mortality. It should also be noted that when the animals were sacrificed (after 
14 days NE treatment), the extreme changes in polyene fatty acid content of phospholipid as 
described by Gudbjarnason et al. (13, 14, 23) were already obvious (see later). 
Phospholipid content and composition 
Differences in the total amount of cardiac phospholipids were found between the 
respective groups of rats (Table 1). The total phospholipid content was lower, although not 
Table 1. The phospholipid content (mean ± SEM) of rat heart after dietary and/or beta-adrenergic 
treatment. 
Diet Injected Number of animals Phospholipid content 
(f.!.moles/g) 
Control Solvent 8 40.6 ± 1.6 
Control NE 8 34.9 ± 2.1 *) 
CLO Solvent 7 33.6 ± 3.3 
CLO NE 7 30.7 ± 2.2*) 
*) p < 0.05 with control fed, solvent injected animals 
Table 2. Percentual distribution of the major phospholipid classes in rat hearts*). 
Control fed rats CLO fed rats 
Solvent NE injected Solvent NE injected 
injected injected 
Lysolecithin 1.3 1.4 1.1 1.2 
Sphingomyelin 4.4 5.2 3.4 4.8 
Phosphatidylinositol 4.3 3.8 3.7 4.7 
Phosphatidylserine 1.5 1.8 1.5 2.4 
Phosphatidylcholine 42.4 41.5 39.8 41.9 
Phosphatidylethanolamine 26.7 31.1 31.8 28.8 
Cardiolipin 14.4 10.4 11.3 13.0 
(Mag)2P 1.9 1.2 0.6 0.5 
Others 3.1 3.5 6.9 2.7 
*) results are the means of 4 determinations of combined phospholipid fractions extracted from 
hearts of the animal groups mentioned in Table 1. (Mag)2P is an abbreviation for: bis-(monoacylgly-
ceryl)phosphate 
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significantly, in the CLO fed animals. A significant decrease (p < 0.05) in the total 
phospholipids per gram wet weight was found upon beta-adrenergic treatment of control 
rats. A similar but non-significant decrease was found upon NE treatment of CLO rats. It is 
known that a high dose of catecholamines causes an increase of the influx of Ca2+ into and 
deposition in myocardial cells, the release of FF A by enhanced lipolysis (27, 36), stimulation 
of phospholipase A 2 activity causing breakdown of the phospholipids ( 48) and preferentially 
those which are rich in polyunsaturated fatty acids. It is possible that in addition to changes 
in total phospholipid content a specific class of phospholipids is affected by catecholamine 
treatment. Therefore we analysed the phospholipid class distribution to see whether the 
decrease in the total phospholipids was preferent for a particular phospholipid fraction. 
Combination of the extracted lipid fractions from hearts of animal groups indicated in 
Table 1 was required to obtain sufficient material for thin layer chromatography and 
phosphorus determination. The mean values for the different phospholipid classes in the 
different groups are presented in Table 2. 
The phospholipid class composition agrees well with earlier data obtained with nit hearts 
by us and by others (29, 38, 52). No dramatic changes were seen after NE treatment which 
suggests that the distribution of specific classes is not affected by NE treatment. 
Percentual distribution of fatty acids in cardiac phospholipids 
Changes in the percentual distribution of the fatty acids in cardiac phospholipids induced 
by diet and stress are presented in Table 3. Chronic administration of beta-adrenergic 
Table 3. Percentual distribution of the fatty acids in the total phospholipids in rat heart after dietary and/ 
or beta-adrenergic treatment*). 
Fatty acids 
DMA 16:0 
16:0 
DMA 18:0 
18:0 
18:1 OJ 9 
18:2 OJ 6 
22:0 
20:4 OJ 6 
20:5 OJ 3 
22:4 OJ 6 
24:1 
22:5 OJ 3 
22:6 OJ.3 
*)mean± SEM 
Control fed rats 
Solvent NE injected 
injected (n = 8) 
(n = 8) 
+ + 
13.2 ± 0.4 13.8 ± 0.6 
+ + 
14.0 ± 2.0 14.4 ± 1.9 
5.9 ± 0.8 7.0 ± 0.5 
25.0 ± 1.3 18.9 ± 1.0") 
0.8 ± 0.3 0.9 ± 0.5 
25.0 ± 1.1 25.7 ± 1.6 
0.0 ± 0.0 0.8 ± 0.5 
+ + 
1.5 ± 0.6 1.1 ± 0.4 
2.6 ± 0.4 2.3 ± 0.2 
11.9 ± 0.9 15.0 ± 0.6b) 
CLO fed rats 
Solvent NE injected 
injected (n = 7) 
(n = 7) 
+ + 
15.0 ± 0.9 13.6 ± 1.0 
+ + 
15.0 ± 1.7 12.7 ± 2.0 
7.3 ± 0.7 7.9 ± 0.6 
11.2 ± 0.9c) 9.4 ± 0.4d) 
0.4 ± 0.2 1.4 ± 1.1 
19.0 ± 0.9c) 21.2 ± 0.8 
4.8 ± 0.2c) 3.7 ± 0.5d) 
+ + 
1.4 ± 0.4 1.5 ± 0.5 
2.8 ± 0.1 3.3 ± 0.4 
23.2 ± 0.6c) 25.4 ± 0.6d) 
"), b) refer to significance of differences between column "control + solvent" vs. "control + NE" 
(a, p < 0.01; b, p < 0.05) 
c) refers to significance of differences between column "control + solvent" vs. "CLO + solvent" 
(c, p < 0.001) 
d) refers to significance of differences between column "CLO + solvent" vs. "CLO + NE" 
(d, p < 0.05) 
DMA = dimethylated acetals 
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amines probably leads to less extreme changes in the fatty acid patterns of CLO fed rats with 
respect to changes in the C 22:6 w 3 content. A 10% CLO diet for 8 weeks resulted in a 
substantial replacement of w 6 fatty acids, e.g. C 18:2 w 6 and C 20:4 w 6 by w 3 fatty acids, 
particularly C 20:5 w 3, C 22:5 w 3 and C 22:6 w 3 as was also described by other 
investigators (13, 22, 23, 26, 44). These changes are very similar to those induced by 
catecholamine stress except for C 20:4 w 6, which is reduced in the case of CLO feeding, but 
hardly under the influence of stress hormones. The percentual distribution of the saturated 
fatty acids and the monounsaturated fatty acids was rather constant in all experiments. 
The percentual distribution of the polyunsaturated fatty acids has the tendency to change 
more after CLO feeding than after NE treatment, although the most extreme values are 
reached when both treatments are combined (Table 3). In view of previously reported 
plateau levels of docosahexaenoic acid of heart phospholipids in aging rats (23), it is not 
surprising to find that the C 22:6 w 3 content of the phospholipids in CLO hearts was hardly 
increased further by NE treatment. A maximum percentage of docosahexaenoic acid 
(25.4% in the total phospholipids of the CLO + NE group compared to 11.9% in the 
control group and 37.5% versus 21.0% in phosphatidylethanolamine) is probably reached. 
Norepinephrine stress hovever, gave a significant further reduction in linoleic acid in CLO 
hearts when the animals were subjected to catecholamine stress (Table 3). Despite a very 
low mortality rate, the extreme changes in polyene fatty acid content in total heart 
phospholipid as previously described by Gudbjamason et aL (23), were found. 
Fatty acid composition in phosphatidylcholine and phosphatidylethanolamine 
As can be seen from Table 4, a CLO diet induces in phosphatidy!choline a significant 
decrease in linoleic acid and arachidonic acid, both w 6 fatty acids. This is compensated by 
an increase in w 3 fatty acids, e.g. eicosapentaenoic acid and docosahexaenoic acid. Linoleic 
acid was reduced by 63 % and arachidonic acid by 17 % respectively. The relative increase of 
docosapentaenoic acid was 28 % and docosahexaenoic acid even increased to 129 %. In 
phosphatidylcholine from rat heart on a CLO diet eicosapentaenoic acid was found to 
represent a quite substantial part of the bound fatty acids (5.0% ). Consequently it can be 
calculated from these results that the relative sum of w 3 + w 6 fatty acids in the 
phosphatidyl choline molecule is rather constant and so is the saturated/polyunsaturated 
ratio of the component phospholipid. It is also remarkable that oleic acid (C 18:1 w 9) did 
not change very much in its relative amount. The polyunsaturated fatty acids account for 
about 45 % of the fatty acids independent of the diet or beta-adrenergic treatment. 
Therefore it is reasonable to assume that the w 6 fatty acids in phosphatidylcholine are 
replaced by w 3 fatty acids. NE stress had no effect on the arachidonic acid content of 
phosphatidylcholine in the hearts of the animals receiving a control diet (Table 4). Emilsson 
and Gudbjamason (14) reported an increase in their experiments. Linoleic acid decreased 
significantly after daily NE administration. 
Docosahexaenoic acid in the total phospholipid as well as the phosphatidylethanolamine 
fraction was increased significantly by NE administration in the control fed rats (Tables 3 
and 5). The differences in effect of NE stress on the arachidonic acid content of phos-
phatidylcholine in the hearts of rats receiving a control diet as found by us and the data by 
Gudbjamason et aL (14) is probably related to the fact that these authors found lower 
arachidonic acid contents in the control fed rats (15% versus 29.4% in our experiments). 
The relative amount of 30 % of this fatty acid is probably already maximal prior to the 
dietary or the NE treatment of the rats. In the phosphatidy!choline fraction of hearts from 
rats receiving a CLO diet the C 18:2 w 6 content is already low ( 4.0 % ). Still norepinephrine 
stress reduces this fatty acid with 35 %. NE stress had no significant effect on the arachidonic 
acid content and the docosahexaenoic acid content in the CLO fed rats. 
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The changes in the fatty acid composition of phosphatidylethanolamine due to NE stress 
and a CLO diet are presented in Table 5. Linoleic acid is reduced with 53% and arachidonic 
acid with 51 %. Docosahexaenoic acid is increased from 21.0% to 34.5%. Like the shifts 
observed in the phosphatidylcholine fraction, there is a diet-induced increase in C 20:5 w 3 
in the phosphatidylethanolamine fraction. The saturated/unsaturated fatty acid ratio 
remains constant. The total amount of w 6 fatty acis in phosphatidylethanolamine decreases 
from 27.4% to 12.6% while there is a simultaneous increase in w 3 fatty acids from 25.4% 
to 40.9%. NE stress similarly affected the fatty acid distribution in phosphatidyl-
ethanolamine as caused by CLO nutrition, although to a less extent (Table 5). Hardly an 
effect is seen on the saturated and monounsaturated fatty acids. For the linoleic acid content 
the effect is less pronounced after NE treatment than after CLO nutrition. This holds 
especially for arachidonic acid which is only slightly reduced by norepinephrine. Also the 
percentage of docosahexaenoic acid is not raised to the same extent by stress as compared to 
the CLO diet. As a result of the CLO feeding linoleic acid is already low and docosahexa-
enoic acid very high in phosphatidylethanolarnine and can hardly be influenced by NE 
treatment. Perhaps this represents the reason that hardly no change is observed in these 
fatty acids. Compared with the data reported by Gudbjamason et al. (23) the changes in the 
fatty acid pattern due to CLO feeding are more pronounced and a relative concentration of 
22:6 w 3 in phosphatidylethanolarnine of34.5% is reached (Table 5). Linoleic acid was even 
found to be as low as 2.1 %. From the data can also be concluded that the cardiac 
Table 4. Changes in the fatty acid composition of phosphatidylocholine in heart tissue of rats after 
dietary and/or beta-adrenergic treatment*). 
Fatty acids 
DMA 16:0 
16:0 
DMA 18:0 
18:0 
18:1 (!) 9 
18:2 (!) 6 
22:0 
20:4 (!) 6 
20:5 (!) 3 
22:4 (!) 6 
24:1 
22:5 (!) 3 
22:6 (!) 3 
Control fed rats 
Solvent NE injected 
injected (n = 8) 
(n = 8) 
+ + 
17.5 ± 0.4 19.3 ± 0.3") 
+ + 
26.7 ± 0.9 25.9 ± 0.4 
5.6 ± 0.8 6.7 ± 0.6 
10.8 ± 0.4 6.6 ± 0.6b) 
0.5 ± 0.3 0.7 ± 0.3 
29.4 ± 0.8 29.5 ± 0.9 
0.2 ± 0.1 0.2 ± 0.1 
0.4 ± 0.2 + 
2.0 ± 0.3 2.3 ± 0.7 
2.1 ± 0.5 2.3 ± 0.3 
4.9 ± 0.6 6.6 ± 0.7 
CLO fed rats 
Solvent NE injected 
injected (n = 7) 
(n = 7) 
+ + 
19.5 ± 0.6c) 17.7 ± 0.8 
+ + 
25.6 ± 0.6 28.0 ± 0.7') 
5.9 ± 0.6 5.4 ± 0.5 
4.0 ± 0.4d) 2.6 ± 0.31) 
0.2 ± 0.1 1.0 ± 0.6 
24.2 ± 0.7d) 26.4 ± 0.9 
5.0 ± 0.4d) 3.3 ± 0.31) 
+ + 
1.7 ± 0.4 1.4 ± 0.3 
2.7 ± 0.1 2.6 ± 0.1 
11.2 ± 0.5d) 11.6 ± 0.4 
"), b) refer to significance of differences between column "control + solvent" vs. "c~ntrol + NE" 
(a, p < 0.01; b, p < 0.001) 
c), ct) refer to significance of differences between column "control + solvent" vs. "CLO + solvent" 
(c, p < 0.02; d, p < 0.001) 
'), 1) refer to significance of differences between column "control + solvent" vs. "CLO + NE" 
(e, p < 0.05; f, p < 0.01) 
*) mean ± SEM, DMA = dimethylated acetals 
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Table 5. Changes in the fatty acid composition fo phosphatidylethanolamine in heart tissue of rats after 
dietary and/or beta-adrenergic treatment*). 
Fatty acids 
DMA 16:0 
16:0 
DMA 18:0 
18:0 
18:1 (1) 9 
18:2 (1) 6 
22:0 
20:4 (1) 6 
20:5 (1) 3 
22:4 (1) 6 
24:1 
22:5 (1) 3 
22:6 (1) 3 
Como! fed rats 
Solvent NE injected 
injected (n = 8) 
(n = 8) 
4.5 ± 0.2 4.9 ± 0.2 
8.2 ± 0.2 9.9 ± 0.6") 
3.9 ± 0.2 4.1 ± 0.2 
23.8 ± 0.4 21.9 ± 0.8 
4.5 ± 0.3 3.7 ± 0.2') 
6.0 ± 0.5 2.8 ± 0.3b) 
0.2 ± 0.2 0.3 ± 0.1 
21.4 ± 1.2 19.0 ± 1.9 
0.7 ± 0.4 0.3 ± 0.1 
+ + 
2.2 ± 0.7 1.9 ± 0.3 
3.7 ± 0.4 3.2 ± 0.2 
21.0 ± 1.8 28.0 ± 1.7b) 
CLO fed rats 
Solvent NE injected 
injected (n = 7) 
(n = 7) 
4.5 ± 0.3 4.8 ± 0.2 
9.4 ± 0.2') 10.0 ± 0.2') 
2.6 ± 0.2d) 2.7 ± 0.2 
22.6 ± 0.5 22.1 ± 0.2 
3.9 ± 0.5 4.4 ± 0.7 
2.1 ± 0.2d) 1.4 ± 0.4f) 
0.4 ± 0.3 0.8 ± 0.1 
10.5 ± 0.3d) 8.9 ± 0.3r) 
3.1 ± 0.2d) 2.5 ± 0.2 
+ + 
3.1 ± 1.0 2.1 ± 0.7 
3.3 ± 0.1 2.8 ± 0.1 g) 
34.5 ± 0.9d) 37.5 ± 0.9e) 
'), b) refer to significance of differences between column "control + solvent" vs. "control + NE" 
(a, p < 0.02; b, p < 0.001) 
'),d) refers to significance of differences between column "control + solvent" vs. "CLO + solvent" 
(c, p < 0.01; d, p < 0.001) 
e), r), g) refers to significance of differences between column "CLO + solvent" vs. "CLO + NE" 
(c, p < 0.05; f, p < 0.01; g, p < 0.001) 
DMA = dimethylated acetals 
*)mean± SEM 
phospholipids from CLO fed rats are less sensitive to changes in their fatty acid patterns due 
to NE treatment than the cardiac phospholipids of control fed animals. 
Positional fatty acid distribution in phosphatidylethanolamine 
The fatty acid distribution on the 1- and 2-position of the phosphatidylethanolamine 
fraction was analyzed. As we had to deal with the determination of the phosphorus content 
of the different phospholipid components (see above), a combination of the extracted 
phosphatidylethanolamine fractions of hearts from a whole group of rats was required to 
obtain sufficient material for determination of the positional distribution of fatty acids. The 
results are presented in Table 6. As can be seen from this table the polyunsaturated fatty 
acids are almost exclusively located at the 2-position of the phospholipid molecule. Linoleic 
acid and docosahexaenoic acid are also found in small amounts at the 1-position. These 
results agree very well with former analyses described by us on the positional distribution of 
the fatty acids in phosphatidylethanolamine from rat heart (38). If the results are compared 
with similar analysis on heart phosphatidylethanolamine from control fed mice (38) which is 
especially rich in docosahexaenoic acid (39.5% ), no polyunsaturated fatty acids were found 
at the 1-position except for small amounts of C 18:2 w 6. In the present work it is 
demonstrated that an increase or decrease in (J) 3 and (J) 6 fatty acids either by dietary or 
pharmacological treatment does not lead to great alterations of the fatty acid distribution 
over the 1- and 2-position. 
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Table 6. Percentuai distribution fo the fatty acids at the 1- and 2-position of phosphatidyiethanoiamine 
in rat heart after dietary and/or beta-adrenergic treatment*). 
Fatty acids Control fed rats CLO fed rats 
Solvent NE injected Solvent NE injected 
injected injected 
1-pos 2-pos 1-pos 2-pos 1-pos 2-pos 1-pos 2-pos 
DMA 16:0 10.6 0.4 12.5 0.6 13.4 0.4 12.4 1.0 
16:0 18.9 4.6 18.9 4.9 21.5 5.4 22.3 5.4 
DMA 18:0 8.4 10.1 5.0 7.0 0.4 
18:0 49.1 5.7 40.2 7.9 46.4 7.6 40.9 6.6 
18:1 {1) 9 7.2 3.4 5.3 3.8 5.8 2.9 4.3 3.8 
18:2 {1) 6 2.7 9.7 0.5 5.3 0.9 2.1 1.9 1.6 
22:0 + 
20:4 {1) 6 0.9 41.1 4.2 32.0 0.8 14.6 1.0 16.3 
20:5 {1) 3 0.4 1.2 1.2 0.4 5.2 3.1 5.5 
22:5 {1) 3 0.5 5.1 2.7 6.3 5.2 5.0 
22:6 {1) 3 1.7 29.6 4.4 37.0 3.2 55.8 4.6 52.4 
others 1.0 2.6 0.8 2.5 2.0 
DMA is an abbreviation for: dimethyiated acetais; *) results are the means of 2 determinations of 
combined phospholipid fractions extracted from hearts of the animal groups mentioned in Table 1. 
ECG patterns 
In Table 7 the experimental groups are shown with the observed mean heart rates and 
incidence of ST segment elevation in the ECG pattern. The heart rates were not different in 
either group of rats. In the CLO diet group 86 % of the animals had ST elevation versus 
25% in the control diet group. It is possible that CLO feeding of rats makes their hearts 
more susceptible to ether anesthesia (without ventilatory assistance-induced ischemia). 
Measurements of ECG have not been carried out on conscious rats so that no definitive 
conclusions on this point can be made. The incidence of ST changes was also significantly 
higher in the CLO fed group treated with NE. This is not surprising if one considers 
previously described necrotic effects induced by excessive NE administration on rat heart 
(16, 42). However, it is important to note that NE treatment of CLO fed rats did not further 
aggravate electrocardiographic abnormalities. 
Table 7. Heart rates and occurrence of ST segment elevation in the ECG patterns of rats after dietary 
and/or beta-adrenergic treatment. 
Diet Injected Number Heart rate*) Incidence of 
of animals (min-1) ST-eievation (%) 
Control Solvent 8 373 ± 10 25 
Control NE 8 353 ± 11 50 
CLO Solvent 7 386 ± 15 86**) 
CLO NE 7 351 ± 11 86*-*) 
*)mean± SEM 
**) p < 0.05 with control fed, solvent injected animals. Statistical evaluation of these incidence rate 
percentages have been carried out with comparative analysis of rate differences and rate ratio. 
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Discussion 
From the results it is clear that both CLO feeding and chronic administration of NE will 
change the fatty acid distribution in the major phospholipids in the rat heart, A substantial 
replacement of OJ 6 fatty acids by OJ 3 fatty acids takes place, At the end of the experimental 
period phosphatidylethanolamine contains the highest amount of OJ 3 fatty acids, but the 
relative changes are more pronounced in phosphatidylcholine, The data obtained are in 
qualitative agreement with those reported by Gudbjamason et aL (13, 14, 23), For rats 
receiving a control diet a mortality of 50 % within 15 days was reported by Emilsson and 
Gudbjamason (14) upon daily administration ofNE with increasing dose, Our results show a 
much lower mortality (10%) when NE was suspended in PEG 400 despite the same changes 
in the fatty acid distribution of the phospholipids, Further studies carried out in our 
laboratory showed that the same amount of catecholamines given in a similar time period 
but now as a constant flow infusion resulted in no mortality at all, and also much less 
pronounced changes in the fatty acid composition of the phospholipids were found (unpub-
lished data), This indicates that not only the rat strain but also the mode of catecholamine 
administration may influence mortality, It also demonstrates that high concentrations of 
catecholamines are needed for substantial changes in the fatty acyl composition of the 
phospholipids occur, Gudbjamason et aL (23) reported an increased sensitivity in rats to 
catecholamines upon CLO feeding, especially when there is a vitamin E deficiency, In the 
present study no differences existed between vitamin E content of control and CLO diet, 
Moreover Ruiter et aL ( 46) demonstrated that the extra addition of vitamin E to the diet of 
fish oil fed pigs did not protect against development of yellow fat disease, which is a 
symptom of vitamin E deficiency, Although in the present work the CLO fed plus NE-
treated grol!p had an increased mortality rate (22 %) , this value is still far below the 
previously reported mortality rate (14), Because there is a marked difference between the 
findings of Emilsson and Gudbjamason (14) and those of our studies with respect to the 
mortality rate while changes in fatty acid composition of the phospholipids were similar, we 
decided to evaluate the occurrence of abnormalities in electrical properties of the heart, 
Interestingly it was observed that CLO feeding in either control orNE injected rats resulted 
in increased rate of incidence of ST-elevations, 86% versus 25% in the control-fed plus 
control-injected rats, 
Presently there is no information available as to whether enzymes involved in the 
biosynthesis or breakdown of cardiac phospholipids are affected by CLO feeding and 
catecholamine stress, Cellular phospholipids are confined to membrane structures and the 
continuous repair and maintenance of these membranes is the primary function of phos-
pholipid turnover, Above that the biomembranes have to keep their physico-chemical 
properties within certain limits (11, 19) for proper functioning, which is primarily deter-
mined by the fatty acid composition of their phospholipids, The main processes which are 
known to disrupt the phospholipid molecules in biomembranes are those induced by action 
of phospholipases and autooxidation, Phospholipid molecules with a high content of 
polyunsaturated fatty acids, as reported in this study, are favorite substrates for both 
biochemical processes, 
It has been repeatedly demonstrated that polyene fatty acids preferentially occupy the 
2-position and saturated fatty acids as well as oleic acid settle at the 1-position (11, 38), 
Independent of whether changes in the fatty acid composition are induced by CLO diet and/ 
or catecholamine stress, the ratio saturated/polyunsaturated fatty acids is hardly influenced 
and changes are only observed within the OJ 6 and OJ 3 fatty acid distribution (Tables 3, 4 and 
5). The shifts of OJ 6/0J 3 distribution in phosphatidylethanolamine were most pronounced 
(Table 5). That catecholamines activate phospholipas~ A2 thereby directly causing break-
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down of cellular phospholipids has been reported (54). In the present study a significant 
decrease (p < 0.05) in the total phospholipids per gram wet cardiac tissue was indeed 
demonstrated when NE was administered to control rats. A non-significant reduction in the 
phospholipids was also found in the CLO group with the same treatment. Apparently, a 
tendency of total phospholipids to decrease upon CLO feeding may have obscured the NE-
induced reduction. In fact, diet-induced phospholipid changes may also occur through 
change in plasma NE and tissue sensitivity to NE in view of previous findings of suppression 
of NE-induced thermogenesis in human obesity by diet and weight loss (15). Cellular 
membranes contain phospholipase A1 and/or A2, which may undergo changes under the 
influence of dietary and catecholamine treatments, although no phospholipase activity 
measurements have been carried out in the present study. 
It is believed that polyunsaturated fatty acids are exchanged in biomembranes by 
reacylation of lysophospholipids rather than by de novo synthesis from the corresponding 
diglycerides (20). NE probably also, activates phospholipase A2 activity in tissues other than 
heart (e.g. adipose tissue), favouring the remotion offatty acids, thereby inducing changes 
in phospholipid fatty acid composition in the heart. However, it is also demonstrated for the 
heart that an exchange of whole phospholipid molecules takes place between membranes 
mediated by phospholipid exchange proteins (10). To what extent each pathway contributes 
to formation of a steady state phospholipid composition of the heart membranes is as yet 
unclear. Finally, autooxidation of polyunsaturated fatty acids, especially those containing 
four and six double bonds, leads to a more rigid membrane structure (12, 18) resulting in a 
disturbance of membrane-localized biochemical processes. Furthermore peroxidized lipids 
have been shown to become preferred substrates for endogenous phospholipases (57). 
Therefore, by what factors the positional distribution of the fatty acids in phospholipids are 
determined is still unclear. 
It has been demonstrated that mitochondrial and plasmalemma! membranes do not have 
the capacity for the de novo synthesis of phosphatidylcholine and phosphatidyl-
ethanolamine. So it is most likely that the positional fatty acid distribution in these 
membranes is determined by acylation-reacylation processes and by phospholipid exchange 
of presynthesized molecules. Discrimination between plasma membranes, mitochondria and 
sarcoplasmatic reticulum has not been carried out in the present work and would offer more 
insight. Vasdev and Kako (56) showed that in rat myocardium, differences in preference 
exist between long chain fatty acids to be incorporated in phospholipids, even a profound 
difference in incorporation between phosphatidylcholine and phosphatidylethanolamine. 
Phosphatidylethanolamine is mainly characterized by a relatively higher content of long 
chain polyunsaturated fatty acids than phosphatidylcholine (compare Tables 4 and 5). 
Despite dietary and beta-adrenergic treatment, resulting in a replacement of w 6 fatty acids 
for w 3 fatty acids with increased chain length and unsaturation, this different character of 
fatty acid composition of phosphatidylcholine and phosphatidylethanolamine does not 
change. In the present work it appears that the polyunsaturated fatty acids account for 
45-50% of the fatty acyl residues and preferentially occupy the 2-position of phosphatidyl-
ethanolamine at which they can exchange for each other due to changes in diet or beta-
adrenergic treatment. Thus supports the idea that reacylation represents the major pathway 
for biosynthesis of these unsaturated molecular species. 
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The effects of dietary mackerel oil on plasma and cell 
membrane lipids, on hemodynamics and cardiac arrhythmias 
during recurrent acute ischemia in the pig 
J. M. Hartog, J. M. J. Lamers*, and P. D. Verdouw 
Laboratory for Experimental Cardiology, Thoraxcenter, *Department of Biochemistry I, 
Medical Faculty, Erasmus University Rotterdam, Rotterdam (The Netherlands) 
Summary: Fish-oil nutrition leads to a change in fatty acid composition of cellular membranes. To 
investigate whether this affects cardiac responses to acute myocardial ischemia, pigs were fed a 9.1% 
(w/w) mackerel-oil (n = 8) or 9.1% (w/w) lard-fat diet (n = 8). Eight weeks mackerel-oil feeding 
reduced plasmacholesterol (51%) and triglyceride (48%), while the n-6 fatty acids of cardiac and 
platelet membrane phospholipids were partially replaced by n-3 fatty acids. After 8 weeks the animals 
were anesthetized and the left anterior descending coronary artery was occluded 6 times for a period of 
5 min at 15 min intervals. Recovery of cardiac function and the incidence of cardiac arrhythmias were 
similar for both dietary groups. However, during the last reperfusions, hyperemic responses were less in 
magnitude and shorter lasting in the lard-fat (81 ± 17 ml/min) than in the mackerel-oil group (129 ± 18 
mllmin). This may be caused by a difference in thromboxane synthesis, as coronary venous blood 
thromboxane B2 levels were higher in the lard-fat (77 ± 6 pg/ml) than in the mackerel-oil group (19 ± 7 
pg/ml, P < 0.05) during peak hyperemia. The low baseline levels of both thromboxane B2 and 6-keto 
prostaglandin F1alpha in fish-oil fed animals originate from the reduced content of precursor fatty acid in 
the membrane phospholipids. In conclusion, despite marked changes in membrane fatty acid composi-
tion induced by prolonged feeding with fish oil, no modification of recovery of cardiac function and of 
incidence of cardiac arrhythmias was found during acute recurrent ischemia. 
Key words: fish oil, phospholipids, myocardial ischemia, ventricular arrhythmias, cardiac function, 
prostaglandins. 
Introduction 
Epidemiological studies have revealed a negative correlation between the consumption of 
fatty sea-fish and coronary heart disease which has been explained by the plasma lipid 
lowering and antithrombotic effects of dietary n-3 fatty acids (2, 11). The exchange of cell 
membrane n-6 fatty acids by dietary n-3 fatty acids and subsequent alterations in prostanoid 
synthesis may represent independent factors influencing cardiac function, ischemia-reperfu-
sion injury and/or incidence of arrhythmias. Several groups of investigators have reported 
that dietary polyunsaturated fatty acids affect arterial blood pressure (26, 28, 35, 39, 42) and 
the susceptibility to arrhythmias (6, 9, 10, 15-17, 29). However, the results are not 
conclusive as hypotensive (26, 28, 35, 42) as well as hypertensive (39) actions have been 
reported. Likewise, the effect of dietary fish oil on the incidence of ventricular arrhythmias 
is controversial as antiarrhythmic (10, 17, 29) as well as arrhythmogenic (16) actions have 
been reported. The harmful effects of diets using cod liver oil might have resulted from the 
toxic side effects of the high levels of vitamin A or D and cetoleic acid or the low level of 
vitamin E in these diets (16, 19). This problem can be overcome by using purified fish oil 
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extracts (EPA) which are supplemented with tocopherols (35). The increase of n-3 fatty 
acids in membrane phospholipids after consumption of high doses of fish oil could contribute 
to a higher susceptibility for cardiac arrhythmias through reduced levels of thromboxane A2 
(TXA2) and prostacyclin (PGI2) (7, 19, 20). Long-term consumption of a linoleic acid rich 
diet increased the survival rate and reduced the occurrence of arrhythmias after coronary 
artery ligation in rats (25, 27). The prevention by indomethacin of this beneficial effect 
suggested the involvement of increased prostaglandin synthesis due to replacement of 
membrane bound fatty acids of n-3 to n-6 type. Arachidonic acid, a prostaglandin of the E 
type, and PGI2 have been shown to exhibit antiarrhythmic activity and to offer protection in 
experimental myocardial ischemia (21, 24, 33) whereas TXA2 has been reported to be 
arrhythmogenic (7, 8). Dietary supplementation with fish oil, which is rich in n-3 fatty acids 
eicosapentanoic and docosahexanoic acids, also exerts a protective effect on experimental 
cerebral infarction in cats (5) and myocardial infarction in dogs (10). Therefore at present no 
clearcut data have been provided to what extent fish-oil nutrition can influence cardiac 
function, ischemia-reperfusion injury and/or the incidence of ventricular arrhythmias. 
The purpose of the present study was therefore to evaluate the effect of dietary fish-oil 
(EPA) on the recovery of cardiac function and the susceptibility to arrhythmias during 
coronary artery occlusion and reperfusion in anesthetized pigs. Experiments were per-
formed in a model (multiple occlusion and reperfusion) which has been shown to result in a 
partial loss of regional function for a substantial period of time (31). Even so, in pigs the 
earliest phase of ventricular arrhythmias already occurs within minutes following coronary 
artery occlusion which frequently ends in ventricular fibrillation (3, 44). 
Materials and Methods 
Experimental animals 
Sixteen Yorkshire piglets of either sex, and 5 weeks of age (7.9 ± 0.2 kg), were housed individually in 
slat-bottomed cages in temperature-controlled animal quarters and divided arbitrarily into two groups. 
Each group followed a different diet for a period of 8 weeks. 
Experimental diets 
The basal diet of both experimental groups was identical (Hope Farms, Woerden, The Netherlands) 
and low in fat content ( < 2% w/w) but with sufficient levels of linoleic acid. The control diet was 
prepared by addition of 9.1% w/w lard fat (Gebro Smilde BV, Heerenveen, The Netherlands) to the 
basal diet. In order to minimize the oxidation of the mackerel oil in the experimental diet, the .9 .1 % w/w 
mackerel oil (EPA extract obtained from A/S Johan C. Martens and Co., Bergen, Norway) was added 
Table 1. Composition (g/100 g) of the diets fed to two groups of young Yorkshire pigs. 
Carbohydrates 
Crude protein 
Crude fat 
Crude fiber 
Moisture 
Lard fat 
Mackerel oil 
9.1% lard-fat diet 
54 
17 
2 
8 
9 
9.1 
9.1% mackerel-oil diet 
54 
17 
2 
8 
9 
9.1 
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Table 2. Fatty acid compositions (%) of the lard-fat and mackerel-oil diets fed to young Yorkshire pigs. 
Fatty acid 
14:0 
16:0 
16:1 
18:0 
18:1 
18:2 n-6 
18:3 n-3 
20:1 
20:5 n-3 
22:1 
22:6 n-3 
24:1 
others 
9.1 % lard-fat diet 
2 
24 
3 
10 
42 
15 
1 
1 
2 
9.1 % mackerel-oil diet 
7 
18 
8 
1 
17 
8 
1 
6 
17 
4 
9 
1 
3 
just prior to consumption. For this reason the oil was packed and sealed under N2 gas in small batches 
for daily use. Composition of the two diets have been presented in Tables 1 and 2. 
The animals were fed in the morning and the portions were usually consumed within one hour. 
Chemical analysis of plasma, platelets and myocardial biopsies 
Before the start and at the end of the dietary period blood plasma triglyceride, total- and HDL-
cholesterol were determined in samples collected by puncturing the subclavian vein (13, 40, 47). 
Thromboxane B2 (TXB2) and 6-keto prostaglandin F1alpha (6-keto PGF1aipha), stable products of the 
prostaglandin synthesis, were determined by radioimmunoassay in coronary venous blood samples 
collected prior to the first coronary artery occlusion and during peak hyperemia of the last reperfusion 
period ( 49). 
During catheterization 50 ml blood was collected and separated platelets were washed and 
homogenized in buffer. The extracted phospholipids were separated from other lipids by thin layer 
chromatography (12, 30). After completion of the occlusion-reperfusion experiment (see later) the 
heart was excised and cooled on ice. The non-ischemic posterior wall of the left ventricle was rapidly cut 
out and homogenized in buffer. Homogenate was prepared as previously described (23). Homogenate 
phospholipids were separated (12, 30). The procedures for phospholipid hydrolysis, formation of fatty 
acid methyl esters, extraction of methylesters and gaschromatographic separation have all been 
described (30). 
Hemodynamic measurements 
After 8 weeks, the 16 animals (now weighing 20.4 ± 0.7 kg), were anesthetized and catheterized 
according to standard procedures (18). Following exposure of the heart via a midsternal split, 
electromagnetic flow probes (Skalar, Delft, The Netherlands) were placed around the ascending aorta 
and the proximal left antenor descending coronary artery (LADCA). The great cardiac vein was 
cannulated. 
Baseline measurements were obtained after a stabilization period of at least 30 minutes. Subse-
quently, the LADCA was clamped for 5 minutes and declamped for 10 minutes. This occlusion-
reperfusion procedure was repeated five more times. When ventricular fibrillation occurred, the 
animals were promptly defibrillated. If such attempts were not successful within 1 minute, the animals 
were excluded from further study. Except for the anesthetics and pancuronium bromide no other drugs 
were used. 
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Statistical analysis 
The changes in biochemical and hemodynamic variables from baseline and/or post-dietary values 
were calculated separately in each experiment and the significance of these changes was determined by 
using the Student's T-test. For the evaluation of the overall difference between the two dietary groups 
analysis of variance for repeated measures was used. Statistical significance was accepted at p < 0.05 
(two-tailed). All data have been expressed as mean ± standard error of mean (mean ± SEM). 
Results 
Plasmalipid levels after the dietary period 
Before the start of the dietary period the plasmalipid levels of the two groups were the 
same (Table 3). After the dietary period of 8 weeks plasma triglyceride, total- and HDL-
cholesterol decreased by 52 ± 7 %, 37 ± 4 % and 38 ± 3 %, respectively in the mackerel-oil 
Table 3. Levels of plasma lipids of young Yorkshire pigs before and after 8 weeks of feeding 9.1% lard-
fat or 9.1 % mackerel-oil diets. 
Plasmalipid Diet Pre-dietary Post -dietary 
(n = 8) (n = 8) 
Triglyceride (mM) lard fat 0.50 ±0.06 0.40 ± 0.03 
mackerel oil 0.49 ± 0.08 0.21 ± O.Ol"·b 
Total cholesterol (mM) lard fat 2.17±0.11 2.45 ± 0.10• 
mackerel oil 1.92 ± 0.12 1.21 ± o.o9a.b 
HDL cholesterol (mM) lard fat 0.91 ±0.09 1.13 ± o.o4a 
mackerel oil 0.97±0.09 0.60 ± 0.04a.b 
a = p < 0.05 versus pre-dietary; b = p < 0.05 versus lard-fat fed animals at comparable time of 
feeding; all data have been presented as mean± SEM. 
Table 4. Fatty acid composition (%) of the phospholipids of cardiac and platelet homogenates of young 
Yorkshire pigs fed with 9.1% lard-fat or 9.1% mackerel-oil diets for 8 weeks. 
Fatty acid Myocardium Platelets 
9.1% lard fat 9.1 % mackerel oil 9.1% lard fat 9.1 % mackerel oil 
(n = 6) (n = 5) (n = 6) (n = 5) 
16:0 19 ±1 19 ±1 21 ±2 23 ±1 
18:0 11 ±1 10 ±1 16 ±1 16 ±4 
18:1 19 ±1 13 ±3a 19 ±3 17 ±1 
18:2 n-6 24 ±1 13 ± 1a 9 ±1 7 ±1" 
20:4 n-6 19 ±1 7 ± 1a 14 ±5 6 ± 1a 
20:5 n-3 0.5 ±0.2 21 ± 1a 0 12 ± 1a 
22:4 n-6 1.7±0.5 1.5±0.4 3.9 ± 2.4 1.2 ± 0.3 
22:5 n-3 1.2±0.2 1.4 ± 0.3 0 2.7 ± 0.3• 
22:6 n-3 1.6 ± 0.1" 6.1 ± 0.13 1.1 ± 0.2 1.8 ± 0.3 
a = p < 0.05 versus lard-fat diet animals. All data have been presented as mean± SEM. The data on 
dimethylated acetals of 14:0 and 16:0, which are present in minor amounts, are not included. 
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fed pigs, whereas no significant change in plasma triglyceride and slightly elevated plasma 
total- and HDL-cholesterollevels were found in lard-fat fed animals (Table 3). 
Fatty acid composition of cardiac and platelet membrane phospholipids 
The n-6 fatty acids 18:2 and 20:4 ·in the cardiac phospholipids of the mackerel-oil fed pigs 
were exchanged for the n-3 fatty acids 20:5 and 22:6 (Table 4). Although no change occurred 
in the total polyunsaturated fatty acid content a dramatic increase bf double bond indices 
12 
PVC's/min 
10 
8 
6 
4 
12 
PVC's/min 
10 
8 
6 
4 
LARD-FAT 
minutes 
MACKEREL-OIL 
minutes 
Fig. 1. Premature ventricular contractions during 6 consecutive 5 min occlusions followed by 10 min of 
reperfusion in anesthetized pigs which had been on a 9.1% lard~fat (top) or 9.1% mackerel-oil diet 
(bottom) for 8 weeks. The mean of the ventricular arrhythmias per min for each occlusion (0-5 min) and 
reperfusion (5-15 min) have been depicted. Because the differences in the incidence of ventricular 
arrhythmias between the two groups were not statistically significant, the SEM bars have been omitted 
for the sake of clarity. Each group consisted of 8 animals, but in the lard-fat dietary group two animals 
died of ventricular asystole; one during the first reperfusion and one during the second reperfusion 
period. 121 =first period; lSI= second period; Ell =third period;~= fourth period; 181 =fifth period; i1ll 
= sixth period. 
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(1.85 ± 0.06 versus 1.28 ± 0.06) in the mackerel-oil fed versus the lard-fat fed pigs was 
observed. Similar changes occurred in platelet membrane phospholipids of the mackerel-oil 
fed pigs (Table 4). 
Ventricular arrhytlunias 
No ventricular arrhythmias were observed during the periodical ECG recordings in the 
dietary period and during the stabilization period before the stress-test. On the other hand, 
severe arrhythmias were observed in both groups during the occlusion and reperfusion 
periods. In the lard-fat fed group 61 ± 24 premature ventricular beats per animal were 
observed, whereas in the mackerel-oil fed group 114 ± 23 premature ventricular contrac-
tions per animal were seen (Fig. 1). In 6 of the lard-fat fed pigs and 7 of the mackerel-oil fed 
animals several periods with more than 5 premature ventricular contractions per minute 
were observed. Bigeminies were only seen in 4 of the mackerel-oil fed animals. Periods of 
ventricular tachycardia were observed in 3 lard-fat fed pigs, but were also more common in 
the mackerel-oil fed group, because 7 animals had periods of ventricular tachycardia. 
Usually the duration of the ventricular tachycardia was not longer than 15 seconds, but if so 
it passed into ventricular fibrillation. There were 8 periods of ventricular fibrillation (in 3 
pigs) in the lard-fat fed animals, and 11 periods of ventricular fibrillation mackerel-oil fed 
animals (in 4 animals). However, defibrillation was unsuccessful in 2 of 3 lard-fat fed animals 
as they went in asystole after defibrillation, respectively, in the first and second reperfusion 
period. The 4 mackerel-oil fed animals, which encountered ventricular fibrillation, could be 
promptly defibrillated. 
Table 5. Cardiovascular performance before the first occlusion and at the end of the last reperfusion 
period of 6 consecutive 5 minute coronary artery occlusions interrupted by 10 minutes of reperfusion in 
anesthetized young Yorkshire pigs fed with 9.1% lard-fat or 9.1% mackerel-oil diets for 8 weeks. 
9.1% lard fat 9.1 % mackerel oil 
baseline last reperfusion baseline last reperfusion 
(in% of (in% of 
baseline) baseline) 
(n = 8) (n = 8) (n = 8) (n = 8) 
HR b · min-1 110 ± 9 87± 8 107 ± 15 96± 9 
MAP mmHg 86 ± 5 76±10 94 ± 5 75± 3 
LVEDP mmHg 7.7± 0.6 114± 13 8.7± 1.3 128 ±22 
co I· min-1 1.8± 0.2 57± 2 1.8± 0.2 65± 4 
max LVdP/dt mmHg · s-1 2570 ±590 59± 13 2030 ±280 62± 4 
SVR mmHg ·min ·1-1 48 ± 3 132± 16 54 ± 6 118± 9 
CBF ml· min-1 31 ± 5 112± 16 32 ± 5 161 ±21" 
CVR mmHg ·min· ml-1 3.9± 0.9 81 ± 18 3.4± 0.5 53± 6a 
cv Oc-sat % 25 ± 3 145 ± 12 23 ± 3 231 ± 27a 
swt % 37 ± 3 78± 12 28 ± 3 77± 8 
Abbreviations: HR = heart rate; MAP = mean arterial blood pressure; L VEDP = left ventricular 
enddiastolic pressure; CO = cardiac output; max LVdP/dt = peak rate of rise in left ventricular 
pressure; SVR = systemic vascular resistance; CBF = left anterior descending coronary artery flow; 
CVR = coronary vascular resistance; cv02-sat = coronary venous Oz-saturation; swt = systolic wall 
thickening; • = p < 0.05 versus 9.1% lard-fat diet group. All data have been presented as mean± SEM. 
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Fig. 2. Systemic hemodynamics during 6 consecutive 5-rnin occlusions interrupted by 10 min of 
reperfusion in anesthetized pigs which had been on a 9.1% lard-fat (left hand panel) or 9.1% mackerel-
oil diet (right hand panel) for 8 weeks. From top to bottom are shown heart rate (HR), mean arterial 
blood pressure (MAP), cardiac output (CO) and the maximum rate of rise of left ventricular pressure 
(max LVdP/dt). For the number of observations in each occlusion-reperfusion period see Fig. 1. The 
SEM bars have been omitted for the sake of clarity. No difft;rences existed between the two groups. 
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Fig. 3. Myocardial performance of the ischemic segment during 6 consecutive 5-min occlusions 
interrupted by 10 min of reperfusion in anesthetized pigs which had been on a 9.1% lard-fat (left hand 
panel) or 9.1% mackerel-oil diet (right hand panel) for 8 weeks. From top to bottom are shown: left 
anterior descending coronary artery blood flow ( CBF), Orsaturation in the great cardiac vein ( cvOr 
sat) and systolic wall thickening (swt). For the number of observations in each occlusion-reperfusion 
period, see Fig. 1. The SEM bars have been omitted for the sake of clarity. Reactive hyperemic flow and 
0 2-saturation in the great cardiac vein were significantly (p < 0.05) larger in the mackerel-oil than in the 
lard-fat dietary group during the last reperfusion periods. 
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Hemodynamics 
Baseline values at the end of the dietary period 
No significant differences in cardiovascular performance of the two experimental groups 
were found after the 8-week dietary period (Table 5). 
Multiple coronary artery occlusion-reperfusion periods 
In the lard-fat fed animals mean arterial blood pressure (MAP) fell to 75 ± 2% of 
baseline (p < 0.05) during the first occlusion, but returned to 95 ± 2% (p < 0.05 vs pre-
occlusion) at the end of the first reperfusion period. During the following occlusion and 
reperfusion periods a similar pattern was observed. Consequently at the end of the last 
reperfusion period MAP had decreased to 76 ± 10% of baseline (p < 0.05, Fig. 2, left hand 
panel). Left ventricular end-diastolic pressure (LVEDP, pre-occlusion: 7.7 ± 0.6 mmHg) 
was elevated to 11.6 ± 1.2 mmHg during the first occlusion period but fell to 8.9 ± 0.9 
mm Hg during reperfusion. During the next occlusion and reperfusion periods the same 
pattern was observed resulting in a LVEDP of 9.1 ± 0.9 mmHg at the end of the last 
reperfusion period. Similar patterns were also found for cardiac output and max LV dP/dt: a 
decrease during coronary artery occlusion followed by a partial recovery during reperfusion 
(Fig. 2, left hand panel). Consequently, at the end of the last reperfusion period these 
parameters had fallen below the first pre-occlusion measurement (Table 5). 
In the mackerel-oil fed animals the changes in MAP, LVEDP (not shown), SV, CO and 
max LV dP/dt due to ischemia-reperfusion were almost similar to those in the lard-fat fed 
animals (Fig. 2, right hand panel and Table 5). 
In both the lard-fat and mackerel-oil fed animals there was a complete loss of systolic wall 
thickening immediately following each occlusion, but almost complete recovery occurred 
upon reperfusion (Fig. 3). At the end of the last reperfusionperiod systolic wall thickening 
was still 79 ± 9 % of the pre-occlusion value in lard-fat fed animals and 77 ± 8 % of the pre-
occlusion value in the mackerel-oil fed animals, which was not statistically different 
(Table 5). 0 2 saturation in the great cardiac vein was compared to pre-occlusion values 
more than tripled in the lard-fat fed pigs (77 ± 2 %) and in the mackerel-oil fed pigs (79 ± 
2%) during peak reactive hyperemia in the early reperfusion (Fig. 3). The reactive 
hyperemic response of the mackerel-oil fed animals exceeded that of the lard-fat fed animals 
(129 ± 18 mllmin vs 81 ± 17 ml/min) during the last reperfusions (p < 0.05), (Fig. 3 and 
Table 5). 
Prostaglandin plasma levels in coronary venous blood 
TXB2 and 6-keto PGF1atpha levels were measured in blood samples collected from the great 
cardiac vein. Prior to the first LADCA occlusion significant higher levels of TXB2 were 
observed in the lard-fat fed animals (39 ± 8 pg/ml) than in the mackerel-oil fed pigs (16 ± 5 
pg/ml, Table 6). On the other hand, much higher TXB2 levels were found in the lard-fat fed 
animals (77 ± 6 pg/ml, vs 19 ± 7 pg/ml, in mackerel-oil fed pigs, p < 0.05) during peak 
hyperemia of the last reperfusion (Table 6). The same phenomenon was seen with the 6-keto 
PGF1atpha: Preocclusion plasma levels were 133 ± 35 pg/ml and 82 ± 6 pg/ml, respectively in 
the lard-fat and mackerel-oil fed animals. During peak hyperemia of the last reperfusion 
period we found a 3-fold increase in the lard-fat fed animals (371 ± 40 pg/ml) and only a 
50% increase in the mackerel-oil fed pigs (p < 0.05, 123 ± 7 pg/ml, Table 6). 
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Table 6. Coronary venous plasma levels of prostaglandins before the first occlusion and during peak 
reactive hyperemia of the last reperfusion period of 6 consecutive 5-minute coronary artery occlusions 
interrupted by 10 minutes of reperfusion in anesthetized young Yorkshire pigs fed with 9.1 % lard-fat or 
9.1% mackerel-oil diets for 8 weeks. 
Thromboxane B2 
6-keto PGFlalpha 
TXB:!6-keto 
PGFlalpha 
9.1% lard fat 
baseline 
(n = 8) 
pg/ml 39 ± 8 
pg/ml 133 ± 3SC 
0.44± 0.13' 
peak hyperemia 
(last reperfusion) 
(n = 6) 
77 ± 6b 
371 ±40b 
0.22± 0.03b 
9.1% mackerel oil 
baseline 
(n = 8) 
16 ±5" 
82 ±63 
0.20 ± 0.06" 
peak hy-
peremia (last 
reperfusion) 
(n = 6) 
19 ±7· 
123 ± 7" 
0.16±0.06 
Abbreviations: TXB2 = Thromboxane B2 ; 6-keto PGF1alpha = 6-keto prostaglandin F 1aipha; 
• = p < 0.05 versus lard-fat diet group; b = < 0.05 versus baseline; ' = n = 7. All data have been 
presented as mean± SEM. 
Discussion 
In the present study a dietary dose of fish oil was employed that supplied equal amounts of 
n-3 fatty acids as consumed by the eskimos reported in the studies by Bang and Dyerberg 
(2). The hypolipidemic effect of a mackerel-oil diet that we observed in pigs is in agreement 
with results obtained in a study on hyperlipidemic patients consuming a nearly identical dose 
of n-3 fatty acids (34). The large decrease in total plasma cholesterol was accompanied by a 
similar fall in the HDL cholesterol. Consequently the HDL-/total-cholesterol ratio remained 
constant. An enhanced clearance of VLDL-particles may have contributed in the decrease 
of plasmalipid levels in the mackerel-oil fed animals, but a decreased rate of VLDL-
synthesis in the liver is probably the most important factor (14, 32, 36, 41, 48). At any rate 
the dramatic plasma lipid changes observed in the present study confirms the efficacy of the 
fish-oil dose (19). Indeed the cellular membrane phospholipids showed a marked polyun-
saturated fatty acid response as well. 
Despite the marked fish oil-induced changes in fatty acid composition of platelet and 
cardiac membranes there were no differences in myocardial performance between the 
mackerel-oil and lard-fat dietary groups. It cannot be entirely excluded that slight 
differences in performance were masked by the presence of the anesthetics during the 
measurements. Pigs are very susceptible to ventricular fibrillation, probably due to the lack 
of collateral flow (3, 37, 45). In addition, coronary artery occlusions from 1()-30 min already 
lead to a complete loss of function for a substantial period of time (3, 4, 44, 46). In order to 
evaluate the effect of changes in cardiac membrane phospholipids on ventricular arrhyth-
mias and cardiac function, it is desirable that a substantial number of animals survive the 
ischemic events and that partial recovery of regional function occurs. Multiple coronary 
artery occlusions of 5 min interrupted by 10 min of reperfusion provide such a model (31). In 
the present study recovery was about the same in both the mackerel-oil and lard-fat diet 
groups. Moreover, the incidence of ventricular arrhythmias was very similar. Hence, the 
changes in cardiac membrane phospholipids do not affect cardiovascular performance 
during acute episodes of myocardial ischemia. Because of the high susceptibility to ventricu-
lar fibrillation, this porcine model is not very suitable for the study of long periods of 
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ischemia. Even in pigs with smaller ischemic segments, the incidence of ventricular fibrilla-
tion remains very high (18, 38, 43). 
The only difference was the more pronounced hyperemic response during the last 
reperfusion periods in the mackerel-oil fed animals. Since arterial blood pressures were 
similar for both groups a larger vasodilatory response of the coronary resistance vessels must 
have occurred in these animals. This difference in coronary resistance can be explained by 
the lower levels of TXA2 in the coronary venous blood. However, it appeared that PGI2 
levels were also reduced due to mackerel-oil nutrition. Apparently the TXA2/PGI2 ratio, 
which was significantly lower in mackerel-oil fed animals, has determined the decrease in 
coronary vascular tone. It is possible that due to the changes in polyunsaturated fatty acid 
composition of the platelets and probably also of the endothelial membranes, the synthesis 
of TXA3 and PGI3 has become predominant (20). Some contribution of the 3-series of 
prostacyclin to the hyperemic response may exist. 
Except for minor but non-significant differences in the incidence of bigeminies or 
ventricular tachycardias no differences in the incidence of ventricular arrhythmias were 
observed between the two dietary groups. Differences in the incidence of ventricular 
arrhythmias of the two dietary groups could have been expected because: 1) the increase of 
docosahexanoic acid in the cardiac membrane phospholipids has been associated with a 
higher susceptibility for cardiac arrhythmias in rats, after consumption of high doses of fish-
oil (15, 16) and 2) altered concentrations of TXA2 and PGI2 have been reported to influence 
the susceptibility to ventricular arrhythmias during ischemia (7, 8, 19, 20, 22, 24, 25, 27, 33). 
In the present study the n-6 fatty acids of platelet and heart membrane phospholipids were 
partially replaced by the n-3 fatty acids eicosapentanoic acid and to a lesser extent by 
docosahexanoic acid. This has affected the synthesis of both TXA2 and PGI2 as reduced 
baseline levels of both TXA3 and 6-keto PGF1alpha were found in mackerel-oil fed pigs in the 
present study. Although the baseline TXAz/PGI2 ratio in the mackerel-oil fed pigs was 
significantly reduced, no influence on the incidence of ventricular arrhythmias was observed 
(7, 8). Perhaps the levels of TXA3 and PGI3 should also be taken into account, but these 
data are not available. It should be noted that the TXB2/6-keto PGF1alpha ratio became 
similar at peak hyperemic response, when most arrhythmias occurred. Supposing that not 
the level of TXA2 and PGI2 but their ratio is important. The absence of dietary-induced 
changes in ventricular arrhythmias can be related to the similar TXBz/6-keto PGF1alpha 
ratios. The 5 min occlusion periods are too short to provoke serious reperfusion arrhythmias 
( 46) and the dietary effect on this type of ventricular arrhythmias remains to be studied. 
We conclude that consumption of high doses of mackerel oil leads to marked decreases in 
plasma triglyceride- and cholesterol-levels and replacement of linoleic and arachidonic acid 
by eicosapentanoic and docosahexanoic acid in platelet and cardiac membrane phos-
pholipids. Although the membrane changes also reduced prostaglandin levels in plasma, no 
differences in heart function, recovery and incidence of ventricular arrhythmias were found 
in this open-chest pig model during multiple coronary artery occlusion-reperfusion periods. 
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CHAPTER 9 
The effects of dietary mackerel oil on the recovery of 
cardiac function after acute ischaemic events in the pig 
J. M. Hartog, J. M. J. Lamers1, P. W. Achterberg, D. van Heuven-Nolsen2 , F. P. Nijkamp2 
and P. D. Verdouw 
Laboratory for Experimental Cardiology, Thoraxcenter, and 1Department of Biochemistry I, 
Erasmus University Rotterdam, Rotterdam, The Netherlands and 2Institute for Veterinary 
Pharmacology, Pharmacy and Toxicology, University of Utrecht, Utrecht, The Netherlands 
Summary 
To investigate the effects of fish oil nutrition on cardiac haemodynamics and the biochemical response 
to ischaemia-reperfusion, young pigs (5 weeks old) were fed a 9% lard fat diet or a mixed diet of 4.5% 
mackerel oil and 4.5% lard fat for 16 weeks. In the mackerel oil fed pigs plasma cholesterol and triglyceride 
levels decreased by 22% and 58% (both p < 0. 05), respectively, while levels in the animals which received 
only lard fat did not change. The n-6 fatty acids present in cardiac and platelet membrane phospholipids 
underwent a partial replacement by n-3 fatty acids in the mackerel oil fed pigs. Under anaesthesia, multiple 
coronary artery occlusions (5 min) were interrupted by 10 min of reperfusion. The extent of recovery of 
cardiac function and reduction of adenine nucleotide levels were similar for both dietary groups. The in-
cidence of reperfusion arrhythmias was significantly lower and the reactive hyperaemic responses were of 
longer duration in the mackerel oil fed animals. These effects cannot be explained by diet-induced alterations 
in thromboxane B2/6-keto-PGF 1a ratio, although a marked reduction in absolute levels of both prostaglan-
dins was seen in the mackerel oil fed pigs (p < 0.05). In conclusion, dietary fish oil caused changes in 
membrane fatty acid composition and plasma prostaglandin levels, although these did not affect alterations 
of cardiac performance during and after short periods of ischaemia. 
Key words: fish oil, ischaemia-reperfusion, cardiac function, arrhythmias, prostaglandins, 
phospholipids, pigs. 
Introduction 
The plasma lipid lowering and antithrombotic effects of dietary fish oils, rich inn-3 fatty acids, 
have been well established (1, 5, 11, 14, 20). Effects of dietary n-3 fatty acids have been reported 
on blood pressure (19, 20, 25, 26) cardiac performance (2, 17, 18), infarct size (4), ischaemic 
insult (13), susceptibility to catecholamine-induced heart necrosis (6, 17, 21) and arrhythmias 
(4, 17). Because fish oil nutrition induces replacement ofn-6 by n-3 fatty acids, the precursor 
fatty acid 20:4 n-6 for prostaglandin synthesis is less available (14). Since prostaglandins have 
been shown to play a role in the recovery of regional myocardial function and arrhythmias 
following release of coronary artery occlusion (3, 27), an effect of prolonged feeding with fish 
oil through alteration of prostaglandin synthesis could be present. 
The purpose of the present study was to evaluate the effect of a mackerel oil diet on arterial 
and coronary venous prostaglandin levels, recovery of cardiac function and the incidence of ven-
tricular arrhythmias during multiple coronary artery occlusions and reperfusions in pigs. Tissue 
levels of ATP, which are generally believed to be critically involved in the recovery of the 
myocardial cell from an ischaemic event, were also measured. 
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Materials and Methods 
Thirteen Yorkshire piglets (5 weeks of age and 7.7 ± 0.2 kg), were fed either 9% w/w lard fat (L, n = 
6) or 4.5% w/w mackerel oil plus 4.5% w/w lard fat (ML, n = 7) for a period of 16 weeks as previously 
described (9, 10). Table 1 shows the fatty acid composition of the two diets. Cardiac sarcolemma was 
isolated from heart biopsies by differential centrifugation (16). Plasma cholesterol and triglyceride (9, 1 0), 
phospholipid composition of platelet and cardiac sarcolemmal membranes (10, 21) and arterial and cor-
onary venous plasma levels of TXB;, and 6-keto-prostaglandin F 1a (6-keto-PGF1a) were measured by 
radioimmunoassay as previously described (24, 26). Prostaglandin synthesis of the coronary vascular bed 
was calculated as the product of coronary blood flow and the difference in arterial and coronary venous pro-
staglandin plasma levels. 
Table 1. Fatty acid compositions(% mole) of the 9% lard fat (L) and 4.5% mackerel oil+ 4.5% lard 
fat (ML) diets fed to the Yorkshire pigs 
Fatty acids 
14:0 
16:0 
16:1 
18:0 
18:1 
18:2 n-6 
18:3 n-3 
20:1 
20:5 n-3 
22:1 
22:6 n-3 
24:1 
others 
L 
2 
24 
3 
10 
42 
15 
1 
1 
2 
ML 
5 
21 
6 
6 
29 
11 
1 
4 
8 
2 
5 
1 
After 16 weeks, the animals (now weighing 48.5 ± 1.5 kg) were anaesthetized and prepared according 
to standard procedures (8, 10). Subsequently, the left anterior descending coronary artery was six times 
clamped for 5 min and declamped for 10 min. At the end of the last reperfusion period two needle biopsies 
were taken from the ischaemic as well as from the non-ischaemic segment (posterior wall) of the left ventri-
cle for the determination of adenine nucleotides (7). 
Results 
Plasmalipid levels and fatty acid composition of cardiac and platelet membranes 
In L plasma triglyceride (from 0.76±0.12 mM to 0.64±0.09 mM), total cholesterol (from 
2.39 ± 0.41 mM to 2.35 ± 19 mM) and HDL cholesterol (from 1.02 ± 0.16 mM to 1.01 ± 0.11 
mM) did not change (p>0.05) during the dietary period. In ML, HDL cholesterol (from 
0.87 ± 0.10 mM to 0.83 ±0.04 mM) was not affected, but triglyceride (from 0.76±0.10 mM 
to 0.31 ± 0.03 mM) and total cholesterol (from 2.40±0.28 mM to 1.75 ±0.11 mM) decreased 
by 58± 3% and 22 ± 9%, respectively (both p <0.05 versus pre-dietary value and L). 
In ML, the relative content ofn-6 fatty acids of heart sarcolemmal phospholipids was lower, 
but the n-3 fatty acid content was higher than in L (Fig. 1). The total polyunsaturated fatty acid 
content was similar for both dietary groups. Because of the higher unsaturation degree of then-3 
fatty acids, the double bond index of ML (1.94 ± 0.04) was appreciably higher than that of L 
(1.65 ±0.03; p <0.05 versus ML). Analogous shifts ofn-6 to n-3 fatty acids were found in the 
fatty acid composition of the platelet membrane phospholipids of both groups (Fig. 2). 
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Fig. 1. Fatty acid composition of heart sarcolemmal phospholipids in pigs after a 16 week dietary period. 
* = p < 0.05 versus 9% lard fat fed animals. DMA = dimethylated acetals. 
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Fig. 2. Fatty acid composition of platelet homogenate phospholipids in pigs after a 16 week dietary period. 
* = p < 0.05 versus 9% lard fat fed animals. DMA = dimethylated acetals. 
Ventricular arrhythmias during coronary artery occlusion and reperfusion 
The incidence of premature ventricular contractions (PVC's) (Fig. 3) was not different during 
occlusion(l5 ± 12and23 ± 11 PVC's/animalinLandML, respectively), butduringreperfusion 
more PVS's were seen in L (26 ± 7 PVC's! animals) than in ML (9 ± 3 PVC's/animal, p < 0.05 
versus L). Eight animals (four in each group) had several periods with more than 5 PVC's per 
minute. Bigeminies were seen in one animal of each group. One animal inLand two animals in 
ML had periods of ventricular tachycardia (all during occlusion). Ventricular fibrillation (VF) 
was not observed in L, but in ML three animals encountered seven episodes ofVF (five of these 
during occlusion). Defibrillation was unsuccessful in one animal, of the ML group, which died 
of ventricular asystole during the fifth reperfusion. 
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Fig. 3. Premature ventricular contractions (PVC's) during 6 consecutive episodes of 5 min occlusion- l 0 
min reperfusion in pigs, which had been on a diet for 16 weeks. The mean of the premature ventricular con-
tractions per minute (PVC's/min) has been depicted for each minute during all6 occlusions (0-5 min) and 
reperfusions (5-15 min). 
Systemic haemodynamics 
In neither of the two groups heart rate, which was significantly higher in ML during pre-occlu-
sion, was affected by the multiple occlusions and reperfusions (Fig. 4). Mean arterial blood 
pressure (MAP), however, decreased to approximately 80% of the pre-occlusion value during 
the first occlusion in both groups but returned to 95% of the pre-occlusion value at the end of the 
first reperfusion. With each following occlusion-reperfusion there was a gradual decrease in 
MAP. Hence, attheendofthelastreperfusionMAPhadfallento 81% ±4% inLand to 79 ±4% 
in ML. Similar patterns were observed for cardiac output (78 ± 6% inLand 75 ± 5% in ML at 
the end of the last reperfusion), and max LV dP I dt (7 5 ± 3% in L and 72 ± 5 % in ML). As ex-
pected, left ventricular end-diastolic blood pressure increased during occlusion, but returned to 
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Fig. 4. Systemic haemodynamics during 6 consecutive episodes of 5 min occlusion - 10 min reperfusion 
in pigs, which had been on the diet for 16 weeks. From top to bottom are shown: heart rate (HR), mean 
arterial blood pressure (MAP), left ventricular end-diastolic pressure (LVEDP), cardiac output (CO) and 
maximum rate of rise in left ventricular pressure (max LVdP/dt). 
occlusion value with each reperfusion. Systemic vascular resistance (not shown) was not affected 
by these procedures. 
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Left ventricular peiformance 
Upon release of the occlusion, reactive hyperaemia occurred in both groups. Peak flows were 
similar, but the hyperaemic response lasted longer in ML than in L (Fig. 5). Therefore, at the 
end of the last reperfusion coronary blood flow was in ML above (24 ± 13%) and in L below 
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Fig. 5. Myocardial performance of the ischaemic segment of the left ventricle during 6 consecutive episodes 
of5 min occlusion- 10 min reperfusion in pigs, which had been on the diet for 16 weeks. From top to bottom 
are shown: left anterior descending coronary artery blood flow (CBF), 0 2 saturation in the great cardiac 
vein (CV02-sat) and systolic wall thickening (SWT). 
Dietary fish oil and cardiac function 105 
(-32 ±5%, p<0.05) the pre-occlusion value. During occlusion, coronary venous 0 2 satura-
tion (CV02-sat) could not be measured, but immediately upon release of the obstruction the 0 2 
saturation in the great cardiac vein rose in both dietary groups to approximately 75% (pre-occlu-
sion values 20-25%). At the end of the last reperfusion CV02-sat was still elevated in ML, 
whereas pre-occlusion values were re-established in L. 
In both groups a complete loss of regional systolic wall thickening (SWT), which was slightly 
lower in ML during pre-occlusion (p < 0. 05 versus L), occurred with each occlusion. Recovery 
was incomplete at the end of each reperfusion and occurred more slowly in ML during the last 
reperfusions. Hence SWT decreased to 71 ± 13% of the pre-occlusion value in L and to 56 
± 14% of that in ML at the end of the last reperfusion. 
Prostaglandin plasma levels in arterial and coronary venous blood 
Before occlusion, arterial as well as coronary venous plasma levels of TXB2 and 6-keto-
PGF1a were appreciably lower in ML than in L. The arterial TXB2/6-keto-PGF1a ratio was 
similar for both groups, but the coronary venous TXB2/6-keto-PGF1a ratio was higher in L 
(Table 2). Although myocardial production of especially TXA2 can be artificially altered by 
post-sampling production, large differences existed in the myocardial production rate ofTXB2 
(-16±98 pg/min in ML versus 1086± 194 pg/min in L, p<0.05) and of 6-keto-PGF1a 
(881 ± 176 pg/min"in ML versus 2466 ± 616 pg/min L, p<0.05). 
Table 2. Arterial (a) and coronary venous (cv) plasma concentrations of prostaglandins before the first 
occlusion (PO) and during peak reactive hyperaemia of the first and sixth reperfusion periods (RP) in 
anaesthetized Yorkshire pigs, fed lard fat (L) or a mixture of mackerel oil and lard fat (ML) 
L (n = 6) ML (n = 7) 
PO 1st RP 6thRP PO 1stRP 6th RPct 
TXB 2 a 70±7 75±6 63±6 28±3b 21 ±5b 51±9' 
cv 107±9 80±8' 79±9' 29±2b 25±2b 32±3b 
6-keto-PGF1, a 83±9 122±11' 98± 11 31 ± 3b 29±2b 48 ± 6b' 
cv 154±4 140±8 111 ±6' 61±6b 76±8b 52±3b 
TXB 2/ a 0.85±0.04 0.63±0.05' 0.68±0.08 0.88±0.04 0.54±0.08' 0.89±0.06 
6-keto-PGF1, cv 0.69±0.06 0.58±0.07 0.71 ±0.07 0.50±0.05b 0.32 ± 0.02b' 0.62±0.04 
b = p < 0.05 versus 9% lard fat fed animals at comparable time; c = p < 0.05 versus PO; d = n = 6. All 
data have been expressed as means ± SEM. 
During the first occlusion-reperfusion episodes no changes in arterial prostaglandin plasma 
levels were present except for an increase of the 6-keto-PGF1a level in L during peak 
hyperaemia of the first reperfusion and an increase ofTXB2 and PGF1a plasma levels in ML 
during the sixth reperfusion. The TXB2/6-keto-PGF1a ratios in arterial blood were lower during 
peak hyperaemia of the first reperfusion in both groups, but not different from preocclusion 
values during the sixth reperfusion. The TXB2/6-keto-PGF1a ratios, the TXB2 and 6-keto-
PGF1a levels in arterial blood did not significantly correlate with the systemic vascular 
resistance (correlation coefficients 0.13, 0. 07 and 0. 01, respectively). 
The coronary venous plasma levels of TXB2 were decreased during peak hyperaemia in L but 
not in ML. In L, a minor production of TXB2 occurred in the coronary vascular bed during the 
first and sixth reperfusion (174 ± 103 pg/min and463 ± 203 pg/min, respectively, both p < 0.05 
versus pre-occlusion value). In view of the fact that most, if not all, TXA2 is produced by the 
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platelets, one might wonder whether the production is correctly estimated from arteriovenous 
concentration differences, in particular when these are small. Another complicating factor might 
be local productions ofTXA2 and perhaps even PGI2 • Similar to pre-occlusion, no myocardial 
production ofTXB2 was found in ML during reperfusion. During the first reperfusion, the cor-
onary venous levels of 6-keto-PGF1a were unchanged in both groups, but in L the level was 
decreased during the sixth reperfusion. Levels of 6-keto-PGF Ia were still significantly lower in 
ML, although myocardial release of PGI2 was enhanced during the first reperfusion 
(2841 ±391 pg/min; p<0.05 versus pre-occlusion value). The TXB2/6-keto-PGF1a ratio did 
not change significantly in the two groups, except for a decrease in ML during the first reperfu-
sion. The TXB2/6-keto-PGF1a ratio of coronary venous blood and the myocardial release of 
6-keto-PGF1a did not correlate with the coronary vascular resistance (correlation coefficients 
0. 07 and - 0.21, respectively, and the incidence of reperfusion arrhythmias (correlation coeffi-
cients 0.08 and -0.10, respectively). 
Because alterations in prostaglandin levels did not explain changes in coronary vascular 
resistance, we searched for other possible contributing factors, such as pH. During peak 
hyperaemia the differences in arterial and coronary venous pH were still doubled but in both 
groups the pH differences had returned to their pre-occlusion values (0.05 ± 0.01 for L and 
0. 04 ± 0. 01 for ML) at the end of reperfusion. During reperfusion, the differences in arterial and 
coronary venous pH correlated with the coronary vascular resistance (correlation coefficient 
-0.43; p<0.05). 
Myocardial energy charge 
As can be seen from Fig. 6, no differences were present in adenylate energy charge between 
the ischaemic and non-ischaemic myocardium. The ATP and total adenine nucleotide contents 
of the ischaemic segments were reduced to the same extent in both dietary groups (Fig. 6). 
Discussion 
The purpose of the study was to evaluate the acute effects of multiple short lasting ischaemic 
events on recovery of regional myocardial function. This appears to be of interest because recent 
studies showed that feeding fish oil to rats for a period of time had a protective effect on ischaemic 
myocardium as measured by creatine kinase leakage or the infarct size ( 4, 13). On the other hand, 
prostaglandin synthesis may be impaired by the replacement ofn-6 by n-3 precursor fatty acids 
in the membranes. The duration of the occlusions in our experiments was only 5 min. This 
prevents the loss of a large number of animals through ventricular fibrillation (28). It has been 
shown that pigs subjected to this type of stresS- have an acute recovery of regional myocardial 
function varying from 50 to 80% (10, 22). In the present study we found that in both dietary 
groups, the ATP content of the ischaemic myocardium was similarly reduced, but since the 
energy charge remained intact, complete recovery is expected after prolonged reperfusion. After 
occlusions lasting 30 min, regional heart function in pigs almost completely recovers after 2 
weeks (23). Because of the short duration of the ischaemic events in the present study, which does 
not result in ultimate loss of function, comparison with the aforementioned studies (4, 13) is not 
possible. 
The pre-occlusion heart rate was slightly higher in ML than in L. Gudbjamason et al. (6) deriv-
ed a significant correlation between heart rate and heart phospholipid 22:6 (n-3) content in 
various species. Although our findings in pigs support this relationship, there is no indication of 
a mechanism by which heart rate would be modulated by alterations of membrane fatty acids. 
Despite the differences in fatty acid composition of the platelet membrane and cardiac sar-
colemmal phospholipids and the subsequent changes in prostaglandin synthesis, no differences 
in systemic haemodynarnics were found between the two dietary groups before, during and after 
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Fig. 6. Myocardial adenine nucleotide levels after 6 consecutive episodes of 5 min occlusion and 10 min 
reperfusion in pigs, which had been on lard fat (L) or mackerel oil + lard fat (ML) diets. From top to bottom 
are shown: adenosine triphosphate (ATP), adenosine diphosphate (ADP), adenosine monophosphate 
(AMP), total adenine nucleotides (TAN) and adenylate energy charge (AEC) which was calculated as 
(ATP+ 1/2 ADP) I TAN. *p<0.05 versus non-ischaemic myocardium. 
the occlusion-reperfusion periods. Slight differences, however, existed in myocardial perfor-
mance of the ischaemic segment, as the reactive hyperaernic response lasted longer in ML, due 
to prolonged arterial vasodilatation. In our previous study using a higher daily dose of mackerel 
oil, we found not only a prolonged, but a more pronounced vasodilatation (10). These effects 
have been explained by diet-induced changes in coronary venous prostaglandin levels measured 
in the last reperfusion period. Recovery of systolic wall thickening was also slower in ML during 
the last four reperfusion periods, but was similar at the end of each reperfusion. 
Although we did not add cyclooxygenase inhibitors to block prostaglandin synthesis of 
platelets or leukocytes, the blood samples were placed in ice to reduce (stop) this production from 
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occurring during separation of plasma from blood cells. Like others, we measured the myocar-
dial release of prostacyclin (3, 15). As observed in our previous experiments, the basal coronary 
venous (10) and now also the arterial levels ofTXB2 and 6-keto-PGF1a were markedly reduced 
in the mackerel oil fed pigs. During the reperfusion periods no increase in coronary venous pro-
staglandin levels was found, which is at variance with the large stimulation previously seen (1 0). 
In that study, the animals received two-fold higher doses of mackerel oil and the coronary artery 
occlusion-reperfusion experiments were done after an 8 week dietary period. The arterial and 
coronary venous prostaglandin levels did not correlate with systemic and coronary vascular 
resistance, respectively. Therefore, other factors must have been more prominent in determining 
the vascular tone, and indeed, the arterial-coronary venous pH differences correlated much more 
closely with coronary vascular resistances. This does not, however, explain the prolonged 
hyperaemic response in ML. 
The incidence of reperfusion arrhythmias did not correlate with coronary venous prostaglan-
din levels. For example, the levels in the three animals which encountered ventricular fibrillation 
were not different from those of the other animals, as has been observed by others (3). It should, 
however, be noted that the incidence of ventricular arrhythmias was low. The model was chosen 
to enable us to estimate the recovery of cardiac function rather than to evaluate the effect on ar-
rhythmias. It is possible that more n-3 fatty acid-derived prostaglandins are produced in ML than 
in L, but that these can not be detected by the radioimmunoassay method used in this study. 
TXA3 and PGI3 are poor agonists and will be produced at a reduced rate, because eicosapen-
taenoic acid is a poor substrate for cyclooxygenase (14, 17). 
We conclude that the membrane fatty acid content changes were paralleled by a reduction of 
the prostaglandin levels in both arterial and coronary venous blood and that no diet-related dif-
ferences in cardiovascular performance and recovery of cardiac function were found in this open-
chest pig model during multiple coronary artery occlusion-reperfusion periods. The lower in-
cidence of reperfusion arrhythmias and the prolonged. hyperaemic response in ML could not be 
correlated with changes in the coronary venous blood levels of prostaglandins. 
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J. M. J. LAMERS, J. M. HARTOG, C. GuARNIERI, I. VAONA, P. D. VERDOUW AND J. F. KosTER. Lipid Peroxi-
dation in Normoxic and Ischaemic-reperfused Hearts ofFish Oil and Lard Fat Fed Pigs. Journal if Molecular and 
Cellular Cardiology ( 1988) 20, 605-615. The in situ and in vitro rate oflipid peroxidation of hearts were determined 
in two groups of pigs which had been fed diets which differed only in fatty acid composition for 8 weeks. During 
the dietary period venous plasma levels of malondialdehyde and lipofuscin were not higher in pigs receiving the 
highly unsaturated fatty acid-containing mackerel oil than those receiving lard fat. Malondialdehyde was pro-
duced in the coronary system of the mackerel oil fed animals. After the heart was subjected to a sequence of short 
periods of ischaemia (5 min) and reperfusion (10 min), myocardial malondialdehyde production in the mack-
erel oil fed pigs did not increase. Contribution of prostaglandin synthesis products to myocardial malondial-
dehyde formation is probably of minor importance. Recovery of regional heart function after the ischaemic 
periods was similar for both dietary groups. In the phospholipids of sarcolemmal preparations isolated from the 
left ventricle of mackerel oil fed animals 18: 2 n-6 and 20: 4 n-6 were partially replaced by 20: 5 n-3 and 22: 6 
n-3. Ischaemia-reperfusion did not alter sarcolemmal fatty acid composition and Ca2+ pumping ATPase activ-
ity. Sarcolemmal membrane from mackerel oil fed pigs exposed in vitro to a free radical generating system 
showed a higher malondialdehyde production than that from lard fat fed pigs. Thus, in spite of the increased 
susceptibility ofheart membranes to free radical generated peroxidation in mackerel oil fed animals, recovery of 
left ventricular function was similar following multiple short-term periods of ischaemia. 
KEY WoRDs: Dietary fatty acids; Polyunsaturated fatty acids; Fish oil; Lard fat; Ischaemia-reperfusion; Lipid-
peroxidation; Sarcolemma; Ca2 + pumping ATPase; Haemodynamics; Prostaglandins. 
Introduction 
The direct and indirect role of oxygen radicals 
in the development of myocardial necrosis due 
to ischaemia and reperfusion has been well 
documented. A large body of evidence has 
been derived from observations that treat-
ment with free radical scavengers (e.g. super-
oxide dismutase, catalase and mannitol) 
reduced the extent of myocardial injury 
(Shlafer et al., 1982;Jolly et al., 1984; Ferrari 
et al., 1985; McCord, 1985) and that 
allopurinol-induced inhibition of xanthine 
oxidase, probably a major source of super-
oxide 0 2 - in post-ischaemic tissue, can delay 
cell death (Manning et al., 1984; Stewart 
et al., 1985). Several reports have shown ele-
vated endogenous generation of free radicals 
and their products, as malondialdehyde 
(MDA) and those detectable by electron spin 
resonance spectrometry in lyophilized tissue 
extracts, during myocardial ischaemia 
(Guarnieri et al., 1980; Meerson et al., 1982; 
Rao et al., 1983). Moreover, perfusion of 
control hearts with free radical producing 
compounds leads to the development of 
Ca2 + -paradox-like myocardial injury (Koster 
et al., 1985). Other factors which may be 
involved are the ischaemia-induced reduction 
Please address all correspondence to:Jos M.J. Lamers, Department of Biochemistry I, Erasmus University Rotter-
dam, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands. 
Abbreviations: MDA, malondialdehyde; GSSG, oxidized glutathion; PUFA, polyunsaturated fatty acid; LADCA, 
proximal left anterior descending coronary artery; EDT A, ethylenediamine tetraacetic acid; TXB2 , thromboxane B2 ; 
6-keto PGF 1., 6-keto prostaglandin F '"; TXA2 , thromboxane A2 ; PGI2 , prostaglandin 12 ; TXB3 , thromboxane B3 ; 
6-keto PGF 2", 6-keto prostaglandin F 2". 
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in cellular concentration of glutathion 
(GSSG) and decreased activity offrcc radical 
scavengers as catalase and superoxide dis-
mutase (Guarnieri et al., 1980; Ferrari et al., 
1985). 
Because free radical molecules contain one 
or more free electrons in the outer orbitals 
they can abstract hydrogen atoms from 
various intra- and extracellular molecules like 
proteins, nucleic acids and polyunsaturated 
fatty acids (PUFAs) in particular because of 
the evidence that support an active role of 
lipid peroxidation products in free-radical 
induced injury (Meerson et al., 1982; Hess 
and Manson, 1984; Sevanian and Hochstein, 
1985; Starn and Koster, 1985; Lucchesi and 
Mullane, 1986). Hydrogen abstraction from 
the cis-cis pentadiene center of an unsatu-
rated fatty acid is purported to be the rate-
limiting step in the auto-oxidation. The 
predominant and thermodynamically most 
stable products are allylic radicals of the 
PUFAs. It is therefore feasible that the nature 
and relative quantities of PUFAs in cardiac 
membranes are important in the regulation of 
the rate and extent oflipidperoxidation in the 
heart. 
In the present investigation the PUF A com-
position of cardiac membranes was altered by 
a dietary intervention (Hartog et al., 1986, 
1987). Myocardial formation of MDA and 
GSSG were determined before and at the end 
of a sequence of brief periods of ischaemia and 
reperfusion. Regional systolic wall thickening 
measurements were used to determine 
whether an altered susceptibility of cardiac 
membranes to free radical attack leads to a 
change in the rate and magnitude of recovery 
of myocardial function. Sarcolemmal fatty 
acid composition were determined in isch-
aemic heart biopsies to examine the possible 
selective loss of PUF As. A free radical-
generating system, Fe3 + -ADP plus dihydrofu-
marate, was used to determine whether the 
cardiac sarcolemmal membrane from mack-
erel oil fed pigs also is more susceptible to free 
radical attack in vitro. 
Materials and Methods 
Experimental animals and diets 
Sixteen Yorkshire piglets of either sex and 
5 weeks of age (7.9 ± 0.2 kg) were housed 
individually in slat-bottomed cages in 
temperature-controlled animal quarters and 
divided arbitrarily into two groups. Each 
group followed a different diet for a period of 
8 weeks, the regimen, preparation and com-
position of which are described in detail by 
Hartog et al. (1986, 1987). The diets mainly 
differed in the contents of 18 : 0, 18 : 1 n-9, 
18 : 2 n-6, 20 : 5 n-3 and 22 : 6 n-3 (lard fat 
diet: 10, 42, 15,0 and 0 mole%, respectively; 
mackerel oil diet: 1, 1 7, 8, 17 and 9 mole%, 
respectively). Before the start of the dietary 
period and thereafter at 2-week intervals 
venous blood samples were collected from 
24-h fasted (to limit possible effects of dietary 
MDA on plasma MDA as found by Draper 
et al., 1984 who studied cod liver oil fed 
rabbits) animals for measurement of plasma 
MDA and lipofuscin concentration. 
Surgical preparation and haemodynamic 
measurements 
After 8 weeks, the 16 animals (now weighing 
20.4 ± 0. 7 kg) were anaesthetized and cathe-
terized according to V erdouw et al. ( 1986). 
Briefly, following exposure of the heart via a 
midsternal split, electromagnetic flow probes 
were placed around the ascending aorta and 
the proximal left anterior descending coro-
nary artery (see Fig. 1). The accompanying 
cardiac vein .was cannulated. Baseline mea-
surements were obtained after a stabilization 
period of at least 30 min. Subsequently, the 
LADCA was clamped for 5 min and 
declamped for 10 min. This occlusion-
reperfusion procedure was repeated five more 
times. The only drugs used in this study were 
the anaesthetics and the muscle relaxant pan-
curoniumbromide. 
Chemical analysis if plasma and myocardial biopsies 
Coronary venous blood samples were col-
lected prior to the first coronary artery 
occlusion and during peak hyperaemia of the 
last reperfusion period (Fig. 1). At the same 
time arterial blood samples were taken from 
the ascending aorta. After separation of blood 
cells by centrifugation at 0 to 4°C, the plasma 
was frozen in liquid N 2 and stored at -80°C. 
The MDA content of the plasma samples was 
measured in the presence of 100 JlM EDT A as 
described by Jackson et al. (1983). The extinc-
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FIGURE I. Surgical preparation and the sites of clamping of the coronary artery, blood sampling, pressure and 
blood flow measurements. SWT, systolic wall thickening; AoF, aorta flow; LVP, left ventricular pressure; AoP, aorta 
pressure; CBF, coronary blood flow. 
tion coefficient of the thiobarbituric acid 
product was taken as 1.56 x 105 for all calcu-
lations of the MDA content. The production 
in nmol MDA per min was calculated from 
the difference in arterial and venous MDA 
levels multiplied by the coronary blood flow. 
In some of the plasma samples water-soluble 
fluorescent substances like lipofuscin existing 
in the protein fraction were also determined at 
excitation and emission wavelengths of 350 
and 460 nm, respectively (Tsuchida et al., 
1985). Calibration of l 00 relative fluorescence 
units was done against a 0.1 ,ug/ml quinine 
sulfate solution in 0.1 N sulfuric acid. Throm-
boxane B2 (TXB2 ) and 6-keto prostaglandin 
F la (6-keto PGF ta), which are the stable 
products of thromboxane A2 (TXA2 ) and 
prostacyclin (PGI2 ), respectively, were deter-
mined in plasma samples by radioimmunoass-
ay (Hartog et al., 1986). GSSG levels in 
plasma were determined as described by 
Ferrari et al. (1985). 
After completion of the occlusion-
reperfusion protocol the heart was 1mme-
diately excised and cooled in 1ce. 
Ischaemic-reperfused and non-ischaemic 
myocardium (about 5 g each) was rapidly cut 
out and homogenized in buffer (0.3 M sucrose, 
5 mM MgS04 , 10 mM imidazole-HCl, 
pH 7 .0) with 5 s bursts of the polytron PT 10 
at dial setting 4. Enriched sarcolemma prep-
arations were isolated from the myocardial 
homogenates as previously described (Lamers 
et al., 1984, 1986). The final membrane pel-
let was resuspended in l ml 160 mM KCl, 
20 mM 4-morpholino-propane-sulfonic acid 
pH 7.4, frozen in liquid N2 and stored at 
-80°C. The procedures for phospholipid 
extraction, subsequent phospholipid hydro-
lysis and formation of fatty acid methylesters 
and gas chromatographic separation have all 
been described before (Montfoort et al., 
1986). Ca2 + -stimulated Mg2 + -ATPase activ-
ity was determined with [y-32P]-labeled ATP 
as substrate and by isobutanol extraction of 
molybdate-complexed 32Pi (Lamers et al., 
1985). The difference between activities at 0 
and 0.5 or 12 ,UM free Ca2 + concentration was 
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taken as the Ca2 + -stimulated portion of the 
ATPase activity. Protein concentrations were 
determined by the method of Lowry et al. 
(1951) with bovine serum albumin as a stan-
dard. 
In vitro measurement rif the rate rif lipid 
per oxidation 
Isolated sarcolemmal vesicles (exactly 450 tJ.g 
of protein) were incubated in 3 ml 0.1 mM 
Fe3+ -1 mM ADP chelate, 3.3 mM dihydrofu-
marate, 160 mM KCl and 20 mM MOPS, 
pH 7.2 at 37°C in a shaking waterbath for 60 
min as described by Kramer et al. (1984). At 
intervals, aliquots of the sarcolemmal reaction 
mixtures were assayed for MDA. Extremely 
low production ofMDA was monitored when 
one of the components Fe3 + -ADP or dihydro-
fumarate was omitted from the incubation. 
Statistic treatment rif the data 
Results are expressed as mean ± s.E.M. Sta-
tistical significance was established by the 
Student's t-test. 
Materials 
Radioactive substances, [y-32P]-ATP and 
[ 14C]-AMP, used for indication of Ca2+ 
pump ATPase and AMPase activity respec-
tively, were obtained from Amersham Inter-
national PLC (Amersham, UK). All other 
chemicals were obtained from either Merck 
(Darmstadt, West Germany) or Boehringer 
(Mannheim, West Germany). 
Results 
Plasma levels rif MDA and liprifuscin during the 
dietary period 
The MDA plasma concentrations of the 
mackerel oil fed animals tended to decrease 
during the 8-week feeding period (Fig. 2). 
Those of the lard fat fed animals followed a 
similar pattern after a slight increase in the 
first 2 weeks. In four pigs of each dietary 
group water-soluble fluorescent substances 
including lipofuscin were measured in plasma 
samples obtained at the end of the dietary 
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FIGURE 2. MDA concentrations in plasma of blood 
taken from the subclavian vein in eight pigs during the 
8-week feeding period (mean ± s.E.M.). Blood samples 
were collected from 24-h fasted pigs that were on a mack-
erel oil ( 8) or lard fat ( 0) enriched diet. MDA assay has 
been carried out as described in the Methods section. 
* P < 0.05 vs. the pre-dietary plasma value. 
period. The relative fluorescence per 10 111 
plasma was 81 ± 12 for the lard fat fed and 
38 ± 7 (P < 0.05) for the mackerel oil fed 
pigs. These fluorescent substances are likely 
Schiff's binding bases formed between perOJci-
dized lipids and serum proteins (Tsuchida 
et al., 1985). The results indicate that supple-
mentation of the diet with mackerel oil does 
not result in higher levels oflipid peroxidation 
products in the plasma. 
MDA production by the lift ventricle bifore and 
immediatelY after ischaemia-reperfusion 
Myocardial MDA production before (19 ± 4 
rimoljmin) and during the last reperfusion 
period (52 ± 19 nmol/min) were not signifi-
cantly different in the mackerel oil fed animals 
(Fig. 3). In the lard fat fed animals we did not 
observe any MDA production either before 
induction of ischaemia, or during the last 
reperfusion. At the end of the last reperfusion 
there was no significant production of GSSG 
(another indicator of oxidative i~ury) in 
either group of animals: 8 ± 45 and 30 ± 17 
nmol/min for the lard fat (n = 4) and 
mackerel oil (n = 6) fed animals, respectively. 
Prior to the first occlusion the coronary 
venous levels of TXB2 (16 ± 5 and 39 ± 8 
pg/ml, respectively, P < 0.05) and 6-keto 
PGF1o (82 ± 6 and 133 ± 35 pg/ml, respec-
tively, P < 0.05) were markedly lower in the 
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FIGURE 3. MDA production by the pig left ventricle 
before and after a sequence of six consecutive 5 min coro-
nary artery occlusions interrupted by 10 min of reperfu-
sion. Coronary arterial and venous blood samples were 
collected prior to (n = 4 LF and 5 MO) the first occlusion 
and during peak hyperaemia of the last reperfusion 
period (n = 5 LF and 8 MO). See Figure 1 for the sites of 
blood sampling and flow measurement. * P < 0.05 vs. the 
corresponding mean value obtained in the lard fat fed 
animals. LF, lard fat fed; MO, mackerel oil fed. Bars rep-
resent mean ± s.E.M. 
mackerel oil than in the lard fat fed animals 
(see Hartog et al., 1986}. The increased coro-
nary venous levels of TXB2 ( 19 ± 7 and 
77 ± 6 pg/ml, respectively, P < 0.05) and 
6-keto PGFt. (123 ± 7 and 371 ± 40 pg/ml, 
respectively, P < 0.05) measured during peak 
hyperaemia of the last reperfusion were also 
much lower in the mackerel oil than in the 
lard fat fed animals. The contribution of 
cyclooxygenase products of 20 : 5 n-3 (TXB3 
and 6-keto PGF 2a) to the myocardial MDA 
formation in the mackerel oil fed animals is 
expected to be minor because 20 : 5 n-3 is a 
very poor substrate for [ydooxygenase 
(Lands, 1982 ; Lamers et al., 198 7) . 
Recovery if regional myocardial function after 
multiple transient periods if ischaemia 
Despite the observed greater susceptibility to 
lipid peroxidation of hearts of mackerel oil 
fed pigs, the ischaemia-reperfusion-induced 
changes in heart rate, mean arterial blood 
pressure, left ventricular end -diastolic pres-
sure and cardiac output were the same 
(Table 1). In both groups of animals regional 
systolic wall thickening was completely abol-
ished during the occlusion periods as a conse-
quence of the lack of any myocardial 
perfusion (collateral blood flow in pigs is less 
than 0.05 ml/min/g; Verdouw et al., 1983). 
Recovery of function during reperfusion was 
partial but similar in both dietary groups 
(Table 1). The only diet-related difference 
was the more pronounced hyperaemic 
response in the mackerel oil fed animals 
during the last reperfusion period, probably 
caused by the observed alterations of the 
TXA2/PGI2 ratio (Hartog et al., 1986). 
Biochemical properties if isolated sarcolemmal 
preparations 
There was no difference in sarcolemmal yield 
between the biopsies taken from non-
TABLE l. Cardiovascular performance oflard fat and mackerel oil fed pigs subjected under 
anaesthesia to a sequence of six consecutive coronary artery occlusions (5 min) 
interrupted by 10 min ofreperfusion 
·Lard fat fed group (n = 8) Mackerel oil fed group (n = 8) 
End of last End of last 
Baseline reperfusion Baseline reperfusion 
HR (beats/min) ll0±9 83 ± 6" 107 ± 15 99 ± ll 
MAP (mmHg) 86 ± 5 60 ± 3" 94± 5 71 ± 5" 
LVEDP (mmHg) 7.7 ± 0.6 9.1 ± 0.9 8.7 ± 1.3 10.3±1.7 
CO (!/min) 1.8 ± 0.2 1.0±0.1" 1.8 ± 0.2 1.2±0.1" 
CBF (ml/min) 31 ± 5 32 ± 7 32 ± 5 50± to•·b 
SWT(%) 37 ± 3 29 ± 4" 28 ± 3 21 ± 2" 
HR, heart rate; MAP, mean arterial blood pressure; LVEDP, left ventricular end-diastolic pressure; 
CO, cardiac output; CBF, left anterior descending coronary artery flow; SWT, systolic wall thickening; 
n, the number of pigs. 
a P < 0.05 vs. corresponding baseline value; b the ischaemia-induced changes in the mackerel oil fed 
animals is significantly different (P < 0.05) from those in the lard fat fed animals. All data are presented 
as mean ± s.E.M. 
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TABLE 2. Yield and purities of sarcolemma isolated from biopsies of the left ventri-
cle of lard fat and mackerel oil fed pigs subjected under anaesthesia to a 
sequence of six consecutive coronary artery occlusions (5 min) inter-
rupted by 10 min ofreperfusion 
Yield (%)" 
AMPase (RSA)b 
Lard fat fed group 
C (n = 8) 
0.38 ± 0.04 
10.7 ± 0.9 
I-R (n = 8) 
0.45 ± 0.05 
13.3 ± 2.4 
Mackerel oil fed group 
C (n = 8) 
0.47 ± 0.04 
12.6 ± 1.8 
I-R (n = 8) 
0.51 ± 0.06 
12.4 ± 2.4 
a Yield of sarcolemma protein is expressed as percentage of total homogenate protein. 
b RSA of 5' -nucleotidase (AMPase) is calculated by dividing the measured specific activity (in 
nmol/min/mg) of sarcolemma through that measured in the corresponding homogenate fraction. 
C, control segment; 1-R, segment subjected to occlusion-reperfusion; n, number of pigs. All 
data are presented as mean ± s.E.M. 
ischaemic and ischaemic-reperfused regions 
of lard fat and mackerel oil fed animals 
(Table 2). No diet-related differences were 
also observed between the purities of the sar-
colemmal preparations, which were estimated 
using the marker enzyme AMPase. The 
results indicate that the differences in diet and 
short-term periods of ischaemia-reperfusion 
had no effect on subcellular fractionation pat-
terns. 
As expected, feeding of mackerel oil 
induced a marked shift in the membrane 
PUFA composltwn as 18: 2 n-6 and 20:4 
n-6 were partially replaced by 20 : 5 n-3 and 
22: 6 n-3 (Table 3). This causes the mean 
number of double bonds per mole fatty acid 
(double bond index) to increase from 
1.28 ± 0.06 (n = 8) in the lard fat fed pigs to 
1.85 ± 0.06 (n = 8, P < 0.05) in the mackerel 
oil fed animals. The sum of PUF As increased 
slightly (P < 0.05) from 33.5 ± 2.2 to 
39.1 ± 1.6 mole % of the total fatty acid pooL 
The results in Table 3 also show that, except 
for a minor component fatty acid 22 : 5 n-3, 
TABLE 3. Fatty acid composition of sarcolemma isolated from biopsies of the left 
ventricle of lard fat and mackerel oil fed pigs subjected under anaes-
thesia to a sequence of six consecutive coronary artery occlusions 
(5 min) interrupted by 10 min ofreperfusion 
Lard fat fed group Mackerel oil fed group 
Fatty acids C (n= 8) I-R (n = 7) C (n= 8) I-R (n = 8) 
14:0 3.8 ± 0.9 3.4 ± 0'.6 4.2 ± 0.6 0.8 ± 0.5 
DMA 16:0 2.9 ± 0.7 1.6 ± 0.5 3.9 ± 1.0 3.2 ± 0.8 
16:0 25.7 ± 0.9 24.7 ± 1.0 26.3 ± 0.9 25.7 ± 1.2 
DMA 18:0 1.4 ± 0.4 1.2 ± 0.3 2.1 ± 0.5 2.1 ± 0.5 
18:0 10.9 ± 0.5 10.5 ± 0.7 10.7 ± 0.6 !0.8 ± 0.9 
18: I n-9 21.8 ± 2.2 20.7 ± 1.9 13.6 ± 1.2" !3.7 ± !.3 
18: 2 n-6 15.7 ± 1.4 17.5 ± 1.! 6.2 ± 0.4" 6.5 ± 0.9 
20: 4 n-6 13.2 ± 1.4 14.4 ± 1.2 6.1 ± 0.3" 6.2 ± 0.2 
20: 5 n-3 0 0.2 ± 0.1 16.9 ± r.o• 16.3 ± 0.6 
22: 4 n-3 2.9 ± 0.5 2.9 ± 0.8 3.7 ± 0.6 5.3 ± 1.2 
22:5 n-3 0.5 ± 0.2 1.2 ± O.lb 1.4 ± 0.2" 1.4 ± 0.2 
22: 6 n-3 1.2 ± 0_.2 !.3 ± 0.2 4.9 ± 0.3" 5.1 ± 0.3 
DMA, dimethylated acetals. 
•, P < 0.05 vs. that obtained in the lard fat fed animals; h, P < 0.05 vs. data from control 
segment. 
C, control segment; 1-R, segment subjected to occlusion-reperfusion; n, number of pigs. All 
data are presented as mean ± s.E.M. 
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TABLE 4. Ca2+ pumping ATPase activities of sarcolemma isolated from biopsies of the left 
ventricle of lard fat and mackerel oil fed pigs subjected under anaesthesia to a 
sequence of six consecutive coronary artery occlusions (5 min) interrupted by 10 
min ofreperfusion 
Lard fat fed group Mackerel oil fed group 
C (n = 6) I-R (n = 6) C (n = 6) I-R (n = 6) 
Activity• 
(nmoljmin/mg) 
Basal 46.0 ± 5.2 52.8 ± 6.9 47.7 ± 10.1 46.0 ± 5.2 
Ca2 + stimulated 61.3 ± 8.3 76.3 ± 7.8 102.9 ± 10.6b 109.1 ± 14.2b 
Affinity for Ca2+ 
Activity ratio (%) 43.6 ± 7.6 41.1 ± 3.8 43.4 ± 5.1 43.6 ± 7.6 
• The activity ratio represents the activity stimulated by 0.5 Jl.M Ca2+ as a percentage of the activity 
stimulated by the maximum Ca2+ concentration (12 Jl.M). This percentage is taken as a rough param-
eter for the affinity of the enzyme for Ca2 + ions. 
C, control segment; I-R, segment subjected to occlusion-reperfusion; n, number of pigs. 
b P < 0.05 vs. the activity measured in a corresponding sample of the lard fat fed animals. 
All data are presented as mean± s.E.M. 
no change in PUF A composition occurs after 
the recurrent ischaemia-reperfusion periods. 
The maximal activity and the Ca2+ affinity 
of the sarcolemmal Ca2 + pumping ATPase, 
from non-ischaemic and ischaemic-reperfused 
myocardium did not differ at the end of the 
experimental protocol (Table 4). The signifi-
cantly higher Ca2+ pumping ATPase activity 
of the membranes of the mackerel oil fed pigs 
may be related to altered fluidity properties of 
the phospholipid bilayer due to a higher 
degree of unsaturation of the membrane fatty 
acids (Table 3). 
The fatty acids with higher degree of 
unsaturation in cardiac sarcolemma of mack-
erel oil fed animals are expected to be more 
readily peroxidized as indeed follows from the 
results on in situ myocardial MDA production 
(Fig. 3). The relative vulnerability to exoge-
nously evoked free radicals of in vitro incu-
bated cardiac sarcolemma preparations from 
the two dietary groups was also examined. 
The free radicals were generated during auto-
oxidation of dihydrofumaric acid in the pre-
sence of Fe3 + -ADP. In the mackerel oil fed 
pigs MDA formation started after a lag phase 
of about 20 min, and had a much higher rate 
in the sarcolemma fraction in which relatively 
high portions of20 : 5 n-3 and 22 : 6 n-3 were 
incorporated (Fig. 4 and Table 3). The lag 
phase may be caused by the presence oflarger 
quantities of vitamin E in the sarcolemma due 
to the dietary supplementation. Hammer and 
Wills (1978) demonstrated that dietary sup-
plementation of vitamin E markedly reduced 
MDA formation in rat liver microsomes 
(measured in the presence of ascorbate) after 
lard fat as well as herring oil diets. In that 
study we can not evaluate the effect of dietary 
vitamin E supplementation on the duration of 
the lag phase because information on the time 
course of MDA production is lacking. 
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FIGURE 4. MDA production by isolated sarco-
lemmal membranes that were incubated in vitro with 
Fe3+ -ADP plus dihydrofumarate. Sarcolemmal vesicles 
were isolated from non-ischaemic myocardium of pigs fed 
mackerel oil ( 8) or lard fat ( o) for 8 weeks. Further 
details of sarcolemmal isolation procedure, incubation 
·conditions and MDA assay are given in the Methods. 
Each point represents the mean (s.E.M.) of determinations 
in five pigs. * P < 0.05 vs. sarcolemma isolated from lard 
fat fed pigs. 
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Discussion 
With reintroduction of molecular oxygen to 
the hypoxic/ischaemic myocardium, there 
may be a burst of highly destructive oxygen 
free radicals from the activated free radical 
producing systems. Peroxidative breakdown 
of membrane PUFAs could be a consequence 
of action of these oxygen free radicals. Das 
et al. ( 1986) showed that in isolated in situ 
porcine hearts the free radical scavengers 
superoxide dismutase and catalase improved 
recovery of cardiac function and reduced 
myocardial MDA production during reperfu-
sion. In the present study, recovery of regional 
myocardial function was similar for both 
dietary groups, but MDA production was 
only detectable in the mackerel oil fed 
animals. Recently, larger amounts of thio-
barbituric acid-reactive substances have been 
found in heart tissue from rats fed with cod 
liver oil for 14 to 21 days, results which are in 
agreement with those of the present investiga-
tion (Herbert and Wills, 1987). The arterial 
and coronary venous concentrations of MDA 
in the present study vary between 2 and 
4 nmoljml which are similar to data reported 
by Liedtke et al. (1984). Das et 'al. (1986) 
reported 100 to 200 times higher (200 to 800 
nmol/ml) coronary systemic concentrations of 
MDA for pig hearts on an extracorporal cir-
culation. It is therefore likely that consider-
able scavenging of free radicals occurs by 
components supplied by the systemic circula-
tion (e.g. ferritin-Fe 2 + complex and Cu2 +-
ceruloplasmin). 
MDA was not produced by the left ventri-
cle of the lard fat fed animals which contrasts 
the significant production in the mackerel oil 
fed animals. This was an unexpected finding 
in view of the similar PUF A content of the 
isolated sarcolemmal membranes (33.5 ± 2.2 
vs. 39.1 ± 1.6 in the lard fat versus mackerel 
oil fed pigs) and the high content of 20 : 4 n-6 
(Table 3). However, a significant production 
of MDA was observed in the in vitro experi-
ments with exposure of cardiac sarcolemma 
from lard fat fed pigs to a free radical gener-
ating system. Three carbon dialdehyde may 
arise from fatty acid hydroperoxide when an 
unsaturated bond resides f3-y to the peroxide-
bearing carbon (Sevanian and Hochstein, 
1985; Starn and Koster, 1985). These cyclic 
peroxides may be the precursors ofMDA and 
other volatile products. To cyclize to com-
pounds bearing a five-membered ring also 
requires a nonconjugated system residing {3-y 
to the peroxyradicaL Hence, such reactions 
leading to MDA require three or more double 
bonds for the fatty acid. Hammer and Wills 
(1978) determined the rate of lipid peroxi-
dation in the presence of ascorbate in sus-
pensions of liver endoplasmic reticulum 
membranes isolated from rats fed on herring 
oil or lard fat diet. The 3.5-fold higher rate of 
MDA formation as seen in the fish oil fed 
animals compares favorably with the present 
observations. 
A number of cyclic peroxides (or 
endoperoxides) produced from PUFAs bear a 
remarkable resemblance to prostaglandins-
notably prostaglandin G2 . The free radical-
induced cyclization reaction in PUF As is, in 
fact, a chemical equivalent to the enzymati-
cally controlled reactions catalyzed by cyclo-
oxygenase (Sevanian and Hochstein, 1985; 
Starn and Koster, 1985). Decomposition of 
cyclic peroxides formed by cyclooxygenase 
can also yield MDA. In the mackerel oil fed 
animals 3- to 4-fold lower concentrations of 
TXB2 and 6-keto PGF la were measured in 
the coronary vein both before and after isch-
aemia. This reduction is most likely caused by 
replacement of the precursor 20 : 4 n-6 by 
20: 5 n-3 within the membrane (Table 3). 
Although knowledge of the production rates 
of TXB2 and 6-keto PGF la would offer a 
more definite proof, it is likely that the 
observed myocardial MDA production in the 
mackerel oil fed pigs prior to the first 
occlusion and at peak hyperaemia originates 
from products of non-enzymatic lipid peroxi-
dation. 
The diets in the present study were supple-
mented with similar amounts of vitamin E 
and selenium to prevent development of 
yellow fat disease due to dietary fish oil 
(Ruiter et al., 1978; Hartog et al., 1987). 
During the entire dietary period plasma 
MDA and lipofuscin content were not higher 
in mackerel oil than in the lard fat fed 
animals. This could be related to this supple-
mentation- of diets with natural anti-
oxydantia. That rabbits receiving large 
amounts offish oil supplemented with tocoph-
erols had much higher plasma MDA concen-
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trations implies a species difference in the 
endogenous scavenging capacity (Thiery and 
Seidel, 198 7). 
The sarcolemmal membrane, relatively 
poor in tocopherols, is probably more suscep-
tible to lipid peroxidation than, e.g., the 
sarcoplasmic reticulum (Kramer et al., 1984; 
Guarnieri et al., 1985; Starn and Koster, 
1985). However, the PUFA composition of 
sarcolemma did not change during recurrent 
ischaemia-reperfusion (Table 3). The 
absence of these proves that attack of gener-
ated free radicals and phospholipase A2 on 
PUF As in membrane phospholipid is accom-
panied by active reacylation. It has been 
shown that for the production of I nmol MDA 
about 9 nmoles PUF A are used (Hammer and 
Wills, 1978). We observed a mean MDA pro-
duction of 52 nmoljmin during the last 
ischaemic-reperfusion period. The great 
cardiac vein drains blood from approximately 
40 g wet wt of left ventricular tissue which 
contains a total of 200 mg sarcolemmal 
protein. If the MDA production rate remains 
constant during recurrent ischaemia-
reperfusion periods (total of 60 min reperfu-
sion time), the total sarcolemmal PUFA 
breakdown will be 0.05 J.Lmoles/mg membrane 
protein. Such a high breakdown should be 
detectable by measurement of mole % of 
PUF As as sarcolemma-enriched membranes 
contain about 0.5 to 0.8 J.Lmol phospholipid-
bound PUFA per mg protein (unpublished). 
Meerson et al. (1982) proposed that lipid 
hydroperoxides may form so-called trans-
membrane clusters by lateral diffusion which 
serve as ion permeability channels. Other 
investigators have shown that membrane-
localized enzymes (e.g. Ca2+ pumping 
ATPase and N a+ pumping ATPase) are 
affected by lipid peroxidation processes as a 
consequence of altered annulus phospholipid 
or as a result of interaction of lipid peroxide 
(radicals) with membrane proteins (Hess 
et al., 1981; Jones et al., 1983; Okabe et al., 
1983; Hess and Manson, 1984; Kramer et al., 
1984; Kim and Akera, 1987). Sarcolemmal 
Ca2 + pumping ATPase, however, remained 
stable after recurrent ischaemia-reperfusion 
in either dietary group. It is possible that the 
heart should be subjected to longer periods of 
ischaemia to demonstrate changes in sarco-
lemmal membrane Ca2 + transport functions, 
although previously we also showed sarco-
lemmal Na+ pumping ATPase activity to 
remain unaltered even after 3 h of ischaemia 
(Lamers et al., 1986). 
In spite of an increased susceptibility to free 
radical generated peroxidative damage of 
heart membranes of the mackerel oil fed pigs, 
the recovery of regional left ventricular func-
tion was similar to that of lard fat fed pigs 
during recurrent myocardial ischaemia-
reperfusion. In recent studies performed with 
rats fed cod liver oil the loss of creatine kinase 
was examined following in situ coronary liga-
tion (Hock et al., 1987) and low flow isch-
aemia using the Langendorff procedure 
(Karmazyn et al., 1987). Only in the in situ 
model dietary fish oil reduced creatine kinase 
release (36%) after 6 h of ischaemia. An 
explanation could be that dietary supplemen-
tation of marine lipids to experimental 
animals produces, in addition to the harmful 
effects of increased membrane lipid peroxi-
dation, some beneficial effects through an 
unknown mechanism. 
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CHAPTER 11 
Does platelet aggregation play a role in the reduction 
in localized intimal proliferation in normolipidemic pigs 
with fixed coronary artery stenosis fed dietary fish oil? 
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Summary 
In order to investigate the effect of fish oil on intimal proliferation of coronary arteries with a fixed 
stenosis normolipidemic piglets received a basic diet to which either 9% (w jw) lard (L, n = 8) or 4.5% 
(w jw) lard and 4.5% (w jw) mackerel oil (ML, n = 8) was added for 4 months. Stenosis was applied by 
implanting a 4.0 X 2.0 mm (i.d.) Teflon constrictor around the left anterior descending coronary artery 
(LADCA) (o.d. 2.7 ± 0.1 mm). During the dietary period ADP-induced platelet aggregation in whole 
blood was higher in L than in ML. Partial replacement of 20 : 4 n - 6 by 20 : 5 n - 3 fatty acids in the 
platelet membranes of ML may have altered platelet aggregation by changes in eicosanoid synthesis. The 
plasma cholesterol and triglyceride levels did not change in L, but decreased in ML. At the end of the 
4-month dietary period the animals were again anesthetized and regional myocardial perfusion (radioactive 
labelled microspheres) and systolic segment length shortening (SLS) were measured while the hearts were 
paced at 160 pulses/min. Perfusion and SLS of the non-LADCA nourished segment were similar for L 
and ML. However, transmural flow to the LADCA perfused myocardium was impaired in both groups, 
but the deficiency in endocardial perfusion was considerably larger in L than in ML, resulting in a larger 
loss of SLS in the former. Remote (2-3 em from the site of the constrictor) luminal encroachment was 
minimal ( < 2%) in both groups, but at the site of the constrictor there was significant encroachment in 
both groups which was higher in L (62 ± 7%) than in ML (11 ± 4%). It is thought that in these 
normolipidemic pigs the reduction in platelet aggregation may play a role in the smaller intimal 
proliferation of the fish oil-fed animals. 
Key words: Fish oil; Platelet aggregation; Coronary artery perfusion; Plasma lipids; Coronary artery 
constriction; Intimal proliferation; Prostaglandin; (Pig) 
Correspondence to: P.D. Verdouw, PhD. Laboratory for 
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Introduction 
Recent clinical trials have stressed the impor-
tance of lowering plasma cholesterol in reducing 
0021-9150j89j$03.50 © 1989 Elsevier Scientific Publishers Ireland, Ltd. 
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the risk of developing ischemic heart disease [1,2]. 
Experimental evidence suggests that eicosa-
pentanoic (EPA) and docosahexanoic (DHA) acids 
lower blood cholesterol and triglyceride levels 
[3-8]. The high contents of these fatty acids in 
fatty marine fish may therefore explain the lower 
incidence of coronary heart disease in populations 
consuming these fish [9-12]. The slower develop-
ment of atherosclerosis in fish oil-fed rhesus 
monkeys is consistent with this hypothesis [13]. 
EPA and DHA not only modify plasma lipids 
but they also affect platelet aggregation, blood 
viscosity and possibly arterial blood pressure and 
formation of prostaglandins and leukotrienes 
[14-18]. These effects are of interest because in 2 
epidemiological studies consumption of fish 
reduced mortality from coronary artery disease 
without affecting cholesterol and triglyceride levels 
[10,11]. Moreover, the addition of 30 rnl cod liver 
oil to atherogenic diets fed to pigs, reduced the 
severity of the atherosclerotic lesions without af-
fecting serum lipids [9]. In this last study platelet 
fatty acid composition was altered, sermp 
thomboxane ~ levels reduced and the interaction 
of platelets with the abraded vessel wall inhibited. 
These factors could account for the lower inci-
dence of atherosclerosis in these animals. Further-
more, negative effects of dietary fish oil consump-
tion have also been reported as cholesterol-in-
duced atherosclerosis was more severe in rabbits 
when their standard diet was supplemented daily 
with 0.4 g EPA [20]. In these rabbits levels of 
plasma cholesterol did not change but those of 
plasma triglycerides tripled. It appears that the 
role of regular fish oil intake on the progression of 
atherosclerosis is still debatable. Moreover, if such 
an action exists it is questionable whether lower-
ing of plasma lipid levels is the prime factor 
responsible. Therefore more information is needed 
on intimal thickening of the arterial wall caused 
by a combination of factors such as mechanical 
disruption of endothelium and mural thrombosis 
while changes in plasma lipids are minimal. 
Several investigators have reported that partial 
constriction of a coronary artery leads to cyclic 
variations in blood flow due to platelet plug for-
mation [21,22]. The combination of locally high 
blood flow and wall shear forces causes hemolysis 
and denudation of the vessel wall leading to 
primary and secondary platelet aggregation. The 
formation of mural thrombi is believed to initiate 
proliferation of smooth muscle cells migrating into 
the intimal layers [23]. In the present study we 
evaluated the effect of fish oil-induced changes on 
coronary artery proliferation in normolipidemic 
pigs with a chronic stenosis. Normolipidemic pigs 
were used to minimize the effects on plasma lipid 
composition. 
Methods 
Animals 
Eight castrated male and 8 female weanling 
Yorkshire piglets (5 weeks of age; 7.7 ± 0.2 kg) 
were housed individually in slat-bottomed cages in 
temperature-controlled animal facilities and di-
vided arbitrarily into 2 groups, each consisting of 
4 castrated male and 4 female pigs. 
Diets 
Both groups of animals received the same basic 
diet (fat content < 2%, w jw) to which either 9% 
lard (wjw; group L) or 4.5% mackerel oil and 
4.5% lard (w jw; group ML) was added (Hope 
Farms, Woerden, The Netherlands). A conse-
quence of the fat supplementation was that both 
EPA (8%, wjw) and DHA (5%, wjw) were pre-
sentin the total fatty acid pool of the diet of ML, 
but absent in that of L Full details of the com-
position of the diets have been described elsewhere 
[7,8,24]. 
Implantation of coronary artery constrictor 
After the animals (now weighing 20 ± 1 kg (L) 
and 21 ± 1 kg (ML)) had been on their diets for 2 
months, they were pretreated with intramuscular 
injections of 300 000 U procaine penicillin G and 
300000 U bezathine penicillin G (Duplocilline", 
Gist Brocades, Delft, The Netherlands) and 
anesthetized with 30 mgjkg ketamine i.m. 
(Aescoket", Aesculaap BV, Boxtel, The Nether-
lands), incubated and connected to a respirator 
for artificial ventilation with a mixture of oxygen 
and nitrous oxide (1 : 2) to which halothane 
(Fluothane", Macclesfield, U.K.) was added. After 
the thorax was opened Via an incision in the left 
third intercostal space and the proximal left ante-
rior descending coronary artery was dissected free 
over a length of 10 mm to place a 4.0 X 2.0 mm 
(i.d.) Teflon® ring around the vessel (o.d. 2.7 ± 0.1 
mm). The diameter of the constrictor was such 
that the minimal narrowing of the lumen did not 
impede coronary blood supply at the time of 
placement After closure of the thorax the animals 
were allowed to recover and the dietary regimen 
was continued for 2 more months. 
Seven animals died during the post-implanta-
tion period. Three animals of L and 2 animals of 
ML died suddenly after 5-7 weeks. In each of 
these animals a thrombus was found ill the 
LADCA (examination within 30 min after sudden 
death). One animal of L died of cardiac failure 
after 8 weeks and 1 animal (ML) was killed be-
cause of postoperative infection after 2 weeks. 
This last animal was excluded from further study. 
Plasma lipids 
Plasma levels of triglycerides and total choles-
terol were determined in fasted animals before the 
start of the dietary period and 8 weeks later using 
methods described earlier [7 ,8]. 
Chemical analysis of platelet membranes 
At the time of implantation of the constrictor 
blood (50 ml) was collected via a catheter located 
in the external jugular vein from 3 male animals of 
each group. Washed platelet suspensions were pre-
pared from these samples, homogenized and the 
total phospholipid fractions extracted and sep-
arated from other lipids by thin-layer chromatog-
raphy. Transmethylation, extraction of methyl es-
ters and subsequent gas chromatographic sep-
aration have all been described [25]. 
Plate let aggregation of whole blood 
A 5-ml heparinized (200 IU jml) blood sample 
was collected from each animal during implanta-
tion of the constrictor. After a 15-min incubation 
time at room temperature, aggregation tests were 
performed either spontaneously or after the ad-
dition of collagen (1 p.gjml) and ADP (1 and 5 
p.M), for 10 min [26]. 
Cardiac function during the experimental period 
Two-dimensional and M-mode echocardio-
grams were recorded with a 5 MHz transducer 
(21200 A Ultrasound Transducer, Hewlett-Pack-
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ard, Palo Alto, CA, U.S.A.) before the start of the 
dietary period, at the time of placement of the 
constrictor and 4, 6 and 8 weeks (weeks 12, 14 and 
16 of the dietary period, respectively) while the 
animals were sedated with ketarnine (30 mgjkg 
i.m.). The images were recorded on videotape 
(Panasonic VHS-Pro, type AG-6200, Matsushita 
Electrical Industrial Co., Ltd., Japan). Three con-
secutive heart beats were selected at the end of the 
respiratory cycle. The M-mode recordings of the 
anterior and posterior left ventricular wall of these 
beats were projected on a videoscreen and the 
end-diastolic (EDT) and end-systolic wall thick-
ness (EST) were determined using a digital tablet 
(Surnmagraphics MM 1201, Summagraphics Co., 
Fairfield, CT, U.S.A.). The systolic wall thicken-
ing was calculated as: 
SWT(%) =(EST- EDT)jEDTX 100. 
Hemodynamic evaluation at the end of the experi-
mental period 
Two months after placement of the constrictor 
(week 16 of the dietary period). the surviving 
animals were anesthetized and instrumented using 
standard techniques [27]. Regional segment length 
changes were measured by sonomicrometry (Tri-
ton Technology, San Diego, CA, U.S.A.) by im-
planting one pair of ultrasonic crystals (5 MHz) in 
the area perfused by the left anterior descending 
coronary artery and another pair in the adjacent 
myocardium. From the tracings regional systolic 
segment length shortening (SLS) was calculated as 
described earlier [28]. Regional myocardial blood 
flows were determined with radioactive labelled 
microspheres using the reference sample technique 
[29]. To this end the left atrium was cannulated 
for the injection of a batch (2 X 10 6) of micro-
spheres (15 ± lp.m (SD)) which were labelled with 
141Ce, 113Sn, 103Ru, 95 Nb or 46Se (NEN Chemicals 
GmbH, Dreieich, F.R.G.). A pacing catheter was 
positioned in the coronary sinus. After the pre-
paration had been stable for at least 30 min the 
heart was paced at 160 pulses/min. Five minutes 
later all systemic hemodynamic and regional 
myocardial function data were recorded and a 
batch of microspheres injected. 
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In order to determine what fraction of the 
myocardial blood flow in the post-stenotic 
myocardium was due to collateral blood flow the 
LADCA was clamped distal to the site of the 
constrictor and another batch of microspheres was 
injected. The flow data obtained with this last 
measurement were considered to be the collateral 
fractions. After this last measurement the animals 
were killed, the hearts excised and treated as de-
scribed earlier before radioactivity was counted in 
a gamma-scintillation counter (Packard, model 
5986) equipped with a multichannel pulse height 
analyzer (Conrac) using suitable windows for dis-
criminating the different isotopes used [29]. 
Quantification of stenosis 
The proximal left anterior descending coronary 
artery, including the constrictor, was excised and 
put in 10% formaldehyde within 30 min after the 
animals had died suddeuly or been killed. Tissue 
was prepared by dissecting through the constric-
tor, such that the contours of the vessel at the site 
of constriction were visualized. Sections were cut 
at 7 JLm thickness and stained with hematoxyli,n 
and elastic tissue stains. The sections were pro-
jected on a videoscreen and the outer contours, 
internal elastic lamina and endothelial lining of 
the vessels were traced. The intimal lesion area 
was calculated as the area between the endothelial 
lining of the lumen and the internal elastic lamina. 
The luminal encroachment was calculated by di-
viding the intimal lesion area by the surface of the 
area surrounded by the internal elastic lamina. 
The media WliS calculated as the area between the 
internal elastic lamina and the outer vessel con-
tours using the method described by Weiner et al. 
[19]. 
Statistical analysis 
All data are expressed as the mean ± standard 
error of the mean (SEM). The data of the 2 groups 
are compared using Student's t-test and analysis 
of variance. Statistical significance is accepted at 
P < 0.05 (two-tailed). 
Results 
Plasma lipids 
Cholesterol (from 2.56 ± 0.42 to 2.33 ± 0.10 
mM) and triglycerides (from 0.64 ± 0.10 to 0.68 ± 
0.10 mM) did not change significantly in L during 
the first 2 months of the dietary period. In ML, 
however, cholesterol decreased from 2.48 ± 0.28 to 
1.69 ± 0.11 mM and triglycerides from 0.52 ± 0.04 
to 0.30 ± 0.04 mM (both P < 0.05). In an earlier 
study we have shown that continuation of the 
diets for another 8 weeks does not further affect 
plasma lipid levels [7]. 
Platelet fatty acid composition 
Table 1 shows the fatty acid composition of the 
total phospholipid fraction of the platelets from L 
and ML at the time of implantation of the con-
strictor. Partial replacement of 20 : 4 n - 6 by 
20 : 5 n - 3 fatty acid had occurred in ML analo-
gous to earlier findings [24]. 
Platelet aggregation 
Fig. 1 illustrates the platelet aggregation data in 
the blood samples collected after 2 months. No 
spontaneous aggregation occurred. In M and L, 
the maximal aggregation induced by collagen (1 
}Lg/ml) was not significantly different. However, 
the aggregation induced by ADP (1 and 5 }LM) in 
L (29 ± 7% and 81 ± 5% of maximal aggregation, 
respectively) was significantly higher than in ML 
(8 ± 2% and 67 ± 13% of maximal aggregation, 
TABLE 1 
FATTY ACID COMPOSITION (mol%) OF PLATELET HO-
MOGENATE PHOSPHOLIPIDS IN PIGS FED A 9% LARD 
(L) OR A 4.5% MACKEREL OIL AND 4.5% LARD (ML) 
DIET FOR 2 MONTHS 
n = number of animals; DMA = dimethylated acetals. 
Fatty acid L(n=3) ML(n=3) 
14:0 0.7±0.1 1.2±0.2 
DMA 16:0 1.3±0.2 2.0±0.3 
16:0 20.0±0.2 22.3±0.3 
DMA18:0 1.7±0.7 0.8±0.1 
18:0 18.1 ±2.0 16.0±0.3 
18:1n-9 22.8± 1.3 21.0±0.8 
18:2n-6 7.7±0.9 7.0±0.1 
20:4 n -6 16.4±2.0 8.1±0.3* 
20:5 n -3 0.4±0.2 10.6±0.3. 
22:4 n'-6 2.4±0.2 1.4±0.4. 
22:5 n -3 0.9±0.1 1.9±0.3. 
22:6 n -3 0.8±0.2 1.3±0.2 
others 6.8±'1.0 6.7± 1.5 
"' P < 0.05 vs. 9% lard fed animals. 
1 !!Qiml Collagen 1 !!M ADP 5 !!M ADP 
Fig. 1. Platelet aggregation of lard (D. n - 6) and mackerel oil 
(Ul. n - 5) fed animals. The data were obtained after an 8-week 
dietary period. Data are presented as mean± SEM. • P < 0.05 
vs. data of lard fed animals. 
respectively). For each pig the aggregation in-
duced by ADP is based on the maximal" value 
found with 1 1-'g/ml collagen. 
Regional myocardial furlction during the dietary 
period 
Before implantation of the constrictor the 
myocardial wall thickness (MWT) at end-diastole 
(EDT) as well as end-systole (EST) of both the 
posterior and the anterior wall increased with time 
independent of the diet (Fig. 2). These changes 
LARD FAT MACKEREL OIL 
" 60l ~ 40 
00 20 
Fig. 2. The end-diastolic(--) and end-systolic(------) 
myocardial wall thickness (MW1) and systolic wall thickening 
(SWI) of the anterior ("') and posterior (e) wall of lard (L, 
n = 8) and mackerel oil (ML, n = 8) fed pigs with a chronically 
implanted 2.0 mm constrictor around the left anterior descend-
ing coronary artery during the dietary period. The arrow 
denotes the time of implantation of the constrictor. The last 
measurements in L were obtained in 4 and in ML in 5 animals 
due to sudden death after implantation of the constrictor. 
• P < 0.05 vs. data of posterior walL 
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had no effect on systolic wall thickening (SWT). 
Four weeks after implantation percentage systolic 
wall thickening of the anterior segment had de-
clined to 72 ± 12% of the pre-implantation value 
in L and to 72 ± 13% in ML. At the end of the 
dietary period there was a further decrease to 
62 ± 9% of the pre-implantation value for L and 
63 ± 7% for ML. 
Heart rates of the slightly sedated but still 
spontaneously breathing animals of L were 166 ± 
10, 142 ± 11 and 110 ± 9 beats/min before and 
after 8 and 16 weeks into the dietary period, 
respectively. The heart rates of the animals be-
longing to ML were very similar as values of 
161 ± 11, 129 ± 9 and 108 ± 12 beatsjmin, re-
spectively, were recorded. 
Hemodynamics at the end of the experimental period 
To eliminate the effects of heart rate on re-
gional myocardial performance all hearts were 
paced at 160 pulsesjmin. Mean arterial blood 
pressure and the peak rate of rise in left ventricu-
lar pressure were similar for both groups but 
cardiac output was 23% lower in L than in ML 
and left ventricular filling pressure 33% higher in 
L than in ML (both P < 0.05) (Fig. 3). 
Transmural perfusion and function of the non-
ischemic posterior myocardial wall segments of L 
and ML did not differ and the data agree closely 
with those reported for conscious pigs [26,27]. 
1001 
:i:~ 50 
::;5 
0 
0 15.=- 3000l ~~:i ,:~ 1500 E.s 0 
Fig. 3. Systemic hemodynamics of lard (0, n = 4) and mackerel 
oil (fll, n = 5) fed pigs with a constrictor implanted around the 
left anterior descending coronary artery. The measurements 
were made while the animals were an~thetized and the hearts 
paced at 160 pulses/min. MAP = mean arterial blood pres-
sure; L VEDP = left ventricular end-diastolic pressure; CO= 
cardiac output; maxL V dP 1 dt = maximum rate of rise in l~ft 
ventricular pressure. Data are presented as mean± SEM. • p 
< 0.05 vs. data in lard fed animals. 
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Fig. 4. Regional myocardial blood flow (RMBF) and its distri-
bution over the subendocardial and subepicardial layers 
(ENDO /EPI) and segment length shortening (SLS) of lard (0, 
n - 4) and mackerel oil (l'il, n - 5) fed pigs. For further details 
see legend of Fig. 2. * P < 0.05 vs. data of non-ischemic 
segment of same dietary group. * * P < 0.05 vs. data of lard 
fed group. 
Transmural perfusion of the anterior wall seg-
ments, which were perfused by the left anterior 
descending coronary artery distal to the constric-
tor, was also very similar for both groups, but 
considerably less than for the non-ischemic seg-
ments (Fig. 4). In spite of similar transmural per-
fusion values of these post-stenotic ischemic seg-
ments a striking difference existed between the 
distribution of flow over the subendo- and subepi-
cardial layers. In L the decrease in perfusion af-
TABLE2 
Fig. 5. Cross sections of the left anterior descending coronary 
artery taken at the site of chronically implanted constrictor of 
lard (A) and mackerel oil {B) fed pigs. Sections were cut at 7 
p.m thickness and stained with elastic tissue stains. Arrows 
indicate staining artifacts due to cutting through the Teflon 
constrictor. Parts of the constrictor are visible as indicated ("' ). 
The location of intimal (I) and medial layers (M) are indicated. 
P = periadventitial tissue. 
LUMINAL ENCROACHMENT AT THE SITE OF THE CHRONICALLY IMPLANTED CONSTRICTOR IN THE LEFr 
ANTERIOR DESCENDING CORONARY ARTERY OF 9% LARD (L) AND 4.5% MACKEREL OIL PLUS 4.5% LARD (ML) 
FED PIGS 
L(n~8) ML(n~7) 
Mean±SEM Range Mean±SEM Range 
Cross-sectional area (nun2 ) 
Vessel 2.89±0.10 2.22-3.14 2.70±0.13 2.22-3.14 
Lumen 0.26±0.06 0.05-0.55 0.54±0.13. 0.18-0.99 
Media 2.21±0.14 1.41-2.68 2.12±0.11 1.78-2.58 
lntinla lesion 0.43±0.07 0.16-0.73 0.05±0.02. 0.01-0.10 
Encroachment(%) 
Lumen 62±7 37-93 11±4. 1-26 
"' P < 0.05 vs. 9% lard fed animals~ n = number of animals. 
fected in particular the subendocardial layers, 
whereas in ML the flow reduction affected both 
layers equally, The systolic segment length shor-
tening in ML exceeded that of L (Fig. 4), When 
perfusion measurements of the post-stenotic zones 
of L and ML were repeated after the left anterior 
descending coronary artery was completely oc-
cluded distally to the site of the stenosis the 
microsphere data revealed that the residual col-
lateral blood flow was similar for both myocardial 
zones (Fig, 4), 
Luminal encroachment at the site of stenosis 
Luminal encroachment was minimal 2-3 em 
distal to the constrictor (1.8 ± 0.3% for L and 
1.7 ± 0.2% for ML). However, all animals showed 
significant intimal proliferation at the site of the 
constrictor (Fig. 5). Luminal encroachment was 
higher in L (62 ± 7%) than in ML (11 ± 4%) due 
to a marked difference in the cross-sectional area 
of the intimal lesion (Table 2). 
Discussion 
Critical interactions between four types of cells 
- monocytes, platelets, endothelium and smooth 
muscle cells - are believed to be involved in the 
development of atherosclerosis [30]. Each of the 
interacting cells can produce growth factors and 
these contribute to the characteristic cellular pro-
liferation of the developing atheroma. Endo-
thelium of hyperlipidemic animals permits mono-
cyte adhesion and migration into the vessel wall 
after which these cells assume the shape of foam 
cells in fatty streaks. They may also promote 
growth factor formation in the endothelial cells 
[23,31]. Platelets, that are part of the thrombi 
which initially cover the intimal defects, secrete 
granule contents containing platelet-derived 
growth factor. The latter stimulates smooth muscle 
cell migration from the media to the intima [30]. 
Several factors - hyperlipidemic-induced changes 
in membrane viscosity, increased wall shear forces, 
wall stress and hypertension - contribute to the 
development of endothelial injury. The prostanoid 
metabolism is probably involved in the molecular 
basis of many of these events [3,5,6]. 
The effects of dietary fish oil upon atheroscle-
rosis may be mediated by (1) reduction of plasma 
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cholesterol, (2) alteration of prostanoid metabo-
lism (e.g., formation of leukotrienes by monocytes 
and endothelial cells), (3) production of platelet 
cell thromboxane A 2 and endothelial cell pros-
tacyclin, ( 4) reduction of viscosity due to altered 
membrane fluidity of the erythrocytes, (5) produc-
tion of endothelium-dependent relaxation, ( 6) de-
creased neutrophil aggregation, and (7) reduced 
accumulation of mast cells in the coronary arteries 
[32]. In the present study, we therefore used a 
chronic ·stenosis of the coronary artery in which 
repeated adherence and degranulation of platelets 
over the 2-month period is probably the major 
factor in producing mitosis of the smooth muscle 
cells [21-23]. 
There are several models for the study of plate-
let-vessel wall interaction, such as the aorta loop 
[33], intra-arterial protheses [34], and electrically-
induced arterial thrombosis [35]. Arterial constric-
tion ( 40-95% luminal narrowing), either by a plas-
tic ring [21,22] or a thread [36], has been used 
before, but these studies were all short lasting. In 
the study by Gertz et al. [36] endothelial damage 
was more prominently present on the proximal 
than on the distal slope of the vessel immediately 
adjacent to the thread. At the point of maximal 
constriction, platelets were attached to subendo-
thelial tissues and microthrombi (platelets with 
some fibrin and erythrocytes) protruded into the 
vascular lumen. It is therefore not surprising that 
we found a marked intimal proliferation at the site 
of the constrictor. As we did not investigate in-
timal proliferation at the vessel wall immediately 
proximally and distally to the constrictor, we have 
no information about local differences in luminal 
encroachment. 
Luminal encroachment was higher in the lard 
than in the fish oil fed animals. Because the con-
strictor produced a fixed stenosis it is unlikely that 
factors such as endothelial-dependent relaxations 
in response to released platelet products, increased 
neutrophil aggregation and accumulation of mast 
cells in the coronary arteries and release of 
leukotrienes, all affecting vascular permeability 
and coronary artery constriction, are involved. 
Fish oil feeding slightly reduced plasma lipid 
levels. However, because we used young normo-
lipidemic pigs, known for their low plasma lipid 
levels, it is unlikely that this played a large role in 
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the modification of the degree of intimal prolifera-
tion produced by fish oil. This assumption is 
further supported by the findings that fish oil 
suppressed the development of atherosclerosis in 
pigs fed atherogenic (high cholesterol) diets 
without affecting plasma lipids. In that study [19] 
platelet fatty acid composition was altered, serum 
thromboxane B, levels reduced, platelet aggrega-
tion and the interaction of platelet with the 
abraded vessel wall inhibited. We also. demon-
strated that coronary venous plasma concentra-
tions of prostaglandin derivatives of thromboxane 
A 2 and prostacyclin were markedly reduced by 
dietary fish oil which was in agreement with the 
observed reduction in 20 : 4 n - 6 content and the 
increase in 20 : 5 n - 3 content in platelet mem-
branes [24]. In the present study we found again a 
partial replacement of arachidonic acid for EPA 
in the total phospholipid fraction of platelet mem-
branes, which points towards similar changes in 
prostanoid concentrations. The reduction in ADP-
induced platelet aggregation in whole blood (Fig. 
1) is in agreement with such alterations in throm-
boxane B, levels. 
In both groups wall thickness at the end of 
diastole of the posterior wall increased gradually 
during the 4 months. The increase in myocardial 
muscle mass and the lower heart rate as the animals 
grow older may be responsible for this observa-
tion. There was no change in percentage systolic 
wall thickening because the wall thickness at 
end-systole also increased. The changes in anterior 
wall thickness were parallel to those in the 
posterior wall before implantation of the constric-
tor, but thereafter percentage and absolute systolic 
wall thickening became less than that of the post-
erior wall. Radioactive microspheres and regional 
systolic segment length shortening were used to 
determine whether proliferation of the endothelial 
layer also affected myocardial blood flow and 
function. When the hearts were stressed by raising 
the heart rate to 160 beats/min the myocardium, 
especially the subendocardium of L, nourished by 
the partially constricted coronary artery was hypo-
perfused and did not function normally. The rea-
son for the apparent beneficial effect of fish oil on 
the distribution of myocardial blood flow cannot 
be explained by differences in systemic hemody-
namic variables such as heart rate, left ventricular 
filling pressure and arterial blood pressure [37]. 
Further investigations are needed to determine 
whether changes in viscosity may have played a 
role. 
Since subendocardial blood flow is the major 
determinant of regional function [38,39] it is not 
surprising that segment length shortening was 
more severely impaired in L than in ML. The 
microsphere data also revealed that placement of 
the constrictor led to the development of func-
tional collaterals which is consistent with earlier 
observations [ 40]. 
We conclude that in pigs the chronic stenosis 
resulted in intimal proliferation at the site of the 
constrictor but that the diet determined the extent 
of this encroachment. Inhibition of platelet aggre-
gation may be responsible for the lower amount of 
intimal proliferation in the mackerel oil fed pigs. 
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CHAPTER 12 
ATHEROSCLEROSIS, A LITERATURE REVIEW 
12.1 Historical notes 
Although atherosclerosis is considered to be a "welfare" disease and is the largest 
single cause of death in Western society [1], it was also common in the antiquity. In 
the beginning of this century Shattock (1909) examined microscopic sections of the 
aorta of King Menephtah, the reputed Pharaoh of the Exodes and found senile 
calcification of the aorta [2]. A few years later Ruffer reported calcified arterial 
lesions in several other mummies [3]. The first written report, however, dates 
already from over 400 years ago as Fallopius (1575) described a "degeneration of 
arteries into bone". Over a century later Cowper (1700) was probably the first to 
remark that the changes in the arterial wall could affect blood flow as he noted that 
"the passage of blood is impeded in thickened arteries" [ 4]. Senac (1749) and 
Morgagni (1761) described coronary artery lesions in individuals with cardiac 
complaints [5]. That these two phenomena were indeed related was established by 
Edward Jenner some 10 years later [5]. 
Rokitansky (1844) thought that blood constituents were deposited on the vessel 
wall [6], however, Risse (1933) and Virchow (1956) stated that the material was 
deposited under the subendothelial surface [7, 8]. 
Albrecht von Haller (1755) applied the term "atheroma" to the arterial lesions 
[4]. Crawford (1960) has defined atherosclerosis as "the widely prevalent arterial 
lesion characterized by patchy thickening of the intima, the thickenings comprising 
accumulations of fat and layers of collagen like fibres both being present in widely 
varying proportions" [9]. Pickering (1963) literally translated the term athero-
sclerosis directly from the Greek as "porridge-like hardness" [10]. It has become 
clear that atherosclerotic process affects all layers of the vessel wall and therefore 
Adams (1964) defined atherosclerosis as "a multifocal proliferative and degenera-
tive condition that affects the lumen, intima and inner part of the media both of 
large elastic arteries and certain muscular arteries in the senescent individual" [11]. 
12.2 Risk factors 
Most epidemiological surveys have shown significant correlations between plasma 
total cholesterol and the incidence of coronary heart disease [12-16]. Coronary heart 
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disease proves to be more common in the population of countries with mean plasma 
cholesterol exceeding 5 mmol/1 (e.g. central and northern Europe, USA and 
Australia [12, 14]. On the other hand atherosclerotic disease is rare in countries 
where average cholesterol levels are lower than 4 mmol/1 (e.g. in the Orient) [12, 17, 
18]. In the Multiple Risk Factor Intervention Trial no such treshold was found, and 
the relationship was curvilinear [19]. Pathological studies show a relationship 
between the grade of atherosclerosis and the plasma cholesterol level [20]. 
In man most of the plasma cholesterol is carried in the low density lipoprotein 
(LDL), and that in particular high levels of LDL-cholesterol may be atherogenic has 
been demonstrated most dramatically in patients with familial hypercholesterolemic 
LDL receptor deficiency [21, 22]. 
The high density lipoprotein (HDL), another major carrier of cholesterol, plays 
an important role in the transport of cholesterol from peripheral tissues to the liver 
where it can be catabolized. Therefore, it is believed that an inverse relationship 
exists between HDL-cholesterol and atherosclerosis [14]. Most retrospective studies 
report a univariate relation between plasma triglyceride level and coronary heart 
disease [23-25], but plasma triglyceride levels appear to be of limited value as an 
independent predictor of coronary heart disease [26]. However, when the plasma 
cholesterol level is below 5.7 mmol/1, plasma triglyceride level becomes an indepen-
dent predictor of risk, after adjustment for all other risk factors [27]. 
Platelet activity may be another factor in the process of atherosclerosis. When 
the endothelium is injured platelets interact with or adhere to the subendothelial 
connective tissue to release their granulae contents [28]. Platelets contain at least 
two mitogens, epidermal growth factor [29, 30] and platelet derived growth factor 
[31-34], and other releasable platelet constituents such as platelet factor 4, beta-
thromboglobuline and products of the lipoxygenase pathway [34]. Enhanced aggre-
gability of blood platelets by smoking, cathecholamines, turbulence and hemolysis 
will lead to degranulation of the platelets releasing the aforementioned factors. 
Other factors which also predispose for atherosclerosis are: age, male sex, race, 
hypertension [19, 20, 35-39], smoking [40-43], diabetes mellitus [38, 44], physical 
inactivity [45-48], stress and behaviour [49, 50], increased blood viscosity [51, 52], 
elevated thromboxane synthesis [53, 54], high arachidonic acid levels combined with 
low eicosapentaenoic and linoleic acid levels of platelet membrane phospholipids 
[54, 55], and low linoleic acid levels of adipose tissue [55]. 
12.3 Current views of the pathogenesis of atherosclerosis 
Brown and Goldstein have modified the Virchow theory into the lipid infiltration 
theory [22, 56, 57]. The lipid content of atherosclerotic lesions is mainly composed 
of cholesterol, cholesteryl esters and phospholipids. Cholesteryl esters present in 
early atherosclerotic lesions are located within foam cells [58-60]. These foam cells 
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originate from macrophages and smooth muscle cells [61-63]. LDL binds to the 
LDL-receptors or scavenger receptors and cholesteryl esters are accumulated in the 
foam cells, leading to progression of the atherosclerotic lesion [22, 64-70]. As the 
lesion grows into the atherosclerotic plaque, a fissure in the latter leads to 
hemorrhage which in turn provokes rapid (further) aggregation of platelets and 
thrombosis [71]. 
Ross has postulated that endothelial injury leads to leakage of serum 
components into the subendothelial tissue and subsequent cellular responses [ 64, 
72]. Platelet aggregation with release of prostanoids and mitogenic factors will be 
initiated, leading to migration and proliferation of smooth muscle cells [28-34, 73-
75]. This sequence of events will result in the eventual formation of an athero-
sclerotic plaque. 
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Figure 1. A proposed unified hypothesis linking the endothelial injury "school" 
and the lipid infiltration "school". See text. With permission from 
Steinberg (108). 
The combination of the lipid infiltration and endothelial injury-hypothesis, enables 
us to best understand the complex processes in atherosclerosis [76]. There may be at 
least six interactions between the two theories (Figure 1): 
1. Elevated LDL levels may damage endothelial cells [64, 77, 78]. The lipid 
infiltration is accompanied by growth factors released from the different cells 
[72]. 
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2. Hyperlipoproteinemia has been reported to exert a proaggregatory action on 
blood platelets [79-81], which might initiate the release of platelet derived 
growth factor (PDGF). 
3. Injury to endothelium will increase the infiltration rate of lipoproteins, cellular 
uptake and degradation at any LDL plasma level [82]. 
4. High LDL plasma levels can stimulate the growth of smooth muscle cells [83]. 
5. Growth factors increase the expression of the LDL receptors on smooth muscle 
cells, thereby increasing the rate of lipid uptake [84]. 
6. Stimulation of smooth muscle cell growth may cause the deposition of large 
amounts of certain intercellular matrix materials, such as glycosaminoglycans 
which trap LDL in the subintimal space [85]. 
As shown in Figure 1 there are several input channels that converge to what may be a 
common final path. The severity of the atherosclerotic lesion may depend on how 
many of these independent input channels are operating and on what level [76]. 
Thus, the process of atherosclerosis is multicausal and cannot be defined in a simple 
model. 
12.4 Possible effects of dietary n-3 PUF A's on atherosclerosis 
In the preceeding chapters we have shown that n-3 PUPA's possess several actions 
which may interfere in the atherosclerotic process (figure 1) as fish oil has been 
shown to: 
1. lower plasmacholesterol and -plasmatriglyceride (chapter 4, 5 and 6) 
2. shift the PGI/TXA ratio to anti-aggregatory (chapter 8 and 9) 
3. decrease platelet aggregation and intimal proliferation (chapter 11) 
In the next chapter we therefore studied the effect of dietary fish oil on regression of 
atherosclerosis in swine. 
12.5 Induction and regression of experimental atherosclerosis 
Swine develop atherosclerotic lesions (Figures 2 and 3) that closely resemble the 
arteria! lesions in human beings with the first early lesions being found at 6 months 
of age [86, 87]. Over the years they develop advanced lesions with complications [88, 
89]. 
Atherosclerosis in swine can be markedly accelerated and intensified by feeding 
atherogenic diets with 2% or more cholesterol and bile salts. Under these conditions 
the first lesions are seen after 7 weeks and develop into impressive fibrous plaques 
within 6 months. These lesions also resemble human atherosclerotic lesions [90], but 
complications like arterial occlusion or thrombosis are not seen within the first year 
[91]. Endothelial damage, induced by balloon abrasion, ionizing radiation or 
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Figure 2. Transverse section of a pig coronary artery stained with elastic tissue 
stains, showing an early atherosclerotic lesion. 
Figure 3. Transverse section of a pig coronary artery stained with elastic tissue 
stains showing moderate fibromuscular thickening. 
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chemical factors, also accelerates the development of atherosclerotic lesions (92-95]. 
The advantage of the balloon technique over the X ray-irradiation method is that 
the primary lesions, similar to that in man, are mainly in the proximal coronary 
arteries and that irradiation effects on the myocardium and lung tissue are absent 
(94]. 
Following the combination of atherogenic diet and balloon abrasion (figure 4) 
pigs develop moderate atherosclerosis within 4 months (96-98], and extreme severe 
atherosclerosis within 6-8 months [98-102]. 
A B 
D 
Figure 4. Endothelial lining before (A), 1 hour after (B), 24 hours after (C) and 
4 months (D) after balloon abrasion of the abdominal aorta (hemotoxyllin 
eosin staining). One day after the balloon abrasion the intimal lining is 
covered with blood platelets and a trhombus is organized. After 4 months 
the fibromuscular thickening had led to flat atheromatous plaques. 
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In animal models regression of atherosclerosis can be demonstrated by withdrawal 
of the atherogenic diet by a low-cholesterol diet and/or other interventions [59, 96, 
97, 99, 101, 103-106]. Depending on the quantification method used, regression of 
atherosclerotic lesions is already detectable 6 weeks after the start of the 
intervention [101 ]. 
12.6 Quantification of atherosclerosis 
Several methods are available to quantify atherosclerosis: angiographic description 
of the lesions, topography of vessel surface involvement with e.g. Sudan IV staining, 
biochemical analysis of vessel wall and morphometric measurements of vessel 
sections. 
Coronary artery lesions can best be quantified by angiographic description or 
morphometrical measurements including lumen area and lesion area, and 
calculation of the ideal lumen area and luminal encroachment [90]. Angiography is 
not very sensitive for the detection of early or extended lesions [98]. 
Table 1 
Quantification of coronary artery atherosclerosis by morphometrical methods in 
pigs following coronary artery balloon abrasion and atherogenic diets consisting of 
> 30% fat, > 2% cholesterol and > 1% sodium cholate for 4 to 6 months. 
lesion area (mm2) luminal encroachment (%) 
4 months 8 months 4 months 8 months 
Weiner et a!. ( 98) 0.25 2.75 8 49 
Weiner et a!. (102) 1.84 44 
Table 1 gives the data on morphometrical lesion measurements in studies on 
coronary artery atherosclerosis at different time intervals. In control animals with a 
9% lard fat low cholesterol diet (n=6) the lesion area is 0.09 ± 0.03 mm2 and the 
luminal encroachment 5 ± 1% after 4 months (unpublished data from our 
laboratory). 
Lesions in the aorta or femoral arteries can be quantified by angiography, 
description of lesions, topography of the surface involvement according to type of 
lesion (non lesion, flat lesion, raised lesion or· complicated lesion) or staining, and 
biochemical analysis of the different kinds of lesions. 
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Table 2 
Quantification of abdominal aorta surface involvement in atherosclerosis by Sudan 
IV staining in pig following balloon abrasion of the abdominal aorta and atherogenic 
diets consisting of >30% fat, >2% cholesterol and >1% sodium cholate for 4 to 6 
months. 
Daoud et al. (96) 
Daoud et a!. (99) 
surface involvement (%) 
4 months 6 months 
21 
43 
Table 2 gives the data of comparable studies on abdominal aortic involvement after 
Sudan IV staining at different time intervals. In mash fed control animals tlie vessel 
wall involvement was less than 1% after 4 months [96]. 
Table 3 
Quantification of cholesterol contents of abdominal aortic atherosclerotic lesions in 
pigs following balloon abrasion of the abdominal aorta and atherogenic diets 
consisting of >30% fat, >2% cholesterol and > 1% sodium cholate for 4 to 6 months. 
Fritz et al. ( 97) 
Fritz et a!. (100) 
Fritz et al. (101) 
cholesterol (J.Lg/mg dry weight) 
total free ester 
4months 6months 4months 6months 4months 6months 
5 
90 
108 
4 11 
34 75 
Table 3 gives the data of cholesterol contents of raised abdominal aortic lesions in 
comparable studies at different time intervals. In mash fed control animals the total 
cholesterol content of non lesions was 3 ug/mg dry weight after 4 months and 1 
ug!mg dry weight after 6 months. The free and esterified cholesterol contents were 1 
ug/mg dry weight after 4 and 6 months [97, 101 ]. In all of these studies the pigs were 
fed a >30% fat, >2% cholesterol and >1% sodium cholate containing atherogenic 
diet and the coronary artery concerned and abdominal aorta were abraded by 
balloon technique at the beginning of the period. From these data it is clear that in 
this experimental set up, atherosclerosis is a very dynamic process [96-98]. 
141 
REFERENCES 
1. Report of the working group of Arteriosclerosis of the National Heart, Lung 
and Blood Institute. Vol. 2, Washington DC: Government Printing Office. 
DREW publication NIH 1981; 82-20~5. 
2. Shattock SG. Royal society of medicine. Pathological section. Lancet I 1909; 
318-9. 
3. Ruffer MA. On arterial lesions found in Egyptian mummies. J Pathol Bact 
1911; 15: 453-62. 
4. Long E. Development of our knowledge of atherosclerosis. In: Blumenthal HT 
(ed). Cowdry's Arteriosclerosis. Springfield, Charles C Thomas, 1967; 5-20. 
5. Morgan AD. The pathogenesis of coronary occlusion. Blackwell, Oxford, 1956. 
6. Rokitansky C. Handbuch der Pathologischen Anatomie. Vol. 2. Vienna, 
Braunmuller und Seidel, 1844. 
7. Risse A. In: Cowdry EV (ed). ArteriosClerosis. New York, Mac Millan, 1933. 
8. Virchow R. Phlogose und Thrombose in Gefass System. Gesamnielte Abhand-
lungen zur wissenschaftlichen Medizin. Frankfurt, Meidinger, 1956; 458. 
9. Crawford T. Some aspects of the pathology of atherosclerosis. Proc Royal Soc 
Med 1960; 53: 9-12. 
10. Pickering G. Arteriosclerosis and atherosclerosis. Am J Med 1963; 34: 7-18. 
11. Adams CWM. Arteriosclerosis in man, other mammals and birds. Bioi Rev 
1964; 39: 372-423. 
12. Keys A (ed). Coronary heart disease in seven countries. Circulation 1970; 41 
(SI): I-1-211. 
13. Kannel WB, Castelli W, Gordon T. Serum cholesterol, lipoproteins, and risk of 
coronary heart disease: The Framingham study. Ann Intern Med 1971; 74: 1-
12. 
14. Pooling Project Research Group. Relationship of blood pressure, serum 
cholesterol, smoking habit, relative weight and ECG abnormalities to the 
incidence of major coronary events: final report of the pooling project. J 
Chronic Dis 1978; 31: 201-306. 
15. Goldbourt V, Holtzman E, Neufeld HN. Total and high density lipoprotein 
. cholesterol in the serum and risk of mortality: Evidence of a treshold effect. Br 
Med J 1985; 290: 1239-43. 
16. Stamler J, Wentworth D, Neaton J. Is the relationship between serum 
cholesterol and risk of death from coronary heart disease continuous and 
graded? JAMA 1986; 256: 2823-8. 
17. Kimura N. Analysis of 10. 000 postmortem examinations in Japan. In: :Keys A, 
White PD (eds). World trends in cardiology: I. Cardiovascular epidemiology. 
New York, Hoeker-Harper, 1956; 159. 
18. McGill HC (ed). The geographic pathology of atherosclerosis. Baltimore, 
Williams & Wilkins Co, 1968; 41. 
19. Multiple Risk Factor Trial Research Group. Multiple risk factor intervention 
trial. Risk factor changes and mortality results. JAMA 1982; 248: 1465-77. 
20. Solberg LA, Strong JP. Risk factors and atherosclerotic lesions: A review of 
autopsy studies. Arteriosclerosis 1983; 3: 187-98. 
21. Brown MS, Goldstein JL. Lipoprotein receptors in the liver: control signals for 
plasma cholesterol traffic. J Clin Invest 1983; 72: 743-7. 
142 
22. Goldstein JL, Brown MS. The LDL pathway and its relation to atherosclerosis. 
Ann Rev Biochem 1977; 46: 897-930. 
23. Goldstein JL, Hazzard WR, Schrott HG, Bierman EL, Motulsk:y AG. Hyper-
lipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myo-
cardial infarction. J Clin Invest 1973; 52: 1533-43. 
24. Gotto AM, Gorry GA, Thompson JR. Relationship between plasmalipid 
concentrations and coronary artery disease in 496 patients. Circulation 1977; 
56: 875-83. 
25. Branner D, Altman S, Loeb! K, Schwartz S, Levin S. Serum cholesterol and 
triglycerides in patients suffering from ischemic heart disease and in healthy 
subjects. Atherosclerosis 1977; 28: 197-204. 
26. Kannel WB, Castelli WP, Gordon T. Cholesterol in the prediction of athero-
sclerotic disease: new perspectives based on the Framingham Study. Ann 
Intern Med 1979: 90: 85-91. 
27. Cambien F, Jaqueson A, Richard JL, Warnet JM, Ducimetiere P, Claude JR. Is 
the level of serum triglyceride a significant predictor of coronary death in 
normocholesterolemic subjects? The Parvis prospective study. Am J Epid 1986; 
124: 624-32. 
28. Baumgartner HR. Platelet interaction with vascular structures. Thromb Diath 
Haemorrh 1972; S51: 161-76. 
29. OkaY, Orth DN. Human plasma epidermal growth factor I beta-urogastrone is 
associated with blood platelets. J Clin Invest 1983; 72: 249-59. 
30. Bower-Pope DF, Ross R. Is epidermal growth factor present in human blood? 
Interference with the radio-receptor assay for epidermal growth factor. 
Biochem Biophys Res Commun 1983; 114: 1036-41. 
31. Ross R, Glomset J, Kariya B, Harker L. A platelet-dependent serum factor that 
stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Nat! 
Acad Sci USA 1974; 71: 1207-10. 
32. Kohler N, Lipton A. Platelets as a source of fibroblast growth-promoting 
activity. Exp Cell Res 1974; 87: 297-301. 
33. Grotendorst GR, Chang T, Seppa HEJ, Kleinman HK, Martin GR. Platelet-
derived growth factor is a chemoattractant for vascular smooth muscle cells. J 
Cell Physiol 1982; 113: 261-6. 
34. Deuel TF, Senior RM, Chang D, Griffin GL, Heinrickson RL, Kaiser ET. 
Platelet factor 4 is chemotactic for neutrophil elastase. Proc Nat! Acad Sci 
USA 1981; 78:4584-7. 
35. Kannel WB, Schwartz MD, McNamara PM. Blood pressure and risk of 
coronary heart disease: The Framingham study. Dis Chest 1969; 56: 43-52. 
36. Kannel WB, WolfPA, Verter J, McNamara PM. Epidemiological assessment of 
the role of blood pressure in stroke. J Am Med Ass 1970; 214: 301-10. 
37. Paul 0. The risks of mild hypertension: A ten year report. Br Heart J 1971; 33: 
116-21. 
38. Stamler J, Berckson DM, Lindberg HA. Risk factors: Their role in the etiology 
and pathogenesis of the atherosclerotic diseases. In: Wissler RS, Geer JC (eds). 
The pathogenesis of atherosclerosis. Baltimore, Williams and Wilkins Co, 1972; 
41-119 
143 
39. Rhoads GG, Blackwelder WC, Stemmerman GN, Hayashi T, Kagan A. 
Coronary risk factors and autopsy findings in Japanese-American men. Lab 
Invest 1978; 38: 304-11. 
40. Crawford T. The Pathology of ischemic heart disease. London, Butterworths, 
1972; 57-9. 
41. McGill HC jr. Atherosclerosis: problems in pathogenesis. In: Paoletti R, Gotto 
AM (eds). Atherosclerosis Reviews Vol. 2. New York, Raven Press, 1977; 27-
65. 
42. Doll R, Hill AB. Mortality in relation to smoking. Ten years observations of 
British doctor. Br Med J 1964; 1: 1399-1410 and 1460-67. 
43. Dawber TR, Kannel WB, Stokes J, Kagan A, Gordon T. Some factors 
associated with the development of coronary heart disease. Six years follow-up 
experience in the Framingham study. Am J Pub! Health 1959; 49: 1349-56. 
44. Bradley RF, Partamanian JO. Coronary heart disease in the diabetic patient. 
Med Clin North Am 1965; 49: 1093-1104. 
45. Morris JN, Everitt MG, Pollard R, Chave SPW. Vigorous exercise in leisure-
time: protection against coronary heart disease. Lancet 1980; II: 1207-10. 
46. Paffenbarger RS, Hyde RT, Wing AL, Hsieh CC. Physical activity, all-cause 
mortality, and longevity of college alumni. N Eng! J Med 1986; 314: 605-13. 
47. Tram ZV, Weltman A, Glass CV, Mood DP. The effects of exercise on blood 
lipids and lipoproteins: a meta-analysis of studies. Med Sci Sports Exerc 1983; 
15: 393-402. 
48. Dufaux B, Assmann G, Hollman W. Plasma lipoproteins and physical activity: a 
review. Inst J Sports Med 1982; 3: 123-38. 
49. Rosenman RH, Brand RJ, Scholtz RI, Friedman M. Multivariate prediction of 
coronary heart disease in the Western Collaborative Group Study. Am J 
Cardiol 1976; 37: 903-10. 
50. Rosenman RH, Brand RJ, Jenkins CD, Friedman M, Straus R, Wurm M. 
Coronary heart disease in the Western Collaborative Group study: final follow-
up experience of 8. 5 years. JAMA 1975; 233: 872-7. 
51. Dormandy JA, Hoare E, Colley J, Arrowsmith DE, Dormandy TL. Clinical 
haemodynamic rheological abd biochemical findings in 126 patients with inter-
mittent claudication. Br Med J 1973; 4: 576-81. 
52. Rainer C, Kawanishi DT, Chandraratna AN, Bauersachs RM, Reid CL, 
Rahimtoola SH, Meiselman HJ. Changes in blood rheology in patients with 
stable angina pectoris as a result of coronary artery disease. Circulation 1987; 
76: 15-20. 
53. Fitzgerald DJ, Roy L, Catella F, Fitzgerald GA. Platelet activation in unstable 
coronary disease. N Eng! J Med 1986; 315: 938-9. 
54. Prisco D, Rogasi PG, Matucci M, Abbata R, Gensini GF, Serneri GGN. 
Increased thromboxane A2 generation and altered membrane fatty acid 
composition in platelets from patients with active angina pectoris. Thromb Res 
1986; 44: 101-12. 
55. Wood DA, Riemersma RA, ButlerS, Thromson M, Macintyre C, Elton RA, 
Oliver MF. Linoleic and eicosapentaenoic acids in adipose tissue and platelets 
and risk of coronary heart disease. Lancet I 1987; 177-83. 
144 
56. Goldstein JL, Kita T, Brown MS. Defective lipoprotein receptors and athero-
sclerosis: lessons from an animal counterpart of familial hypercholesterolemia. 
N Engl J Med 1983; 309: 288-96. 
57. Brown MS, Goldstein JL. How LDL receptors influence cholesterol and 
atherosclerosis. Sci Am 1984; 251: 58-66. 
58. Rapp JH, Connor WE, Lin DS, Inahara T, Porter JM. Lipids of human 
atherosclerotic plaques and xanthomas: clues to the mechanism of plaque 
progression. J Lipid Res 1983; 24: 1329-35. 
59. St Clair RW. Atherosclerosis regression in animal models: current concepts of 
cellular and biochemical mechanisms. Prog Cardiovasc Dis 1983; 26: 109-32. 
60. StClair RW. Metabolism of the arterial wall and atherosclerosis. In: Paoletti R, 
Gotto AM jr (eds). Atherosclerosis Reviews Vol. 1. New York, Raven Press, 
1976; 61-117. 
61. Ross R, Glomset JA. The pathogenesis of atherosclerosis. N Eng! J Med 1976; 
295: 369-77, 420-5. 
62. Fowler S, Shio H, Haley HJ. Characterization of lipid laden aortic cells from 
cholesterol-fed rabbits. Lab Invest 1979; 41: 372-8. 
63. Schaffner T, Tayler K, Bartucci EJ, Fischer-Dzoga K, Beeson JH, Glagov S, 
Wissler RW. Arterial foam cells with distinctive immunomorphologic and 
histochemical features of macrophages. Am J Pathol 1980; 100: 57-80. 
64. Ross R. Atherosclerosis: A problem in the biology of aterial wall cells and their 
interactions with blood components. Arteriosclerosis 1981; 1: 293-311. 
65. Goldstein JL, Anderson RGW, Brown MS. Coated pits, coated vesicles, and 
receptor mediated endocytosis. Nature 1979; 279: 679-84. 
66. Goldstein JL, Ho YK, Basu SK, Brown MS. Binding sites on macrophages that 
mediates uptake and degradation of acetylated low density lipoprotein, 
producing massive cholesterol deposition. Proc. Nat! Acad Sci USA 1979; 76: 
333-7. 
67. Brown MS, Goldstein JL, Krieger M, Ho YK, Anderson RGW. Reversible 
accumulation of cholesteryl esters in macrophages incubated with acetylated 
lipoproteins. J Cell Bioi 1979; 82: 597-613. 
68. Brown MS, Basa SK, Falak JR, Ho YK, Goldstein JL. The scavenger cell 
pathway for lipoprotein degradation: Specificity of the binding site that 
mediates the uptake of negatively-charged LDL by macrophages. J Supramol 
Struct 1980; 13: 67-81. 
69. Haberland ME, Fogelman AM, Edwards PA. Specificity of receptor-mediated 
recognition of malondialdehyde-modified low density lipoproteins. Proc Nat! 
Acad Sci USA 1982; 79: 1712-6. 
70. Van der Schroeff JG, Havekes L, Emeis JJ, Wijsman M, Van der Meer H, 
Vermeer BJ. Morphological studies on the binding of low-density lipoproteins 
and acylated low-density lipoproteins to the plasma membrane of cultured 
monocytes. Exp Cell Res 1983; 145: 95-103. 
71. Benditt EP, Benditt JM. Evidence for a monoclonal origin of human athero-
sclerotic plaques. Proc Nat! Acad Sci USA 1973; 70: 1753-6. 
72. Ross R. The pathogenesis of atherosclerosis - an update. N Eng! J Med 1986; 
314: 488-500. 
73. Childs CB, Proper JA, Tucker RF, Moses HL. Serum contains a platelet 
derived growth factor. Proc Nat! Acad Sci USA 1983; 79: 5312-6. 
145 
74. Assoian RK, Komoriya A, Meyers CA, Miller DM, Sporn MB. Transforming 
growth factor beta in human platelets: identification of a major storage site, 
purification, and characterization. J Bioi Chern 1983; 258: 7155-60. 
75. Tucker RF, Shipley GD, Moses HL, Holley RW. Growth inhibitor from BSC-1 
cells closely related to platelet type beta transforming growth factor. Science 
1984; 226: 705-7. 
76. Steinberg D. Lipoproteins and athersclerosis. A look back and a look ahead. 
Arteriosclerosis 1983; 3: 283-301. 
77. Hendriksen T, Eversen SA, Carlander B. Injury to human endothelial cells in 
culture induced by low density lipoproteins. Scan J Clin Lab Invest 1979; 39: 
361-8. 
78. Ross R, Harker L. Hyperlipidemia and atherosclerosis. Science 1976; 193: 
1094-100. 
79. Shattil SJ, Anaya-Galindo R, Bennet J, Colman RW, Cooner RA. Platelet 
hypertensitivity induced by cholesterol incorporation. J Clin Invest 1975; 55: 
636-43. 
80. Carvalho AC, Colman RW, Lees RS. Platelet function in hyperlipoproteinemia. 
N Engl J ·Med 1974; 290: 434-8. 
81. Insel PA, Nirenberg P, Turnhall J, Shattil SJ. Relationships between membrane 
cholesterol, alpha-adrenergic receptors and platelet functions. Biochemistry 
1978; 17: 5269-74. 
82. Carew TE, Pittman RC, Marchaud ER, Steinberg D. Aortic endothelium is an 
active site of low density lipoprotein degradation in vivo in normal rabbits. Clin 
Res 1983; 31: 382A. 
83. Fischer-Dzoga K, Fraser RA, Wissler RW. Stimulation of proliferation in 
stationary primary cultures of monkey and rabbit aortic smooth muscle cells. I. 
Effects of lipoprotein fractions of hyperlipemic serum and lymph. Exp Mol 
Pathol 1976; 24: 346-59. 
84. Chait A, Ross R, Albers J, Bierman F. Platelet derived growth factor stimulates 
low density lipoprotein receptor activity. Proc Nat! Acad Sci USA 1980; 77: 
4084-8. 
85. Ross R, Klebanoff SJ. The smooth muscle celL I. In vivo synthesis of connective 
tissue proteins. J Cell Bioi 1971; 50: 159-71. 
86. Rowse! HC, Mustard JF, Downie HG: Experimental atherosclerosis in swine. 
Ann NY Acad Sci 1965; 127: 743-62. 
87. Luginbuhl H, Jones JE. The morphology and morphogenesis of atherosclerosis 
in aged swine. Ann NY Acad Sci 1965; 127: 763- 79. 
88. Getty R. The gross and microscopic occurrence and distribution of sponta-
neous atherosclerosis in the arteries of swine. In: Roberts JC jr, Strauss R 
(eds). Comparative Atherosclerosis. New York, Harper, 1965; 11-20. 
89. Gresham GA, Howard AN. Comparative pathology of spontaneously occuring 
and experimentally induced atherosclerotic lesions. Methods Archiev Exp 
Pathol 1966; 1: 314-36. 
90. Wissler RW, Vesselinowitch D. Differences between human and animal 
atherosclerosis. In: Schetler G, Weizel A (eds). Atherosclerosis III. New York, 
Springer-Verlag, 1974; 319-29. 
91. Florentin RA, Nam SC, Daoud AS, Jones R, Scott RF, Morrison ES, Kim DN, 
Lee KT, Thomas WA, Dodds WJ, Miller KD. Dietary- induced atherosclerosis 
146 
in miniature swine. Exp. Mol Pathol 1968; 8: 263-301. 
92. Lee KT, Jarmolych J, Kim DN, Grant C, Krasney JA, Thomas WA, Bruno AM. 
Production of advanced coronary artery atherosclerosis, myocardial infarction 
and sudden death in swine. Exp Mol Pathol 1971; 15: 170-90. 
93. Nam SC, Lee WM, Jarmolych J, Lee KT, Thomas WA. Rapid production of 
advanced atherosclerosis in swine by a combination of endothelial injury and 
cholesterol feeding. Exp Mol Pathol 1973; 18: 369-79. 
94. Lee WM, Lee KT. Advanced coronary atherosclerosis in swine produced by 
combination of balloon-catheter injury and cholesterol feeding. Exp Mol 
Pathol 1975; 23: 491-9. 
95. Scott RF, Thomas WA, Lee WM, Reiner JM, Florentin RA. Distribution of 
intimal smooth muscle cell masses and their relationship to early athero-
sclerosis in the abdominal aorta's of young swine. Atherosclerosis 1979; 34: 
291-301. 
96. Daoud AS, Jarmolych J, Augustyn JM, Fritz HE, Singh JH, Lee KT. 
Regression of advanced atherosclerosis in swine. Arch Pathol Lab Med 1976; 
100: 372-9. 
97. Fritz KE, Augustyn JM, Jarmolych J, Daoud AS, Lee KT. Regression of 
advanced atherosclerosis in swine. Chemical studies. Arch Pathol Lab Med 
1976; 100: 380-5. 
98. Weiner BH, Oakene JS, Jarmolych J, Fritz KE, Daoud AS. Comparison of 
pathologic and angiographic findings in a porcine preparation of coronary 
atherosclerosis. Circulation 1985; 72: 1081-6. 
99. Daoud AS, Jarmolych J, Augustyn JM, Fritz HE. Sequential morphologic 
studies of regression of advanced atherosclerosis. Arch Pathol Lab Med 1981; 
105: 233-9. 
100. Fritz KE, Daoud AS, Augustyn JM, Jarmolych J. Morphological and bio-
chemical differences among ·grossly-defined types of swine aortic atherosclero-
tic lesions induced by a combination of injury and atherogenic diet. Exp Mol 
Pathol 1980; 32: 61-72 
101. Fritz KE, Augustyn JM, Jarmolych J, Daoud AS. Sequential study of bio-
chemical changes during regression of swine aortic atherosclerotic lesions. 
Arch Pathol Lab Med 1981; 105: 240-6. 
102. Weiner BH, Ockene JS, Levine PH, Cuenoud HF, Fisher M, Johnson BF, 
Daoud AS, Jarmolych J, Hosmer D, Johnson MH, Natale A, Vaudreuil C, 
Hoogasian JJ. Inhibition of atherosclerosis by cod-liver oil in a hyperlipidemic 
swine model. New Eng! J Med 1986; 315: 841-6. 
103. Manilow MR, Blaton V. Regression of atherosclerotic lesions. Arteriosclerosis 
1984; 4: 292-5. 
104. Jarmolych J, Daoud AS, Fritz KE, Augustyn JM, Singh JK, Kim DN. Morpho-
logical effects of moderate diet and clofibrate on swine atherosclerosis. Arch 
Pathol Lab Med 1978; 102: 289-93. 105. Augustyn JM, Fritz KE, Daoud AS, 
Jarmolych J, Lee KT. Biochemical effects of moderate diet and clofibrate on 
swine atherosclerosis. Arch Pathol Lab Med 1978; 102: 294-7. 
106. Kim DN, Schmee J, Ho HT, Thomas WA. The "turning off' of excessive cell 
replicative activity in advanced atherosclerotic lesions of swine by a regression 
diet. Atherosclerosis 1988: 71: 131-42. 
CHAPTER 13 
MACKEREL OIL AND ATHEROSCLEROSIS IN PIGS 
L.M.A. Sassen 1, J.M. Hartog 1, J.M.J. Lamers 2, M. Klompe 3, L.J. Van Woerkens 1 
and P.D. Verdouw 1. 
1 Laboratory for Experimental Cardiology (Thoraxcentre), 2 Department of Bio-
chemistry I and 3 Oogziekenhuis, Erasmus University Rotterdam, Rotterdam, The 
Netherlands 
Summary 
In 35 pigs atherosclerosis was induced by balloon abrasion and a diet containing 2% 
(w/w) cholesterol and 7% (w/w) lard fat. After 4 months of induction 9 animals were 
killed (I) for analysis of the extent of atherosclerosis, while the diet of the other 26 
pigs was changed to a low (w/w) cholesterol diet containing either 9% (w/w) lard fat 
(L), 9% (w/w) fish oil (F) or 4.5% (w/w) lard fat and 4.5% (w/w) fish oil (LF). This 
diet was continued for three months to induce regression of atherosclerosis. The 
cholesterol-rich diet increased plasma total cholesterol, but did not affect plasma 
triglycerides. Low-cholesterol feeding decreased plasma total cholesterol in all 3 
groups, but triglycerides only in LF and F. Lipid infiltration of the aortic wall was 
similar in I, L, LF and F. In the denudated coronary arteries of I mean luminal 
encroachment was 11 ± 2 %. This was similar in L (13 ±. 4 %) but significantly lower 
(P<0.05) in LF ( 6 ±. 2 %) and in F (3 ± 1 % ). In the non-abraded coronary arteries of 
I mean luminal encroachment was 1.3 ±. 0.3 %. For F and LF similar values were 
found, but in L there was an increase to 11 ±. 3 % during low-cholesterol feeding. 
ADP-induced platelet aggregation was lower in LF and F than in L. Thromboxane 
A2 production was only reduced in F, while the production of the weak 
thromboxane A3 agonist was larger in F than in LF. It is concluded that fish oil 
retards the progression of and causes regression of coronary atherosclerosis. 
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Introduction 
Anatomical evidence of regression of coronary atherosclerosis has been 
demonstrated after combined colestipol-niacin therapy in non-smokers who have 
undergone coronary bypass surgery [1]. Lowering of LDL-cholesterol and the 
concomitant increase in HDL-cholesterol appear to be the two major factors 
associated with the reduction in the number of lesions in the native coronary 
arteries of these patients. Armstrong et al. showed that in non-human primates 
coronary atherosclerosis regressed both morphologically [2] and biochemically [3] 
after 40 months of low-cholesterol feeding following an induction period of 17 
months. Clarkson et a!. [4] found that in rhesus monkeys cholesterol-induced 
coronary atherosclerosis regressed after total cholesterol levels were decreased from 
15 mM to 5 mM, but still progressed in half of the animals in which cholesterol was 
reduced to only 7.5 mM (normal values 3.4-5.4 mM [5] ). Regression of athero-
sclerosis has also been shown in pigs on removal of cholesterol from the diet [ 6-8]. 
Weiner et al. [9] have shown that fish oil added to an atherogenic diet can retard the 
formation of plaques in coronary arteries of pigs but it is not known whether marine 
oil can also cause regression of atherosclerosis. 
The purpose of the present study was to assess the effect of regular intake of 
mackerel oil on the regression of atherosclerosis. We have previously shown that the 
amounts of fish oil used in the present study markedly reduce levels of plasma 
cholesterol and triglycerides in normolipidemic pigs, whereas lard fat did not exert 
these effects [10, 11]. In the mackerel oil fed pigs prostanoid formation and 
aggregation of platelets were also lower than in the lard fat fed pigs [10, 11] . 
Material and Methods 
Induction of atherosclerosis 
Blood samples for measurement of blood lipids were obtained from overnight fasted 
castrated male Yorkshire piglets (five weeks of age, 9.4 ± 0.2 kg, n=48). The animals 
were then started on a diet containing 7% (w/w) lard fat and 2% (w/w) cholesterol 
(Hope Farms, Woerden, The Netherlands, see Tables I and 2). Initially the animals 
received 200 g daily, but the portions were increased with 200 g each month as the 
animals gained weight. After 2 weeks the endothelium of the left anterior 
descending coronary artery and descending aorta was removed by the balloon 
abrasion technique [6-7, 9]. Hitherto the overnight fasted piglets (now weighing 11.0 
± 0.2 kg) were pretreated with an intramuscular injection of 300, 000 U procain-
penicillin-G and 300, 000 U benzathin-penicillin G (DuplocillineR, Gist Brocades, 
Delft, The Netherlands), anaesthetized by inhalation of a mixture of oxygen and 
nitrous oxide (1:2) and 1% halothane (FluothaneR, Macclesfield, UK) and 
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connected to a respirator for artificial ventilation. Following an intravenous 
injection of 5000 IU of heparin (ThromboliquineR, Organon Teknika B.V., Boxtel, 
the Netherlands) the animals were catheterized via the left external carotid artery. 
For denudation of the left anterior descending coronary artery a 4 F Fogarty 
embolectomy catheter (Edwards Laboratories, Santa Ana, California, USA) was 
introduced under the guidance of fluoroscopy. The balloon was inflated with 0.3 ml 
air and pulled back quickly [12]. This procedure was repeated twice to ensure 
effective denudation of the coronary artery. The descending aorta was catheterized 
with a 7F Fogarty embolectomy catheter and the balloon was subsequently inflated 
with 3 ml air and pulled back to the aortic arch. This procedure was also repeated 
twice. After the carotid artery was stitched, the incision was closed in one layer, the 
animals were allowed to recover and the dietary period was continued. The efficacy 
of this abrasion technique was evaluated in a few animals prior to the study (figure 
1). 
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Figure 1 
The efficacy of the abrasion technique. An example of a coronary artery with intact 
endothelium is shown on the left hand side (A), while the example on the right hand 
side (B) was taken from one of the animals that died suddenly one day after the 
procedure. 
Thirteen animals encountered sudden death during the immediate post-operative 
period. Autopsy showed ruptures of the coronary artery in five animals and 
perforation of the left ventricle in two animals. No coronary artery lesions or 
thrombosis were found in the six other animals. 
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Extent of atherosclerosis after 4 months of high-cholesterol feeding 
Fourteen weeks after balloon denudation (total dietary period 4 months), nine 
randomly chosen animals (I) were sacrificed to establish the severity of athero-
sclerosis (see below). 
Diets after four months of high-cholesterol feeding 
The remaining animals (n=26) were arbitrary divided over three groups and their 
diet was changed to low cholesterol but with a different fatty acid composition for 
each group. 
Table 1 
Composition of the atherosclerotic induction diet and the three low-cholesterol 
diets 
Induction diet Post-induction diets 
------------------------------
Ingredients I L LF F 
Corn (extruded) 32 32 32 32 
Wheat (extruded) 18 18 18 18 
Soybean meal 14 14 14 14 
Wheat middling 9 9 9 9 
Dehydrated skinned milkpowder 14 14 14 14 
CaHP04.H20 1.3 1.3 1.3 1.3 
CaC003 1.1 1.1 1.1 1.1 
NaCI, iodinized 0.3 0.3 0.3 0.3 
MgO 0.05 0.05 0.05 0.05 
MgS04 0.05 0.05 0.05 0.05 
KH2P04.2H20 0.36 0.36 0.36 0.36 
Choline chloride 50% (wt/wt) 0.18 0.18 0.18 0.18 
Vitamin and trace element mixesl 0.7 0.7 0.7 0.7 
Lard fat 7.27 9.10 4.55 
Fish oil 4.55 9.10 
Mixed tocopherols 0.03 0.03 0.03 O.o3 
Cholesterol 1.83 0.01 0.02 0.03 
lVitamin and trace element mixes supply the following per 100 g diet: retinol 1400 
IU; cholecalciferol 140 IU; alpha-tocopherol 8 mg; menadione 0.2 mg; thiamin 
hydrochloride 1.8 mg; riboflavin 1.8 mg; pyridoxine HCl 1.4 mg; niacin 3.6 mg; 
vitamin C coated 20 mg; D-calcium pantothenate 3.6 mg; folic acid 0.4 mg; cyano-
cobalamin 0.004 mg; biotin 0.1 mg; inositol4.5 mg; iron subcarbonate (57% Fe) 9.1 
mg; FeS04.H20 (30% FE) 14 mg; Cu2 (OH)zC03 (55%Cu) 2.3 mg; ZnO (78% Zn) 
11 mg; MnO (62%Mn) 9.1 mg; Na2Se3.5H20 (45%Se) 0.08 mg; Ca(I03)z (65% I) 
0.2 mg; CoC03 (47% Co) 0.09 mg; The composition (g/100 g) is on a as-fed basis. 
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Table 2 
Fatty acid composition (mole %) of the induction diet and the three post-induction 
diets 
Fatty acid 
14:0 
16:0 
16:1 
18:0 
18:1 
18:2 n-6 
18:3 
20:1 
20:5 n-3 
22:1 
22:6 n-3 
24:1 
others 
I 
(n•9) 
L 
(n•9) 
LF 
(n•9) 
F 
(n•8) 
Figure 2 
Induction diet 
I 
2 
24 
2 
9 
41 
16 
1 
1 
4 
12% CHOL + 7 % LARD FAT I 
2% CHOL + 7% LARD FAT 
4' MONTHS OF INDUCTION 
Post-induction diets 
-------------------------------
L LF F 
2 5 7 
24 21 18 
3 6 8 
10 6 1 
42 29 17 
15 11 8 
1 1 1 
1 4 6 
8 17 
2 4 
5 9 
1 1 
2 1 3 
3 MONTHS OF REGRESSION 
Schematic overview of the dietary groups. Each group received a low fat basal diet to 
which 9% (w/w) fat was added. The 13 animals which died immediately following the 
endothelial denudation are not included. 
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Nine animals (L) received 9% (w/w) lard fat, nine animals (LF) 4.5% (w/w) lard fat 
and 4.5% (w/w) mackerel oil (AS Johan C Martens and Co, Bergen, Norway) and 
eight animals received 9% (w/w) of mackerel oil (F) for 3 months. These diets will be 
called post-induction diets (Tables 1 and 2). For convenience the experimental 
groups have been schematically presented in figure 2. 
Plasma lipids 
Plasma levels of triglycerides [13], total [14] and HDL-cholesterol [15] were 
determined before the start of, and at one month intervals during the dietary period. 
Collection of blood samples occurred after an overnight fast by puncturing the 
jugular vein. During the first 2 months, samples were taken from conscious animals, 
but after the third month the animals were first sedated with 30 mg.kg-1 ketamine 
i.m. (AescoketR, Aesculaap BV, Boxtel, the Netherlands). 
Platelet aggregation 
After 7 months ( 4 months of induction and 3 months of post-induction) a 5 ml blood 
sample was collected and placed in tubes containing 1000 IU heparin. After a 15 
minutes incubation time at room temperature, whole blood aggregation tests were 
performed after the addition of2 JLg.ml-1 collagen or 5 uM ADP for 10 minutes in an 
electrical aggregometer [16]. For measurement of the prostanoid production the 
aggregation-reaction was stopped after ten minutes of stimulation with 2 JLg.ml-1 
collagen by placing the blood sample on ice. After centrifugation (at 2000 g for 5 
minutes) the plasma was stored at -800C. The levels of the thromboxane A (TXA) 
derivatives HHT and HHTE were determined by high pressure liquid chromato-
graphy [17]. HHT (12 L-hydroxy-5, 8, 10-heptadecatrienoic acid) and HHTE (12 L-
hydroxy-5, 8, 10, 14-heptadecatetraenoic acid) are stable products which are, 
through the cyclo-oxygenase pathway, derived from arachidonic (20:4 n-6) and 
eicosapentaenoic acid (20:5 n-3), respectively, and reflect TXA2 and TXA3 
· formation [17-20]. The platelets were counted and TXA production was calculated 
on basis of the platelet concentration. 
Chemical analysis of the aortic vessel wall 
Samples ( 40-200 mg) were excised from lesion (abdominal) and non-lesion 
(ascending) areas of the aorta, dissected free of adventitia and directly frozen in 
liquid nitrogen and stored at -80°C until analysis. In principle the method of Bligh 
and Dyer [21] was used for lipid extraction. Briefly, tissue samples were 
homogenized in chloroform I methanol/distilled water ( 4:10:5, v/v/v) with a polytron 
PT 10 (half-setting). After centrifugation at 1500 gmax for 5 min and washing the 
pellet by rehomogenization in 1.9 ml of the same solvent, the 2 supernatants were 
combined and supplemented with 1.5 ml chloroform and 1.5 ml water. After 
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vigorous mmng the upperphase was discarded and, when necessary, the inter-
mediate solid material dissolved by dropwise addition of methanol. Subsequently the 
mixture was dried under nitrogen at 37°C and the residue dissolved in 0.2 ml 2-
propranolol. Cholesterol, triglyceride and phospholipid contents were measured 
enzymatically (GHOD-PAP and GPO-PAP, Boehringer, Mannheim, FRG; and PAP 
150 of Biomerieux, Cherbourieres, Les Bains, France). In the delipidized extracts 
protein [22] and DNA [23] contents were measured. 
Grading of coronary artery atherosclerosis 
From the coronary arteries biopsies were taken at 5 mm intervals. All biopsies from 
the heart and aorta were immediately fixed in 10% formalin. Tissue samples were 
routinely processed for light microscopy: embedded in paraffin, cut at 7 urn thick-
ness and stained with haematoxylline azophlo:xine and recorsine fuchsine. The 
sections were projected on a video screen and the outer contours, external and 
internal elastic lamina, and endothelial lining of the vessels were traced using an 
integrated image analysis system (IBAS-2000, Kontron, Oberkochen, FRG). The 
surface between the endothelial lining of the lumen and the internal elastic lamina 
was taken as the lesion area [24]. The encroachment was defined as the ratio (x 
100%) of the surface of the lesion area and the corrected (by circular shape factor) 
surface of the area surrounded by the internal elastica lamina [24, 25]. The media 
area was the difference between the surfaces circumscribed by the internal and 
external elastic lamina. 
Statistical analysis 
All data are described as mean ±standard error of the mean (SEM). The data were 
analyzed statistically using the paired and unpaired Student's t-tests and a one way 
analysis of variance with repeated measurements followed by the Newman-Keul 
procedure for multiple comparisons of mean values. Statistical significance was 
accepted at P< 0.05. 
Results 
Experimental animals 
After 4 months the animals weighed 55 ± 1 kg. During the 3 months of low 
cholesterol feeding the animals increased their weight to 91 ± 3 kg(L), 88 ± 4 kg(LF) 
and 94 ± 3 kg(F). There were no differences in the weight gain of the 3 groups during 
these 3 months. 
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Plasma lipids 
During the four months of 2% (w/w) cholesterol feeding plasma levels of total 
cholesterol doubled, primarily due to a tripling of the VLDL- + LDL-cholesterol 
content as HDL-cholesterol levels increased by less than 30% (figure 3). 
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Figure 3 
Plasma lipid levels during the 4 month induction period. 
* = p<0.05 versus pre-atherogenic diet value. 
4 8 
weeks 
12 16 
A consequence of these changes was that the ratio betv{een HDL-cholesterol and 
total cholesterol decreased from 0.50 ±. 0.01 mm to 0.31 ±. 0.01 mm (P<0.05). Levels 
of plasma triglycerides (0.59 ± 0.03 mM) were not affected by this diet (figure 3). 
During the 3 months of low-cholesterol feeding total cholesterol decreased in all 3 
groups, the changes being the most pronounced in the fish oil fed animals ( ~ 1.28 ±. 
0.33 mM in L, -2.37 ±.0.34 mm in LF and -2.35 ±. 0.35 mm in F,figure 4). The largest 
changes already occurred during the first weeks after the animals had changed from 
the high- to the low-cholesterol diet. Although HDL-cholesterol also decreased in 
all 3 groups, there was an increase in the HDL-total cholesterol ratio (0.48 ± 0.03 in 
L, 0.44 ±. 0.02 in LF and 0.40 ± 0.01 in F). The plasma triglyceride levels were 
significantly reduced in the first 6 weeks in LF and F, but returned to those 
measured in L after 12 weeks. 
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Figure 4 
Changes in plasma lipid levels during the 3 month post-induction period on low-
cholesterol diets. D L = 9% lard fat, (n=S); Ill LF = 4.5% lard fat and 4.5% fish oil, 
(n=9); 1 F = 9% fish oil, (n=9). * = P<0.05 versus L. 
Platelet aggregation and prostaglandin production 
Collagen-stimulated platelet aggregation was similar in L, LF and F (not shown), 
but the ADP-stimulated aggregation was lower in LF and F than in the animals 
which received lard fat only (figure 5). 
The total amount of thromboxane A derivatives, measured after 10 min of 
stimulation with collagen, was similar in L (62 ± 5 pg/109 platelets), LF (67 ± 6 
pg/109 platelets) and F (58± 7 pg/109 platelets). HHT production was lower in F ( 49 
± 6 pg/109 platelets) than in LF (55 ± 6 pg/109 platelets) and L (62 ± 5 pg/109 
platelets). None of the animals belonging to L produced HHTE (figure 5), which is in 
accordance with the absence of eicosapentanoic acid in the platelet membrane [26]. 
Not all fish oil fed animals produced HHTE (figure 5). A large production of HHTE 
was found in 4 of the 7 animals ofF but only 2 of 9 animals of LF produced some 
HHTE. 
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Collagen (2 ug/ml)- and ADP (5uM)-induced platelet aggregation in the 3 post-
induction groups after 3 months of low cholesterol feeding. For measurement of the 
prostanoid production the collagen-induced aggregation was stopped after 10 
minutes. HHTE was not produced in the animals which received only lard fat. o L = 
9% lard fat, (n=8); Ill LF = 4.5% lard fat and 4.5% fish oil, (n=9); Ill F = 9% fish oil, 
(n=9). * = P<0.05 versus L; x = P<0.05 versus F. 
Lipid infiltration in the abraded and the non-abraded segments of the aortic wall 
After 4 months of cholesterol feeding (I) all lipid concentrations in the lesions of the 
abdominal aorta were higher than in the non-lesions of the ascending aorta (Table 
3). 
During the following 3 months of low-cholesterol feeding, there were no changes 
in the lipid contents of the non-lesions in any of the 3 post-induction groups. 
Cholesterol and phospholipid infiltration in the lesions tended to increase in all 3 
groups during low-cholesterol feeding. On the other hand, triglyceride contents of 
the lesion and the non-lesion areas did not differ at the end of the post-induction 
period. Expression of lipid contents as umol!g protein and DNA gave similar 
differences between the lesion and the non-lesion areas of I and the three post-
induction groups (not shown). 
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Table 3 
Lipids, protein and DNA contents of the aortic vessel wall 
Induction Group 
Abdominal Aorta 
(abraded) 
I 
(n=6) 
cholesterol (JLmol/g)a 4.07 ± 0.46* 
triglyceride (JLmol/g) 3.05 ± 0.64* 
phospholipids (JLmol/g) 3.71 ± 0.27* 
protein (mg/g) 160 ± 14 
DNA (mg/g) 1.91 ± 0.25 
Ascending Aorta 
(non abraded) 
cholesterol (JLmol/g) 2.82 ± 0.36 
triglyceride (JLmol/g) 
phospholipids (JLmol/g) 
protein (mg/g) 
DNA (mg/g) 
1.35 ± 0.28 
2.92 ± 0.07 
166± 3 
2.45 ± 0.13 
Post-induction Groups 
L 
(n=6) 
5.10 ± 0.60* 
1.92 ± 0.45 
4.56 ± 0.30* 
168 ± 15 
2.45 ± 0.20 
2.63 ± 0.13 
1.38 ± 0.23 
2.91 ± 0.10 
235 ± 42 
2.18 ± 0.29 
LF 
(n=7) 
5.54 ± 0.66* 
2.19 ± 0.34 
4.37 ± 0.50* 
185 ± 20 
2.03 ± 0.14 
2.60 ± 0.12 
1.68 ± 0.43 
2.91 ± 0.17 
222± 23 
2.71 ± 0.40 
F 
(n=7) 
4.83 ± 0.47* 
2.05 ± 0.31 
4.06 ± 0.17* 
208 ± 30 
2.15 ± 0.10 
2.82 ± 0.11 
1.67 ± 0.73 
2.92 ± 0.19 
228 ± 31 
2.67 ± 0.52 
For the composition of the diets see tables 1 and 2. a = All units per g wet weight. 
* = P<0.05 versus ascending aorta in the same group. 
Luminal encroachment of the abraded and non-abraded coronary arteries 
Mean luminal encroachment of the abraded left anterior descending coronary artery 
was 11 ± 2 % and of the non-abraded left circumflex coronary artery 1.3 ± 0.3 % after 
4 months of 2% (w/w) cholesterol feeding (I, Table 4). During the post-induction 
period, feeding with only lard fat had no effect on the mean luminal encroachment 
of the abraded coronary arteries, but addition of fish oil caused a dose-dependent 
decrease. In the non-abraded left circumflex coronary artery mean luminal 
· encroachment increased to 11 ± 3 % in L. Addition of fish oil to the low-cholesterol 
diet inhibited this increase (Table 4). 
158 
Table 4 
Luminal encroachment of the abraded and non-abraded coronary arteries. 
Induction Group 
LADCA 
(abraded) 
lesion area (mm2) 
encroachment(%) 
media (mm2) 
LCXCA 
(non-abraded) 
lesion area (mm2) 
encroachment(%) 
media (mm2) 
I 
(n=9) 
0.22 ± 0.03* 
11± 2* 
0.86 ± 0.06 
O.Q3 ± 0.01 
1.3 ± 0.3 
0.94 ± 0.08 
Post-induction Groups 
L 
(n=8) 
LF 
(n=9) 
F 
(n=9) 
0.27 ± 0.03 
13± 2 
0.90 ± 0.08 
0.10 ± o.o2*+x 0.09 ± o.o2x+ 
6 ± 1*+X 3 ± 1+XO 
0.83 ± 0.08 0.97 ± 0.05 
0.30 ± 0.06+ 0.02 ± 0.01X 
11 ± 3+ 0.9 ± 0.3X 
1.08 ± 0.11 0.84 ± 0.08 
0.05 ± 0.02X 
1.1 ± 0.4X 
0.82 ± 0.12 
For the composition of the diets see Tables 1 and 2. 
* = P<0.05 versus non-abraded vessel of the same group; 
+ = P<0.05 versus I; x = P<0.05 versus L; o = P<0.05 versus LF; LADCA = left 
anterior descending coronary artery; LCXCA = left circumflex coronary artery. 
Discussion 
In the present study addition of 2% (w/w) cholesterol to the 21 energy% fat (15 
mol% linoleic acid) containing diet increased plasma cholesterol from 2 mM to 4 
mM. Weiner et al. added 2% (w/w) cholesterol and 1% sodiumcholate to a 30 
energy% fat (mainly saturated fatty acids) containing diet causing increases up to 14 
mM during an induction period of 8 months [24]. This partly explains the lower 
mean luminal encroachment (11%) in the abraded coronary arteries of the present 
study compared to that found by Weiner et al. (44%). The total cholesterol content 
of the abdominal aortic lesions in the present study was 4.1 JLmol!g wet weight, which 
is about 27 JLmol!g dry weight. Fritz et al. [ 6] found a cholesterol content of about 38 
JLmol/g dry weight in the aortic wall with mean plasma levels of cholesterol of 14 
mM. Other factors contributing to the difference in luminal encroachment in the 
coronary arteries and lipid infiltration in the aortic wall may be the difference in the 
duration of the induction period and performance of the abrasion technique. 
Three months of low-cholesterol feeding lowered the plasma cholesterol levels 
(figure 4). In the animals with fish oil added to the diet (F and LF) these decreases 
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were more pronounced than in the animals in which only lard fat (L) was added, 
which is consistent with earlier observations in normolipidemic pigs [10, 11, 19]. The 
reduction in ADP-induced platelet aggregation was less in F than in LF. The data on 
platelet aggregation in F are not in agreement with the changes in HHT and HHTE 
production, which were measured in vitro after the aggregation reaction. However in 
the in vivo situation the effects offish oil on the synthesis ofprostacyclin I2 and I3 by 
endothelial cells should also be taken into account [19, 27-29]. 
At the end of the induction period the lesions in the abdominal aorta contained 
more cholesterol than the non-lesions in the ascending aorta. Three months of low 
cholesterol feeding did not affect the lipid contents of the lesions and non-lesions in 
either group. Further studies are needed on the localization (intra- or extra-
cellularly) and precipitation forms of cholesterol( ester) for definite proof of lack of 
regression [30]. 
Addition of fish oil to the low-cholesterol diet decreased luminal encroachment in 
the abraded coronary arteries, whereas addition of lard fat only inhibited further 
intimal proliferation. In the non-abraded coronary arteries intimal proliferation was 
negligible after 4 months, but developed during the following 3 months when only 
lard fat was added to the low-cholesterol diet. Although in L cholesterol levels were 
lower during lard fat feeding than during high-cholesterol feeding they were still 
higher than in low-cholesterol fed pigs of the same age [31]. This is consistent with 
the findings of Clarkson et a!. [ 4], who also found progression of lesions in half of 
the animals whose cholesterol levels remained elevated as compared to baseline 
values whereas in the animals with normal levels of cholesterol, lesions did regress. 
Lesions did not develop in the non-abraded arteries of the pigs with fish oil added to 
the diet, proving that fish oil can also prevent progression of coronary athero-
sclerosis. 
In LF and F the return to normal cholesterol levels most likely is involved in the 
regression of coronary artery sclerosis, but it cannot explain the dose dependent 
effect. The results on platelet aggregation also cannot elucidate this dose-dependen-
cy, because platelet aggregation was only reduced in LF. Several factors such as 
leukotrienes, tissue plasminogen activator, platelet derived growth factor, inter-
leukin-1 and tumor necrosis factor, have also been implicated in the development 
(or regression) of atherosclerosis and are also modulated by fish oil (for review see 
references 32, 33). 
Lipid infiltration could not be determined in the coronary arteries, as the samples 
were used for the measurement of luminal encroachment. If the results obtained in 
the aorta can be extrapolated to the smaller blood vessels there appears to be a 
discrepancy between these two variables, which are both frequently used for the 
grading of the severity of atherosclerosis. An additional complication is that 
widening of a lumen at the site of the lesion not necessarily implies a regression of 
the atherosclerotic process [8]. Further studies on the constitution of the plaques 
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are needed to assess whether the data on intimal thickening in the present investiga-
tion represent a true regression of the atherosclerotic process. 
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CHAPTER 14 
EPICRISIS 
The experimental data described in this thesis show that dietary n-3 polyunsaturated 
fatty acids (PUPA's) exert some actions which may be beneficial in the prevention 
and treatment of cardiovascular disease. 
We arrived at this conclusion by comparing the effects of fish oil diets with a 
control diet enriched with lard fat. The control as well as the fish oil diet supplied 
sufficient amounts of n-6 PUP A's. Hence, the diets used in our studies only differed 
in fatty acid composition. 
As summarized in chapter 1 fish oil has a strong hypotriglyceridemic and a 
moderate hypocholesterolemic effect in man. In our studies in pigs (chapters 4 and 
5) the hypocholesterolemic effect was, at variance with the hypotriglyceridemic 
effect, dose dependent. Comparing our results with those of Ruiter et a!. [1], we 
conclude that in normolipidemic pigs the hypotriglyceridemic effect reaches a 
maximum at a daily dose of 150 mg EPA/kg bodyweight, but that the hypocholeste-
rolemic effect is only observed at much higher doses (table 1). 
Table 1 
Effects of dietary n-3 PUPA's on plasma cholesterol (CHOL) and triglyceride (TG) 
levels in randomized controlled studies in normolipidemic pigs. 
REFERENCE 
grams 
EPA/kg/day 
Ruiter et a!. (1) 0.15 
Hartog et a!. (chapter 5) 0.30 
Hartog et a!. (chapter 4) 0.60 
* = p < 0.05 versus control group 
PERIOD 
IN 
WEEKS 
4 
16 
8 
change in % 
---------------
CONTROL CHOL TG 
OLIVE OIL +3 -44* 
LARD FAT -29* -54* 
LARD FAT -47* -60* 
The lowering of triglycerides occurred almost exclusively in VLDL, but that of 
cholesterol was observed in all lipoproteins (chapter 6). Based on the decrease of 
lipoprotein lipase activity it is reasonable to assume that fish oil reduces VLDL 
secretion and that the reduction of cholesterol content of the other lipoproteins is a 
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secondary phenomenon. Increased clearance of VLDL and of faecal bile-salts by fish 
.oil have also been reported, but most other reports indicate that fish oil decreases 
VLDL synthesis (chapters 1 and 6). In hypercholesterolemic pigs (chapter 13) 
plasma triglyceride levels did not change, but the fall in plasma cholesterol was 
accelerated and increased by fish oil in the regression period. In that study hyper-
cholesterolemia was induced by high cholesterol feeding prior to the introduction of 
fish oil containing low cholesterol diets. The plasma cholesterol is mainly carried in 
the LDL particle [2]. Therefore the hypocholesterolemic effect of the fish oil is less 
than in the normolipidemic pigs (final plasma cholesterol level 1.7 versus 1.3 mM; 
chapters 4 and 13). 
Plasma cholesterol is a major risk factor for atherosclerosis (chapter 12). Fish 
oil can retard the development of atherosclerotic lesions by its cholesterol lowering 
properties. However, the mean plasma cholesterol levels (5.6 mM) of the Eskimos 
[3] do not differ from people of similar age living in the USA (5.4 mM) [4], or The 
Netherlands (5.7 mM) [5]. Vegans and vegetarians in Western countries have even 
lower plasma cholesterol levels ( 4.3 and 4.9 mM, respectively) than Eskimo's [3, 6, 
7]. Therefore, it is likely that other than the hypocholesterolemic effects of the n-3 
PUF A's play also a role in the prevention of ischemic heart disease. 
In our studies (chapters 9, 10 and 11) the main fish oil PUPA's eicosapen-
taenoic acid (EPA) and docosahexaenoic acid (DHA) were incorporated in cardiac, 
sarcolemma and platelet membrane phospholipids. At the same time arachidonic 
acid content of the phospholipids was lowered, which confirms other reports 
(chapter 1). Although the myocardial sarcolemma membrane composition and 
double bond index were markedly changed in the fish oil fed pigs (chapters 8, 9 and 
10), minor effects were seen in the functional properties of isolated membrane 
vesicles. For example the activities of the 5' nucleotidase and Ca2+ pumping A TPase 
after Ca2+ stimulation were slightly higher, and adenylate cyclase was more sensitive 
to isoproterenol stimulation in the fish oil fed group (chapters 3 and 10). The latter 
finding is interesting in view of the observations of Gudbjarnason et a!. made some 
10 years ago [8]. They found an increased mortality in cod liver oil fed rats induced 
by catecholamines (1-5 mg/kg norepinephrine s.c.). We could not confirm 
Gudbjarnason's data in a similar study, using a daily dose of 1-4 mg/kg norepine-
phrine suspended in PEG 400 s.c. in order to slow down the release (chapter 7). The 
differences in mode of cathecholamine administration may have influenced the 
mortality rates. Administration of norepinephrine via an implanted osmotic pump 
resulted in no mortality at all, but also less pronounced effects on fatty acid 
composition of the phospholipids (chapter 7). It should be noted, however, that in a 
more recent study with a daily dose of 1 mg!kg isoproterenol s.c. Gudbjarnason et a!. 
were unable to reproduce their own observations [9]. 
During the dietary period plasma malondialdehyde (MDA) and lipofuscin, as a 
measure of in vivo lipidperoxidation, were not increased in the fish oil (0.6 g EPA/kg 
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body weight/day) fed pigs (chapter 10). Isolated sarcolemmal membranes of fish oil 
fed pigs exposed to a free radical generating system showed an increased MDA 
production (chapter 10). The addition of natural antioxidants like vitamin E and 
selenium to the diets probably reduced the rate of peroxidation of the PUPA's in 
vivo. Indeed, morphological e)!:amination of the fish oil fed pigs gave no signs of lipid 
peroxidation in organ tissues (chapter 4 and 5), except for some in the subcutaneous 
fat tissue. The pigs receiving 0.6 g EPA/kg bodyweight/day for 8 weeks had an 
increased lipofuscin content in the subcutaneous fat, which indicates a slight vitamin 
E deficiency (LHJC Danse, personal communication). For this reason the vitamin E 
content of the diets was increased when we investigated the effects of fish oil on 
atherosclerosis (chapter 13). Here we found no signs of yellow fat disease. The 
finding that the heart produced MDA in fish oil fed pigs, but not in lard fat fed pigs 
was surprising. Experimentally induced ischemia-reperfusion, did not affect the rate 
of this MDA production in the fish oil fed pigs (chapter 10). This observation is 
important as free radicals are believed to play a crucial role in the development of 
damage in the ischemic, reperfused, or infarcted myocardium. 
Cardiac function during normoxia was not affected by dietary fish oil (chapters 
4, 5, 8 and 9). During multiple short-lasting intermittent occlusions the hyperemic 
response was prolonged in the fish oil fed animals (chapters 8 and 9), probably by 
changes in the thromboxane-prostacyclin ratio (TXA/PGI). In one study the 
incidence of reperfusfon arrhythmias was slightly lowered after fish oil feeding 
(chapter 9). The mechanism of this effect can not be deducted from this study as this 
ischemia-reperfusion model was designed to measure the recovery of cardiac 
function after repeated ischemic events and not to study the mechanism of 
reperfusion arrhythmias. Several other investigators have reported on the protective 
effects of dietary fish oil on infarct size [10-12]. Changes in TXA/PGI ratio may be 
responsible for these beneficial effects of fish oil consumption in these experiments 
[10-12]. 
In pigs with fixed coronary artery stenosis the cardiac function was better 
preserved in the fish oil fed animals during a pacing stress test (chapter 11). 
Myocardial blood flow to the jeopardized region was also better preserved, as was 
the distribution of the myocardial bloodflow to the subendothelial layers. The latter 
could not be explained by differences in systemic hemodynamic parameters and 
further studies are required to confirm this observation. The improved suendo-
cardial blood flow was also not caused by an increased collateral blood flow (chapter 
11). Examination of the stenosed vessels showed less intimal proliferation in the fish 
oil fed pigs. 
The TXA generation was decreased after fish oil consumption (chapters 8, 9 
and 13), while the PGI production was decreased to a Jesser extent (chapter 8 and 
9). Others have reported no effect on PGI prodution while TXA synthesis was 
decreased (chapter 1). Differences in doses and subsequent phospholipid EPA 
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content may account for these controversial effects. The TXA3 generation by 
platelets, shown in chapter 13, was only a small fraction ( <15%) of the total TXA 
generation. The changes in prostanoid concentrations may have an important impact 
on the platelet-vessel wall interaction. The conclusions of our studies and other 
reports (chapter 1) are summarized in figure 1. 
STANDARD DIET 
PL = Phospholipids 
AA = Arachidonic acid 
PGI2 = Prostacyclin 
PGI3 = Prostacyclin· 
FISH( OIL) CONSUMPTION 
EPA = Eicosapentaenoic acid 
TXA2 = Thromboxane 
cAMP = Cyclic adenosine monophosphate 
Figure 1 Prostanoid synthesis and platelet function 
Platelet aggregation induced by low doses of ADP was decreased after fish oil 
consumption (chapters 11 and 13). In the hypercholesterolemic pigs the platelet 
aggregation was not affected in both fish oil (0.2 and 0.4 g EPA/kg bodyweight/day) 
treated groups (chapter 13). Our measurements were performed in whole blood. At 
present this method has not been used on this issue by others yet, but it seems 
preferrable as it is a more direct method (chapter 1). In vivo methods would be most 
suitable, but are not available. 
In the pigs with the fixed coronary artery stenosis fish oil attenuated the extent 
of intimal proliferation (chapter 11). We believe that in this modified arterial 
thrombosis model wall shear forces at the site of the constrictor have produced local 
hemolysis and denudation of the vessel wall. ADP released by the damaged ery-
throcyts and collagen of the denuded vessel wall have Jed to platelet adherence to 
the vessel wall, platelet aggregation was initiated which ultimately led to the 
formation of a mural thrombus. TXA and granular products like platelet derived 
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growth factor are released leading to vasoconstriction, secondary platelet 
aggregation and intimal proliferation. Fish oil may have attenuated this process 
primarily by reduction of the TXA synthesis, rather than by lowering the plasma 
cholesterol levels, as these were also low in the lard fat fed animals (chapter 11). 
Nearly 30% of the patients undergoing percutaneous transluminal coronary angio-
plasty (PTCA) suffer restenosis of the coronary artery by thrombosis and/or intimal 
proliferation within six months after the procedure [13, 14]. According to the 
"response to injury theory" by Ross [15] endothelial damage and flow turbulences 
initiate platelet aggregation and release of mitogenic factors, leading to migration of 
smooth muscle cells and monocyts and subsequent intimal proliferation. Therefore, 
fish oil might have a beneficial in patients undergoing PTCA procedures. Indeed, 
fish oil has prevented restenosis in a few studies on PTCA patients [16, 17, 18]. As in 
the aforementioned studies [16, 17] the plasmacholesterol levels were not affected 
by the fish oil supplements the inhibition of platelet vessel wall interaction is 
probably the major contribution to the prevention of restenosis in these patients. 
These studies, however, need to be confirmed in more controlled investigations. 
The lesions of coronary arteries and abdominal aorta found in pigs after a 4 
months induction period (chapter 13) were comparable to the data reported by 
Weiner eta!. and Fritz eta!. as shown in table I and 3 in the overview of chapter 12. 
However, more marked lesions are found after a longer induction period (chapter 
12). 
In the atherosclerotic pigs fish oil consumption caused a marked regression of 
luminal encroachment of the abraded left anterior descending coronary artery, but 
had no effect on the minor lesions found in the also abraded abdominal aorta 
(chapter 13). The cholesterol lowering effect of dietary fish oil may have played a 
major role in this regression. The platelet aggregation was decreased by the low dose 
of fish oil, but was not by the high dose of fish oil. The data on TXA generation were 
not in agreement with the data on platelet aggregation in this study. Both measure-
ments (platelet aggregation and TXA generation) were, however, performed in 
vitro. The physiological role of endothelium and its product PGI should also be 
taken into account, as the TXA/PGI ratio is the main determinant of in vivo platelet 
aggregation. In other experiments it was shown that the TXA/PGI ratio was 
increased after fish oil consumption (chapters 8 and 9). Therefore, the in vitro 
aggregation tests may mask the in vivo situation. There seems to be a discrepancy 
between the effects on luminal encroachment of the coronary arteries and lipid 
content of the aortic wall after fish oil consumption (chapter 13). Futher long-lasting 
studies may help to clarify this issue. Perhaps the three month regression period is to 
short to establish an effect on the lipid content of the arterial lesions (chapter 12). 
It has been established that ischemia and reperfusion damage of myocardial 
cells is caused by free radical generation, intracellular Ca2+ overload and phospho-
lipid breakdown (chapter 7 and 10). In our experiments we found no effect on in 
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vivo MDA production (chapter 10). The in vitro Ca2+ stimulated Ca2+ pumping 
A TPase activity was slightly higher in the fish oil fed pigs, while the basal activity was 
riot affected (chapter 10). Presently there is no evidence that the enzymes involved 
in the breakdown of phospholipids are influenced by dietary fish oil (chapter 3 and 
7). 
Progressive Ca2+ overload appears also to be an important latent precursor of 
overt arteriosclerosis [19]. Whether modification of Ca2+ overload plays a role in the 
prevention of atherosclerosis by fish oil consumption needs to be investigated. 
From the preceding paragraphs it is clear that dietary n-3 fatty acids may be 
beneficial in the prevention of development of ischemic heart disease. The 
mechanisms by which this can occur are schematically presented in figure 2. 
ENDOTHELIAL INJURY" I 
THROMBIN I 1 COLLAGEN MONOCYT ADHESION 
!r:J r- PLATELET ADHERENCE I LEUKOIRIENES 
,.,;.,~, [I.._ '""""";"7,., 1 
! 
L~ PLATELET A7CRECAT!ON - § 
I MACROPHAGE$ .t- LDL-_. SMOOTH MUSCLE CELLS-, CHOL ! PLATELET PLUG I 
CLOT 
fl.-~ ATH;.OHA ·---o~~~.------.....111 
THRoH7osrs I 
~ ~ ! SPASM 
FIBRINOLYSIS ! 
Figure 2 The atherosclerotic proces 
FISSURE 
RUPTURE 
Endothelial injury and LDL-cholesterol are according to current views the primary 
factors which initiate the development of an atherosclerotic lesion (chapter 12). 
Endothelial injury can be caused by mechanical stress (e.g. hypertension, high blood 
viscosity), or by viral, immunological, chemical (e.g. smoking, lipid peroxidation), or 
radiation origin. In this context it is interesting that immunological responses can 
also be modified by fish oil consumption [20, 21]. Lipid peroxidation could be 
increased after high n-3 PUFA intake, but this can be prevented, at least in the pig, 
by dietary supplementation of natural antioxidants (chapter 10). Dietary fish oil 
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definitely affects the prostaglandin metabolism and thereby the responses to endo-
thelial injury, but this issue needs further investigation. The shift in TXA/PGI ratio 
by fish oil may also play a role in the prevention of coronary spasm. The hypo-
cholesterolemic effect of the high doses of n-3 PUPA's found in all our studies can 
not be disregarded, but its importance is still controversial. Other possible effects of 
n-3 fatty acids on the process of atherosclerosis have recently been discussed by Leaf 
and Weber [22]. 
The extent of atherosclerosis in man is difficult to assess. Intervention studies 
on the arrest of atherosclerosis in man deal with the difficulties of long follow up 
and less sensitive methods on quantification [23-25]. At present angiography is the 
only clinical tool to evaluate atherosclerotic lesions. In the future doppler-, echo-
graphic- and magnetic resonance phase shift techniques may offer possibilities to 
quantify the extent of atherosclerosis more precisely. A newly developped technique 
to study arteriolar flow is the retinal fluorotachometry [26], which may offer possi-
bilities to quantify arteriosclerosis. 
In conclusion dietary fish oil produces several biochemical effects which poten-
tially modify the development and regression of atherosclerotic lesions. Whether 
these effects found in experimental studies can be extrapolated to the human 
situation requires clinical trials. Fish oil supplements could then become a valuable 
part of the therapeutic arsenal against ischemic heart disease. Until now only 
mixtures of EPA and DHA were tested. However, recently pure concentrates of 
EPA and DHA have become available which enables investigators to study 
seperately the effects of these fatty acids. As n-6 PUF A's share many but not all 
beneficial effects with n-3 PUPA's, comparison with a n-6 PUPA's rich diet is 
relevant too. The provided evidence in this thesis of the effects of dietary fish oil on 
plasmalipid levels, prostaglandin synthesis, platelet aggregation and atherosclerosis 
warrants further clinical trials. However, combination of fish oil supplements with 
anticoagulants will lead to increased bleeding tendency and, therefore, must be 
dissuaded. Another important message of this thesis is that n-3 PUPA's are 
susceptible to peroxidation, but this seems to be prevented by addition of natural 
antioxidants to the diet. It is premature to give a dietary advice on the base of this 
thesis, as the effects described in this thesis were found after rather high doses of 
fish oil. The inclusion of several fish dishes per week will supply only a modest 
amount of n-3 PUPA's and it is unpredictable if such a diet will exert an anti-
atherogenic effect. 
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SAMENVATTING 
Uit epidemiologische onderzoeken onder vee! vis etende Eskimo's en Japanners is 
gepostuleerd dat de meervoudige onverzadigde lange keten vetzuren van de n-3 
familie in de vis beschermen tegen ischemische hartziekten. 
De laatste decennia is vee! onderzoek gedaan naar de effecten van deze n-3 
vetzuren. Echter de resultaten van deze studies waren vaak controversieel. Dit kan 
voor een deel verklaard worden door een verschil in dosering of de keuze van het 
controle dieet, zoals besproken in het overzichts verhaal (hoofdstuk 1). Vele studies 
waren echter ongecontroleerd. 
De opzet van dit proefschrift was om via goed gecontroleerde studies meer 
duidelijkheid te verschaffen over de effecten van n-3 vetzuren op de verschillende 
onderdelen van het atherosclerotisch proces. Voor deze studies werd een biggen 
model gekozen. Het varken vertoont namelijk grote overeenkomsten met de mens in 
anatomie, fysiologie en vet stofwisseling. Een studie naar catecholaminen gevoelig-
heid in levertraan gevoede ratten was gebaseerd op eerder onderzoek van 
Gubjarnason et al. (hoofdstuk 7). 
In de in dit proefschrift beschreven studies werd een cholesterol en vooral 
triglyceriden verlagend effect van visolie aangetoond (hoofdstuk 4, 5 en 6). De 
effecten worden verklaard door een verlaging van de VLDL synthese (hoofdstuk 1 
en 6). De plasmacholesterol verlagende effecten worden pas waargenomen bij hoge 
doseringen n-3 meervoudig onverzadigde vetzuren. De geconsumeerde n-3 vetzuren 
worden ingebouwd in de membranen van hart, bloedplaatjes en andere cellen. De 
inbouw van n-3 meervoudig onverzadigde vetzuren (eicosapentaeenzuur, 20:5 n-3, 
en docosahexaeenzuur 22:6 n-3) gaat ten kosten van de hoeveelheid arachidonzuur 
(20:4 n-6) in de membraan fosfolipiden (hoofdstuk 4, 5, 7, 8, 9 en 11). Hierdoor 
worden de eigenschappen van deze membranen veranderd (hoofdstuk 1, 3 en 10). 
De prostaglandinen synthese ondergaat grote veranderingen na visolie consumptie. 
De thromboxaan synthese wordt fors verlaagd terwijl de prostacycline productie 
minder wordt verlaagd (hoofdstuk 8 en 9). Ook worden er prostaglandinen uit n-3 
vetzuren gesynthetiseerd, maar dit is echter slechts een fractie ( <15%) van de to tale 
productie (hoofdstuk 13). De bloedplaatjes aggregatie is verminderd na visolie 
consumptie. In een biggenmodel met een Iichte vernauwing van de kransslagader 
bleek visolie de intima proliferatie te remmen, vermoedelijk via een remming van de 
interactie tussen bloedplaatjes en de beschadigde vaatwand (hoofdstuk 11). In 
atherosclerotische biggen gaf visolie een regressie van de kransslagader vernauwin-
gen, waarschijnlijk via een krachtige verlaging van het plasmacholesterol (hoofdstuk 
13). In de hier beschreven studies.werden geen effecten van visolie op bloeddruk 
gevonden. Wei gaf visolie een versterkte doorbloeding van de kransslagader tijdens 
reperfusie (hoofdstuk 8 en 9) en een verlaging van het aantal ritmestoornissen 
tijdens reperfusie in een van deze studies (hoofdstuk 9). De versterkte bloeddoor-
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stroming van de kransslagader na een kortdurende afsluiting van dit vat wordt 
waarschijnlijk veroorzaakt door de veranderingen in prostaglandinen synthese. 
Concluderend, visolie heeft effecten op verschillende onderdelen van het 
atherosclerotisch proces. Echter de effecten op bloedplaatjes - vaatwand interactie 
moeten nog nader worden onderzocht, want juist dit onderdeel lijkt een van de 
belangrijkste aangrijpingspunten te zijn. Ret is waarschijnlijk dat visolie 
supplementen een waardevolle rol kunnen spelen in de therapie van ischemische 
hartziekten. Verdere klinische evaluatie zal moeten aantonen of de in dit proef-
schrift beschreven effecten van hoge doseringen visolieconcentraten ook bij de mens 
haalbaar zijn. Ret gebruik van visolie preparaten in combinatie met antistolling 
moet worden afgeraden in verband met een verhoogde bloedingsneiging. Ret is 
echter niet mogelijk om op basis van dit proefschrift een algeheel voedingsvoor-
schrift te geven. Ret nuttigen van enkele vismaaltijden per week zal slechts een 
geringe hoeveelheid n-3 meervoudig onverzadigde vetzuren opleveren. Ret is tot op 
heden niet duic,lelijk of dergelijke hoeveelheden beschermen tegen hart en vaat-
ziekten. 
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